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Enterococci are Gram-positive lactic acid bacteria, widespread in 
the environment, present in water, soil, plants and animals, including 
humans. They typically colonize the skin and mucous membranes, namely 
the gastrointestinal tract. However, enterococci, and most notably 
Enterococcus faecalis and Enterococcus faecium, have become 
problematic causative agents of several nosocomial infections, including 
urinary tract infections, bacteraemia, surgical sight infections, and 
endocarditis. Besides being opportunistic pathogens, the resilient bacteria 
of the genus Enterococcus are key factors contributing to the ripening, 
flavour, and the organoleptic properties of fermented food products.  
 
The ubiquitous nature of enterococci derives from a number of 
features, which can be intrinsic to the genus or specific to some species or 
even strains. These traits allow probing the environment in order to adapt, 
enabling a survival and fitness advantage. They are encoded in numerous 
genes that can be easily transferable due to the high genomic promiscuity 
of enterococci. These genes have been ascribed a role in virulence as they 
are relevant to different stages of the bacterial infection process, including 
  xvi 
adhesion, colonization, invasion, evasion of the immune system and spread 
through the hostʼs tissues. Enterococcal virulence factors can be either 
secreted (cytolysin, proteases, hyaluronidase, superoxide), surface 
associated (enterococcal surface protein, aggregation substance, 
extracellular polymeric substances, pilin gene clusters, enterococcal 
microbial surface component recognizing adhesive matrix molecules), or 
intracellular. At the time this thesis work began, researchers were starting 
to realize that virulence factors in enterococcal clinical isolates were also 
present in isolates from other environments, in particular, where 
enterococci play beneficial roles, namely food. Since dissemination of 
virulence factors among food isolates was no longer crucial, other issues 
started to become relevant in the still debated enterococcal virulence. 
 
 
A thorough search in the literature clearly shows recurrent 
incongruent results between genotype and phenotype of the virulence 
factor cytolysin. Moreover, the phenotypic assays are not performed under 
the same conditions and only a few cyl genes are screened for in the 
majority of the experiments. Therefore, in the first part of this work, we 
developed a new genotypic and phenotypic screening for cytolysin. Based 
on our methodology, a much higher correlation was obtained compared to 
any previously described screening. Complete agreement between 
genotypic and phenotypic assays was seen for all 55 strains tested, which 
belong to four enterococcal species, namely E. faecalis, E. faecium, 
Enterococcus durans and Enterococcus hirae. The proposed PCR 
screening for the complete cyl locus gives a measure of the gene reservoir 
of the strain, while the phenotypic assay is still the only test that allows 
demonstration of active cytolysin production. 
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In the second part of this work, the goal was to evaluate the roles of 
fsrB and gelE, two genes that encode for well-characterized enterococcal 
virulence factors, in the potential virulence of E. faecalis food strains. 
Virulence of unrelated Enterococcus isolates, including dairy strains 
carrying fsr and gelE operons, was compared in the Galleria mellonella 
insect model. E. faecalis dairy strains were able to kill larvae and were as 
virulent as one of the most widely used strains for virulence studies. In 
contrast, E. durans and E. faecium strains were avirulent or poorly virulent 
in G. mellonella. To evaluate the role of fsrB and gelE in the virulence of E. 
faecalis dairy strains, both genes were deleted independently in two strains. 
Although both mutations significantly attenuated virulence in G. mellonella, 
the fsrB mutant strains were more strongly attenuated. Our work 
demonstrates that the presence of functional fsrB, and to a lesser extent 
gelE, significantly contributes to the virulence of E. faecalis food isolates, 
and that the presence of these genes in dairy enterococci should be 
considered with caution. The simple G. mellonella animal model may 
provide insights for risk assessment of food isolates. 
 
Next, we further characterized the non-starter E. faecalis cheese 
isolate QA29b, which harbours virulence genes and proved to be virulent in 
a G. mellonella virulence model. We looked at traits relevant to the host 
pathogen interaction, in particular adhesion, colonization and infection. 
QA29b demonstrated high ability to form biofilms, to adhere to epithelial 
cells and was readily eliminated by J774.A1 macrophage cells. This work 
illustrates for the first time that cps genes, that are associated with 
virulence, may be differentially transcribed between isolates, and therefore 
may not be phenotypically expressed. It also constitutes the first study of 
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traits important for interaction, colonization and infection in the host 
performed on a good food isolate representative of E. faecalis. Overall, 
QA29b characterization shows that, despite its virulence potential in an 
insect model, this food strain is readily eliminated by mammalian 
macrophages, indicating that fine-tuned approaches combining cellular and 
mammalian models are needed to address and elucidate the multifactorial 
aspect of virulence potential associated with food isolates. 
 
In the last part of this work, we were able to associate the 
extracellular production of autoinducer-2 (AI-2) in E. faecalis VE14089, a 
plasmid-cured derivative of E. faecalis V583, to the presence and 
expression of luxS gene. This gene is also present in other clinical and 
commensal isolates as well as in food isolate QA29b. AI-2-mediated 
quorum sensing has been extensively studied in relation to the regulation of 
microbial behaviour and has been recognized as an interspecies 
communication molecule, which may influence community structure and 
function. When compared with the wild type, the luxS mutant had no 
apparent phenotype regarding growth, biofilm formation, adhesion to Caco-
2 cells, resistance to oxidative stress and survival inside macrophages. 
However, microarray comparison of gene expression revealed that the luxS 
mutation caused pleiotropic effects in gene expression, affecting genes 
involved in DNA, fatty acid and intermediary metabolites metabolism, which 
could not be complemented by extracellular AI-2 addition. This study shows 
that, in E. faecalis, differential gene expression related to the luxS mutation 
cannot be ascribed to quorum sensing and that LuxS has, at least, a role in 
metabolism. 
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In conclusion, the main findings presented in this thesis reveal that 
there is, until now, no virulence trait exclusive to strains isolated from 
clinical settings, and that the sole presence of these traits does not allow 
the identification of a strains' habitat. We showed that the presence of 
virulence associated genes, and therefore an associated virulence 
potential, does not necessarily translate to a virulent and pathogenic 
behaviour in E. faecalis food isolates. Also, we showed that to determine 
the outcome of the persistence and resilience of enterococci, not only the 
presence of a specific gene is important but also the whole genome plays a 
pivotal role. We revealed for the first time that the LuxS enzyme from the 
genus Enterococcus is responsible for the production of the interspecies 
communication molecule, AI-2. Taken together, the data reported in this 
thesis showed the potential for virulence of enterococcal dairy strains in 
specific virulence models, while being avirulent in other models. This 
highlights the problem that their pathogenic potential in humans cannot be 
entirely excluded, and therefore, reiterating the need to keep a close 
surveillance of their presence in food. 
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Os enterococos são bactérias lácticas, disseminadas no meio 
ambiente, presentes na água, solo, plantas e animais, incluindo o ser 
humano. Para além da colonização da pele e de mucosas, tal como o 
tracto gastrintestinal, os enterococos, especialmente as espécies 
Enterococcus faecalis e Enterococcus faecium, têm-se tornado agentes 
responsáveis por diversas infecções nosocomiais nomeadamente do tracto 
urinário, bacterémias, infecções cirúrgicas, e endocardites. Para além de 
serem agentes patogénicos oportunistas, as resilientes bactérias do 
género Enterococcus são agentes essenciais que contribuem para a 
maturação, sabor e outras propriedades organolépticas de produtos 
alimentares fermentados. 
 
A natureza ubíqua dos enterococos pode ser atribuída a diversas 
características, quer intrínsecas do género quer específicas de certas 
espécies, que conferem uma vantagem nas suas capacidades de 
adaptação e sobrevivência. Facilmente transferíveis devido à elevada 
promiscuidade genómica dos enterococos, estes factores estão 
codificados em inúmeros genes que lhes permitem sondar o meio 
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ambiente de modo a adaptar o seu comportamento quer às condições 
ambientais quer à densidade celular. Estes genes desempenham um papel 
na virulência pois são relevantes nas diferentes etapas do processo de 
infecção, nomeadamente na adesão, colonização, invasão, evasão do 
sistema imunitário e disseminação nos tecidos do hospedeiro. Envolvidos 
neste processos estão vários factores de virulência, incluindo aqueles 
estudados nesta tese, nomeadamente citolisina, Fsr, gelatinase, cápsula. 
No início do trabalho que levou a esta tese, os investigadores começavam 
a aperceber-se que os factores de virulência presentes em enterococos 
isolados de ambientes clínicos também podiam ser encontrados em 
enterococos isolados de outros ambientes, tais como de produtos 
alimentares onde os enterococos desempenham um papel benéfico. Uma 
vez que a pesquisa da disseminação de factores de virulência deixara de 
ser crucial, outros aspectos começaram a tornar-se relevantes na ainda 
debatida virulência em enterococos, nomeadamente, a incongruência entre 
genótipo e fenótipo relativamente ao factor de virulência citolisina (Capítulo 
2), o potencial de virulência de estirpes alimentares de E. faecalis 
associado à presença dos genes fsrB e gelE (Capítulo 3), o papel de 
alguns factores de virulência na relação com o hospedeiro de estirpes de 
E. faecalis alimentares (Capítulo 4) e a contribuição para a virulência da 
proteína LuxS, responsável pela produção extracelular do autoindutor-2 
(AI-2) possivelmente envolvido certamente na comunicação entre E. 
faecalis e outras bactérias dentro e fora do hospedeiro humano (Capítulo 
5). 
 
 
Na primeira parte deste trabalho, e relativamente ao factor de 
virulência citolisina, uma cuidadosa pesquisa na literatura revelou que não 
Resumo 
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só os ensaios fenotípicos não eram realizados em condições idênticas 
como também, na maioria dos trabalhos publicados, poucos dos oito genes 
do operão cyl eram pesquisados, levando frequentemente a resultados 
incongruentes entre o genótipo e o fenótipo. Entre as 55 estirpes testadas 
nesta tese, pertencentes a quatro espécies diferentes de enterococos, 
nomeadamente E. faecalis, E. faecium, Enterococcus durans e 
Enterococcus hirae, e usando uma nova metodologia de pesquisa 
genotípica e fenotípica, foi possível obter uma concordância perfeita entre 
os ensaios genotípicos e fenotípicos. 
 
Na segunda parte deste trabalho, o objectivo foi avaliar o papel dos 
genes fsrB e gelE, dois genes que codificam para factores de virulência 
bem caracterizados em enterococos clínicos, no potencial de virulência de 
estirpes alimentares de E. faecalis. A virulência de isolados não 
relacionados do género Enterococcus, incluindo estirpes lácteas 
portadoras dos operões fsr e gelE, foi então comparada no insecto modelo 
Galleria mellonella. As estirpes lácteas de E. faecalis foram capazes de 
matar as larvas sendo tão virulentas quanto uma das estirpes mais 
utilizadas em estudos de virulência. Por oposição, as estirpes das espécies 
E. durans e E. faecium mostraram-se avirulentas ou pouco virulentas em 
G. mellonella. De modo a avaliar o papel dos genes fsrB e gelE na 
virulência de estirpes alimentares de E. faecalis, os dois genes foram 
independentemente deletados em duas estirpes. Embora ambas as 
mutações tenham significativamente atenuado a virulência em G. 
mellonella, esse efeito foi mais pronunciado nas estirpes mutantes no gene 
fsrB. Este trabalho demonstrou que a presença de um gene fsrB funcional, 
e de uma forma menos acentuada de um gene gelE, contribui 
significativamente para a virulência de isolados alimentares de E. faecalis e 
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que a presença desses genes em enterococos lácteos deve ser 
considerada com precaução. G. mellonella, sendo um modelo simples, 
pode apresentar vantagens na avaliação do risco associado a isolados 
alimentares. 
 
O isolado de queijo E. faecalis QA29b, portador de genes de 
virulência e previamente identificado como virulento no modelo de 
virulência G. mellonella, foi estudado no que respeita a fenótipos 
relevantes para a interacção com o hospedeiro que podem ter impacto na 
capacidade de provocar infecções e colonizar o hospedeiro humano. Este 
trabalho constituiu o primeiro estudo deste tipo de características num E. 
faecalis alimentar, que pertence ao Complexo Clonal 72, sendo, por isso, 
um bom representante dos E. faecalis alimentares. QA29b demonstrou, 
por um lado, uma elevada capacidade de formar biofilmes e aderir a 
células epiteliais, e por outro foi prontamente eliminado por células de 
macrófago J774.A1. Este trabalho evidenciou, pela primeira vez, que os 
genes cps, associados à virulência, podem ser transcritos de forma 
diferencial entre diferentes isolados, podendo não ser fenotipicamente 
expressos. Apesar de demonstrar ter um potencial de virulência num 
modelo de insecto, este isolado alimentar mostrou ser prontamente 
eliminado por macrófagos de mamíferos. Este trabalho mostra que 
optimizar métodos que combinem modelos celulares e animais é 
necessário de modo a abordar e elucidar o aspecto multifactorial do 
potencial de virulência associado a isolados alimentares. 
 
Na última parte deste trabalho a produção extracelular de AI-2 em 
E. faecalis VE14089, um derivado de E. faecalis V583 curado dos seus 
plasmídeos,  foi associada à presença e expressão do gene luxS. Este 
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gene encontra-se também presente em outros isolados clínicos e 
comensais bem como no isolado alimentar QA29b. A percepção de 
quórum mediada por AI-2 tem sido extensamente estudada na regulação 
do comportamento microbiano e foi reconhecida enquanto molécula de 
comunicação entre espécies, podendo influenciar a estrutura e função da 
comunidade. Quando comparada com a estirpe selvagem, o mutante luxS 
não demonstrou ter nenhum fenótipo quanto ao crescimento, formação de 
biofilme, adesão a células Caco-2, resistência ao stress oxidativo ou 
sobrevivência no interior de macrófagos. No entanto, a análise por 
microarray da expressão génica revelou que a mutação luxS teve efeitos 
pleiotrópicos, afectando genes envolvidos no metabolismo de DNA, ácidos 
gordos e intermediários metabólicos, não sendo complementados pela 
adição extracelular de AI-2. Este estudo mostrou que, em E. faecalis, a 
expressão diferencial génica relacionada com a mutação luxS não pode 
ser atribuída à percepção de quórum e que o LuxS tem, pelo menos, um 
papel no metabolismo. 
 
 
Concluindo, o trabalho apresentado nesta tese evidenciou, pela 
primeira vez, que uma estirpe láctea de E. faecalis tem tanto potencial de 
virulência quanto uma estirpe clinica da mesma espécie. No entanto, ficou 
também claro com este trabalho  que a presença de genes associados 
com virulência em E. faecalis alimentares não se traduz necessariamente 
num comportamento virulento e patogénico e que a persistência e 
resiliência de enterococos depende tanto do papel desempenhado pela 
presença de genes específicos quanto pelo restante genoma. Tendo em 
conta que os enterococos alimentares, bem como os comensais e clínicos, 
fazem parte de comunidades polimicrobianas, onde a existência de 
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comunicação inter-espécies poderá desempenhar um papel de relevo na 
capacidade para colonizar ou infectar o hospedeiro, estudou-se o papel do 
LuxS em vários fenótipos relevantes no processo de colonização e 
infecção por E. faecalis. Mostrou-se pela primeira vez que o enzima LuxS, 
presente no género Enterococcus, também em estirpes lácteas, é 
responsável pela produção da molécula de comunicação entre espécies, 
AI-2. A totalidade dos dados relatados nesta tese revelam que o potencial 
patogénico de Enterococcus em humanos não pode ser inteiramente 
excluído, reiterando a necessidade de manter uma estreita vigilância da 
sua presença em alimentos. 
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°C  degree Celsius 
2×YTGlu  2×YT supplemented with 0.5 % glucose 
A  adenine (in a nucleotide sequence) 
A  alanine (in an amino acid sequence) 
Ace  adhesin of collagen of E. faecalis 
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C  cysteine (in an amino acid sequence) 
C  cytosine (in a nucleotide sequence) 
CC  clonal complex 
CcpA  catabolite control protein A 
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CPS  capsular polysaccharide 
cre  catabolite responsive element 
Cyl  cytolysin 
CYS  L-cysteine 
CYSTA L-cystathionine 
D  Aspartic acid 
Dam  DNA adenine methylase 
Dcm  DNA cytosine methylase 
DNA  deoxyribonucleic acid 
DPD  (S)-4,5-dihydroxypentan-2,3-dione 
DS  diffusion sensing 
E  glutamic acid 
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GI  gastrointestinal 
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H  histidine 
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HGT  horizontal gene transfer 
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HypR  hydrogen peroxide regulator 
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int  intergenic 
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JCVI  J. Craig Venter Institute 
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NCBI  National Center for Biotechnology Information 
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PFGE  pulsed field gel electrophoresis 
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pH  hydrogen potential 
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RBS  ribosome-binding site 
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RNA  ribonucleic acid 
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S  serine 
S/I  similarity/identity 
SAH  S-adenosyl-L-homocysteine 
SAM  S-adenosyl-L-methionine 
Scm  second collagen adhesin of E. faecium 
SI  survival index 
spp.  species 
SprE  serine protease 
SRH  S-ribosyl-L-homocysteine 
ST  sequence type 
T  threonine (in a amino acid sequence) 
T  thymine (in a nucleotide sequence) 
TCA  tricarboxylic acid 
TCS  two-component system 
Tpx  thiol peroxidase 
UTI  urinary tract infection 
UV  ultraviolet radiation 
V  valine 
v/v  volume/volume 
VBNC  viable but nonculturable 
VRE  vancomycin-resistant Enterococcus 
W  tryptophan 
w/v  weight/volume 
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WT  wild type 
Y  tyrosine 
μg  microgram 
μL  microliter 
μM  micromolar 
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WHO 
Description of the genus Enterococcus (ex Thiercelin and Jouhaud 
1903) 
 
Enterococcus (En.te.ro.cocʻcus. Gr. n. enteron intestine; Gr. n. coccus a 
grain, berry; M.L. masc. n. Enterococcus intestinal coccus) cells are ovoid, 
occur singly, in pairs, or in short chains, and are frequently elongated in the 
direction of the chain. Gram positive. Endospores are not formed. May be 
motile. Facultatively anaerobic. Optimum growth temperature, ca. 35 °C. 
Strains grow at 10 and 45 °C. Most strains survive heating at 60 °C for 
30 min. Grow in 6.5 % NaCl and at pH 9.6. Hydrolyse pyrrolidonyl-β-
naphthylamide. Chemoorganotrophs. Metabolism fermentative. The 
predominant end product of glucose fermentation is L-lactic acid. Oxygen or 
other hydrogen acceptors may alter the end products of carbohydrate 
metabolism. Hydrogen peroxide may or may not accumulate in the 
presence of oxygen. Do not contain haem compounds. Benzidine negative 
and usually catalase negative, but some strains may produce 
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pseudocatalase. Some strains synthesize cytochromes or catalase or both 
when they are provided with haemin. The minimal nutritional requirements 
are generally complex. React with group D antisera; some strains also react 
with group Q antisera. 
Some strains possess respiratory quinones (menaquinones or 
demethylmenaquinones). Long-chain fatty acids are predominantly of the 
straight-chain saturated or monounsaturated types; some strains produce 
cyclopropane ring acids. 
Peptidoglycan type: Lys-D-Asp or Lys-Ala2-3. 
The G+C content of the DNA ranges from 37 to 45 mol %. 
Type species: Enterococcus faecalis. 
Nucleic acid hybridization studies, in particular DNA-rRNA hybridization 
studies, demonstrate that members of the genus Enterococcus are closely 
related to each other but not to members of the genus Streptococcus. 
Enterococci can easily be differentiated from streptococci by their ability to 
grow in 6.5 % NaCl and at pH 9.6. Moreover, in contrast to most 
streptococci (exceptions are Streptococcus lactis, Streptococcus cremoris, 
and Streptococcus uberis), they can grow at 10°C. 
 
(Schleifer et al., 1984) 
 
With the previous description Schleifer and Kilpper-Bälz (Schleifer et 
al., 1984) revived in 1984 the genus Enterococcus. However, Thiercelin 
was the first to use, in 1899, the term “enterocoque” to indicate the 
intestinal origin of a Gram-positive diplococcus, and 4 years later, together 
with Jouhaud, the genus Enterococcus was proposed as new (Domig et al., 
2003; Khan et al., 2010). Nonetheless, Enterococcus as a new genus did 
not endure, since, in 1906, Andrewes and Horder described Thiercelinʼs 
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“enterocoque” as a group of streptococci so characteristic of the human 
intestine that the term "Streptococcus faecalis" could be applied to it 
(Andrewes and Horder, 1906). Based on a serological typing system for 
haemolytic streptococci developed by Lancefield (Lancefield, 1933), 
Lancefield, this time with colleague Hare, continued, in 1935, that 
association between the two genus, relating cultures of the intestinal 
enterococci to group D haemolytic streptococci (Lancefield and Hare, 
1935). Sherman was the first to clearly mention, in 1937, that the term 
"enterococcus" had a somewhat variable and hazy meaning (Sherman, 
1937), existing in the literature a synonymous usage of enterococci, faecal 
streptococci and group D streptococci. At the same time he also stated 
that, despite being hard at that time to justify a generic segregation of the 
enterococci from the other streptococci making them an independent 
genus, enterococci represent one of the clearly defined primary divisions of 
the streptococci, probably the most clearly marked subdivision of the whole 
genus, the other three being the pyogenic, viridans and lactic groups 
(Sherman, 1937). 
The genus Enterococcus was revived and separated from 
Streptococcus sensu lato based on genomic studies, which relied on DNA-
DNA and DNA-rRNA hybridization studies (Schleifer et al., 1984). This 
separation was further confirmed by 16S ribosomal RNA (rRNA) sequence 
analysis, which showed that, within the previously described 
Streptococcus-Enterococcus group, organisms fall into three clusters 
defined by Enterococcus, the lactic acid streptococci and streptococci of 
the pyogenic and oral groups (Ludwig et al., 1985). Since the revival of the 
genus a total of 40 enterococcal species have been described (Table 1.1), 
though 5 species might need to be renamed due to being synonyms to 
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previously described enterococcal species or belonging to other genus 
((Euzéby, 1997), related website last visited: 2012.03.20)). 
Even if theyʼre not in presence of optimal growth conditions, the 
enterococcal phenotypic characteristics allow them to grow in diverse and 
broad range of conditions, conferring them the ability to colonize a wide 
variety of environments. 
WHERE can they be found? 
WHERE / Enterococci can be found in diverse habitats 
Bacteria of the genus Enterococcus are ubiquitous in nature and 
their role is often unclear. They can occupy the most varied niches if their 
viability or basic growth needs are met. Even if some species specificity 
can be seen in certain habitats (Table 1.1), they are naturally found in 
animals, plants, and in the environment (Figure 1.1). 
Animals, plants and environment / Habitat diversity 
In opposition to parasitism, where one organism benefits at the 
expense of its host, and mutualism, where both organisms benefit, 
commensalism is not as easy to define as the previous ones. By definition, 
commensals benefit from their relationship with their host without causing 
harm neither benefiting it. 
Enterococci have been identified as human commensals since their 
presence in the gastrointestinal (GI) tract was reported, still in the 19th 
century. In healthy humans they are mainly associated with the GI tract but, 
although they are less commonly found at other body sites, enterococci can 
also be recovered from the skin, the vagina, and the oral cavity (Fisher and 
Phillips, 2009). They have also been associated with a multitude of other 
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healthy animals: from warm-blooded animals, such as other mammals and 
birds (including production animals, such as livestock and fowl), to other 
vertebrates, like fish (Bulushi et al., 2010; Albesharat et al., 2011), 
amphibians and reptiles (Cox and Gilmore, 2007), and even invertebrates, 
like molluscs (Valenzuela et al., 2010) and insects (Devriese and Baele, 
2006; Cox and Gilmore, 2007). 
Certain host-specific variations in the occurrence of different 
enterococcal species in different animal hosts are known to exist. Other 
species variations have also been described regarding the hostʼs age, 
compartments colonized and the species distribution, as well as the effect 
due to feeding on species colonization (Devriese and Baele, 2006). 
Plants represent a harsh environment with physicochemical 
conditions that fluctuate widely and rapidly over short periods of time, such 
as temperature and osmotic conditions within the same day. The aerial 
plant surfaces are mainly aerobic, overall poor in nutrients, and exposed to 
UV radiation. Even in these considered non-host conditions, so different 
from the usual stable temperature, shielded from UV rays, anaerobic and 
nutrient rich environment of the GI tract of animals where they are 
commensal, enterococci can find a secondary habitat (Albesharat et al., 
2011). Enterococci have been found on the most diverse plant materials, 
like fruit, root and bulbous vegetables, as well as salads and cereals 
(Schwaiger et al., 2011).  
Enterococci are also widely present in natural environments such as 
soil, sediments, sand and water (Whitman et al., 2003; Devriese and Baele, 
2006; Brownell et al., 2007; Albesharat et al., 2011; Wright et al., 2011). 
Several enterococcal species have been isolated from these niches, such 
as E. faecium, E. faecalis, E. casseliflavus, E. hirae, E. durans and E. 
mundtii (Łuczkiewicz et al., 2010; Albesharat et al., 2011). 
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Table 1.1. Compilation of enterococcal species names, groups, isolation materials, 
and date. As described by Williams et al. (Williams et al., 1991), De Graef et al. (De 
Graef et al., 2003) and Koort et al. (Koort et al., 2004) enterococci can be classified 
in 6 different groups that are indicated by roman numbering (u: for unknown), with 
the type species of each group indicated in bold type. The species in need of 
renaming are at the bottom of the table ((Euzéby, 1997), related website last 
visited: 2012.03.20). 
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i 1984 Enterococcus avium ! ! ! ! ! ! ! ! ! !
i 1984 Enterococcus malodoratus !
i 1989 Enterococcus pseudoavium !
i 1989 Enterococcus raffinosus ! ! ! ! ! !
i 2004 Enterococcus hermanniensis ! ! !
i 2005 Enterococcus devriesei ! ! !
ii 1989 Enterococcus cecorum ! ! ! ! ! ! !
ii 1993 Enterococcus columbae ! ! ! !
iii 1991 Enterococcus dispar ! ! !
iii 1998 Enterococcus asini !
iv 1984 Enterococcus faecalis ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! !
iv 2001 Enterococcus haemoperoxidus !
iv 2001 Enterococcus moraviensis !
iv 2001 Enterococcus ratti !
v 1984 Enterococcus durans ! ! ! ! ! ! ! ! ! ! ! ! ! !
v 1984 Enterococcus faecium ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! ! !
v 1985 Enterococcus hirae ! ! ! ! ! ! ! ! ! ! ! ! ! !
v 1986 Enterococcus mundtii ! ! ! ! ! ! ! ! ! ! !
v 2001 Enterococcus villorum ! ! !
v 2003 Enterococcus canis !
vi 1984 Enterococcus casseliflavus ! ! ! ! ! ! ! ! ! ! !
vi 1984 Enterococcus gallinarum ! ! ! ! ! ! ! ! ! ! ! !
u 1991 Enterococcus saccharolyticus !
u 1991 Enterococcus sulfureus !
u 2002 Enterococcus pallens !
u 2003 Enterococcus phoeniculicola !
u 2004 Enterococcus italicus ! !
u 2005 Enterococcus aquimarinus !
u 2005 Enterococcus canintestini !
u 2006 Enterococcus caccae !
u 2006 Enterococcus silesiacus !
u 2006 Enterococcus termitis !
u 2007 Enterococcus camelliae !
u 2008 Enterococcus thailandicus !
Enterococcus flavescens = E. casseliflavus, Enterococcus porcinus = E. villorum, Enterococcus seriolicida = Lactococcus garvieae, Enterococcus 
solitarius = Tetragenococus halophilus, Enterococcus saccharominimus = E. italicus.
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Figure 1.1. WHERE enterococci are found: habitat occurrence and features, and 
flow of presence perpetuation. 
 
In addition to natural environments, in man-made environments 
enterococci can also resort to their survival mechanisms. Enterococci are 
capable of surviving on contaminated environmental surfaces for prolonged 
time periods (Devriese and Baele, 2006; Boyce, 2007). They have been 
shown to survive for one week to two months on countertops, for greater 
than seven days on fabric chairs, for seven days to four months on dry 
polyvinyl chloride surfaces, and for a few days to more than three months 
on cloth and plastic surfaces (Boyce, 2007). 
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Perpetuation of enterococci in nature and man-made 
environments 
Even if they are mainly known as warm-blooded animal 
commensals, we have seen that enterococci have a great diversity in their 
ecology and can be found retaining viability in numerous other 
environments. From the GI tract of animal where they can be found in 
impressive concentrations, < 107 CFU/g stool (Fisher and Phillips, 2009), 
they are excreted and the faeces end up in the environment. These organic 
wastes of human or production animal origin can be used as manure to 
fertilize soil for farming. This is a potential source of bacterial cross-
contamination of vegetables, along with sewage sludge or irrigation with 
wastewater (Kühn et al., 2003). Anyhow, they end up being found on 
plants, in soil, and in the water. Sludge and sewer water may eventually 
reach lakes, rivers, or the sea, ending up on sandy terrains. The 
interconnection between all these environments perpetuates the presence 
of enterococci in nature, from water to soil, from plants to animals (Figure 
1.1). 
In order to respond to hostile environment and preserve their 
viability, enterococci can activate several survival strategies including 
starvation and the viable but nonculturable (VBNC) state. The VBNC state 
is defined as a survival mechanism activated by bacteria in response to 
multiple environmental stresses and allowing microorganisms to conserve 
their viability despite the loss of their own culturability (Lleò et al., 2005). 
VBNC aquatic enterococci, present in drinking or swimming water, ingested 
by humans, maintaining the adhesive properties, are capable of binding 
intestinal cells, resuscitating, and then colonizing the GI tract (Signoretto 
and Canepari, 2008). 
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The members of the genus Enterococcus can also be found in 
many food products of vegetable, meat and dairy origin (Ogier and Serror, 
2008).  
The presence of enterococci in the GI tract of animals may lead to 
contamination of meat at the time of slaughtering. They have been 
consistently isolated from beef, poultry, and pig carcasses, as well as from 
fresh raw meat from those animals. Besides raw meats, enterococci have 
been associated with processed meats, like several types of fermented 
sausages, where heating of processed meats during production may confer 
enterococci a selective advantage. 
Enterococci are also recognized to be an essential component of 
the natural microbiota of many dairy products, predominating in some of 
them over lactobacilli and lactococci. Dairy products, like traditional 
European cheeses made from raw ewes' or goats' milk (Khan et al., 2010), 
contain many different species of enterococci, where E. faecalis and E. 
faecium are the species most commonly isolated with E. durans being also 
frequently isolated (Fortina et al., 2008; Ogier and Serror, 2008). 
Their recovery and persistence in a variety of cheeses, also 
produced from pasteurized milk, is justified by their ability to survive under 
adverse conditions, such as temperatures and salinity (Fortina et al., 2008). 
Previous studies have shown that in addition to cheese technology, 
environmental contamination of the milk is also a relevant factor in 
microbial development in cheeses, particularly traditional raw-milk cheeses 
(Ogier and Serror, 2008). Contaminating microorganisms may enter the 
milk either directly from the faecal matter of animals or even humans or 
indirectly from contaminated water sources, from the surface of the 
animals, from milking equipment, and from bulk milk holding tanks 
(Foulquié Moreno et al., 2006; Ogier and Serror, 2008).  
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Enterococci have been identified as having a role in ripening, flavour 
development, and bacteriocin production in cheeses. During milk curdling 
and cheese ripening, complex interactions occur in the microbial community 
of artisanal products (Carraro et al., 2011). Probably by proteolysis, 
lipolysis, and citrate breakdown (Ogier and Serror, 2008; Khan et al., 2010), 
the presence of enterococci throughout ripening positively affects taste, 
colour, and the sensory profile of the full-ripened cheese (Devriese and 
Baele, 2006; Ogier and Serror, 2008). In addition to their technological 
properties and potential contribution to the organoleptic properties of 
fermented food products, many strains of enterococci may also act as 
protective agents against various pathogens, such as Listeria 
monocytogenes, Staphylococcus aureus, Clostridium botulinum, 
Clostridium perfringens, and Vibrio cholera (Devriese and Baele, 2006; 
Ogier and Serror, 2008; Khan et al., 2010). 
As well as being considered as normal parts of the food microbiota 
and an important component of artisanal cultures, enterococci have also 
been involved in food intoxication and spoilage (Foulquié Moreno et al., 
2006; Pérez-Pulido et al., 2006), have the ability to produce biogenic 
amines in cheese, fermented sausages (Ogier and Serror, 2008) and cured 
meat products (Foulquié Moreno et al., 2006), and have also been 
associated as indicators for poor hygiene in the cheese production process 
(Klein, 2003; Foulquié Moreno et al., 2006). However, in the mammary 
gland of the healthy animal, milk maintains a microbial load. Fresh milk 
drawn from a healthy animal normally contains a low microbial load (less 
than 103 CFU/mL) (Fotou et al., 2011). Even if, until recently, the species 
diversity and relative abundance of bacteria naturally present in milk were 
largely unknown, it is now clear that the presence of a microbial load in milk 
is not necessarily associated with a poor hygiene. Furthermore, the 
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application of proper sanitary conditions in the milking practice and 
fermentation processes assures the avoidance of contamination while 
preserving the natural flora of the milk and hence providing its special 
characteristics (Fotou et al., 2011). 
Even if they have previously been only associated with faecal 
contamination, enterococci have a great diversity in ecology where they are 
now considered naturalized. The species distribution seems to be niche 
dependent, even if we cannot exclude biased isolation and identification 
results coming from bacteria in the VBNC state, low initial CFU, suboptimal 
growth conditions or even difficulty in identification of more recent species, 
which could result in the enrichment of some species. Nevertheless, 
enterococci are organism whose ubiquitous presence in nature perpetuates 
its own presence feeding back the cycle. 
WHY & HOW / Characteristics and mechanisms that 
allow enterococci to colonize and survive diverse 
habitats 
Enterococci are able to inhabit the most diverse habitats. This 
ubiquitous nature of enterococci is possibly due to a number of features, 
which can either be intrinsic to the genus or specific to some species or 
even strains, and that enable a survival and fitness advantage. These 
characteristics are encoded in numerous genes, which have been 
associated with virulence and the ability to cause infection, can easily be 
transferable due to high genomic promiscuity of the genus, and allow to 
probe the environment in order to adapt the behaviour both to the 
environmental conditions and to cell density (Figure 1.2). 
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Figure 1.2. HOW enterococci are able to interact with their habitat: intrinsic and 
acquired characteristics and mechanisms. Hyl: hyaluronidase; O2—: superoxide 
anion; Cyl: cytolysin; CylLs: small cytolysin subunit; CylLL: large cytolysin subunit; 
QS: quorum sensing; AI-2: autoinducer-2; GBAP: gelatinase biosynthesis-
activating pheromone; Fsr: E. faecalis regulator; GelE: gelatinase; SprE: serine 
protease; Esp: Enterococcal Surface Protein; AS: Aggregation Substance; EPS: 
exopolysaccharide; PGCs: Pilin Gene Clusters; MSCRAMMs: Enterococcal 
Microbial Surface Component Recognizing Adhesive Matrix Molecules; TCSs: 
Two-component systems; ECF: extracytoplasmic function. 
 
The Enterococcus genus has been unevenly studied: some strains 
have not been identified to the species level, there is understandably far 
less information regarding the newer species, and only two species, E. 
faecalis and E. faecium, have been studied in depth. The main focus has 
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been biased towards fitness characteristics and mechanisms of E. faecalis 
and E. faecium since, besides their commensal coexistence with humans, 
they have been associated with pathogenic behaviours and regarded as a 
health concern for humans, which will be further discussed in the part 
WHEN & WHAT of this introduction. 
Intrinsic characteristics of the genus 
Enterococci are able to resist hostile condition since strains can 
grow both in aerobic and anaerobic conditions, between 10 and 45 °C, 
survive heating at 60 °C for 3 min, and grow in 6.5 % NaCl, at pH 9.6 and 
tolerate the presence of 40 % (w/v) bile salts (Fisher and Phillips, 2009). 
They are intrinsically resistant to or tolerant to many antibiotics and are 
readily able to acquire more resistances (Giridhara Upadhyaya et al., 
2010). There are nonetheless several exceptions to these general genus 
characteristics. Some species, specially the newly identified ones, lack one 
or more of these features (Benachour et al., 2005), which can make them 
difficult to identify. However, even lacking some of these extreme survival 
features, enterococci remain hardy bacteria able to survive in extreme 
conditions.  
In-depth studies revealed more details about E. faecalis ability to 
survive under adverse conditions. Like S. aureus, E. faecalis is one of the 
few bacteria that are completely lysozyme resistant (Le Jeune et al., 2010). 
Exponentially growing cells can resist stresses such as heat, high 
osmolarity, and the presence of ethanol, detergents, hydrogen peroxide, 
sodium hypochlorite, and heavy metals, with a cation homeostasis which is 
thought to contribute to its resistance to pH, salt, metals and desiccation 
(Benachour et al., 2005; Fisher and Phillips, 2009). Moreover, adaptation 
by pre-exposure of the culture to sublethal stresses leads to a substantial 
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increase in resistance to the corresponding, usually lethal, stress 
(Benachour et al., 2005). When E. faecalis is grown at non-stress 
temperatures, subsequently cultured cells do not have the resilience to 
warm and cold environments that would occur if the first generation were 
grown at stressful temperatures (Fisher and Phillips, 2009). Starvation 
promoted by exhaustion of the carbon and energy source glucose or 
incubation in an oligotrophic microcosm strongly enhances the resistance 
of E. faecalis to environmental stresses and can be correlated with the 
increased synthesis of many proteins (Benachour et al., 2005).  
Bacteriocins 
Diverse enterococcal species, such as E. faecalis, E. faecium, and 
E. mundtii, have already been associated with the ability to produce an 
impressive array of bacteriocins (Franz et al., 2007; Fisher and Phillips, 
2009). Bacteriocins are substances elaborated by specific strains of 
bacteria that are lethal against other strains of the same or related species. 
They are ribosomally synthesized, small, cationic, amphiphilic (rather 
hydrophobic), extracellularly released antimicrobial peptides (Foulquié 
Moreno et al., 2006; Fisher and Phillips, 2009). Their production is favoured 
during lower growth rates, such as in stressful growth conditions (Fisher 
and Phillips, 2009), and have the cytoplasmic membrane as their primary 
target (Foulquié Moreno et al., 2006). 
Termed enterocin, cytolysin, enterolysin or mundticin, these 
enterococcal bacteriocins are preferentially active against Gram-positive 
bacteria. The lytic effect together with the wide range of targets makes 
these enterococcal bacteriocins valuable for the fermented food industry, 
inhibiting Gram-positive food-spoilage and foodborne pathogenic bacteria 
(Franz et al., 2007; Javed et al., 2010). The production of these bactericidal 
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peptides provides a competitive advantage to enterococci when competing 
for an ecological niche and, in combination with the previously mentioned 
intrinsic characteristics of the genus, may explain why these bacteria are so 
robust in nature and why they occur in such a wide variety of ecological 
niches. 
Putative virulence traits 
As indicated by case fatality rates and/or the ability to invade the 
tissues of the host, the degree by which a microorganism is able to cause 
disease, in man, animals, or plants, beyond that intrinsic to the species 
background (Michaux et al., 2011), is determined by its virulence factors. 
Even if they are not required for the viability per se of bacteria, these 
virulence factors have already been described and recognized as being 
involved in the different steps by which an organism is able to cause 
disease: adhesion, colonization, invasion, immune response inhibition 
(immune evasion and/or immunosuppression), obtaining nutrition from the 
host, and toxin production. 
Coded by genes in chromosomal DNA, bacteriophage DNA or 
plasmids, several virulence factors have already been identified in the 
genus Enterococcus, mainly regarding E. faecalis species, but also in E. 
faecium. The association of these factors with virulence has mainly been 
made through the use of virulence models. However, none of the 
enterococcal virulence models adequately mimic the particular 
physiopathological conditions that would clearly distinguish between 
pathogenic and non-pathogenic strains (Ogier and Serror, 2008), and the 
virulence attributed to a virulence factor, in its particular virulence model, 
cannot be necessarily generalized to other virulence models, such as 
different hosts. 
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Virulence factors are not exclusive to enterococcal strains isolated 
from diseased hosts. They are also present in commensal isolates and 
strains found in other ecological niches, without presenting any pathogenic 
effect clearly associated to them (Franz et al., 2001; 2003; Lepage et al., 
2006; Solheim et al., 2009; Giridhara Upadhyaya et al., 2010). It is still not 
clear whether the presence of these factors in E. faecalis isolates from 
clinical and commensal isolates contributes to the virulence in humans 
(Giridhara Upadhyaya et al., 2010), or even if some of them can be 
beneficial in the commensal relationship with the human host. Enterococcal 
virulence is subtle and complex, involving both pathogen and host factors, 
and all of these factors rarely occur in a single strain (Michaux et al., 2011). 
Even if virulence factors have been associated with a pathogenic 
potential, they are mainly fitness factors for bacteria. The previously 
described enterococcal virulence factors in the literature can be either 
secreted, surface associated, or intracellular. 
Secreted factors 
Several secreted factors have been associated with enterococcal 
virulence in virulence models. Some of these secreted factors have been 
associated with toxin production, giving a fitness advantage when 
competing with other organisms for an ecological niche as well as giving an 
arsenal for attack or defence when in presence of other organisms, but also 
with obtaining nutrition from the environment, the colonization process, and 
immune evasion.  
Cytolysin (Cyl) 
The Cyl (hemolysin/ bacteriocin) system involves production of an 
extracellular product, the Cyl, that consists of two small lantibiotic-like 
peptides ʻʻLL and LSʼʼ, which act extracellularly and in concert to manifest 
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toxicity or lytic activity and contribute to virulence in infection models 
(Clewell, 1990).  
Cyl is capable of lysing erythrocytes, such as human, horse, sheep 
and rabbit (Giridhara Upadhyaya et al., 2010). Animal models have 
suggested that haemolytic E. faecalis strains are more virulent than non-
haemolytic strains, and an association between a haemolytic phenotype 
and an increased severity and adverse outcome for patients with 
bacteraemia caused by E. faecalis has been reported (Reynaud Af 
Geijersstam et al., 2007; Giridhara Upadhyaya et al., 2010). 
Proteases: Gelatinase (GelE) and Serine Protease (SprE) 
GelE, previously referred in the literature as coccolysin, is a well-
known secreted hydrophobic zinc-metalloprotease (Waters et al., 2003; 
Thurlow et al., 2010; Bøhle et al., 2011). GelE has the capacity to cleave 
and degrade a broad range of host substrates, including insulin, casein, 
haemoglobin, gelatine, collagen, fibrinogen, fibrin, endothelin-1, bradykinin, 
LL-37, and complement components C3 and C3a (Waters et al., 2003; 
Thurlow et al., 2010). The gelE gene, that encodes GelE, is located on the 
chromosome and is regulated in a cell-density-dependent manner (Fisher 
and Phillips, 2009). 
The quorum sensing (QS) system encoded by the FsrABDC 
proteins is necessary for the coexpression of GelE and E. faecalis 
virulence-related SprE, located directly downstream, from a promoter 
located upstream of the gelE gene (Fisher and Phillips, 2009). The 
FsrABDC system and GelE have been shown to be relevant for 
enterococcal virulence in different animal models (Del Papa and Perego, 
2011). SprE has been shown to contribute to disease in animal models but 
its mechanistic contribution is not known at this time (Thurlow et al., 2010). 
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Commonly considered a virulence factor of E. faecalis, one of the 
known contributions of GelE producing strains is its involvement in efficient 
biofilm formation (Benachour et al., 2005; Thurlow et al., 2010; Bøhle et al., 
2011; Del Papa and Perego, 2011), functioning to encourage lysis and 
subsequent extracellular DNA (eDNA) release of a sub-population of cells 
which could aid in colonization establishment (Pinkston et al., 2011). For 
the GelE producing population, the co-production of SprE functions as an 
immunity protein, protecting it from self-destruction (Thomas et al., 2009). 
Biofilm formation, due to the protease activity of GelE, has been linked to 
the pathogenesis of enterococcal endocarditis (Giridhara Upadhyaya et al., 
2010; Thurlow et al., 2010; Del Papa and Perego, 2011), as well as 
bacteraemia, urinary infections and oral infections (Zoletti et al., 2011). 
In addition to assisting in the establishment of biofilm, it has been 
suggested that GelE may also play a role in dissemination. Since GelE is 
known to degrade adhesins, and to also cleave collagen, it has been 
speculated that GelE could potentially encourage disassociation of E. 
faecalis from collagen through either loss of the corresponding adhesin or 
by cleaving the collagen to which it is bound. In established vegetations, 
and directed by QS, GelE, as well as SprE, could aid in the release of cells 
from the collagen matrix to encourage dissemination of bacteria from the 
primary site of infection (Pinkston et al., 2011). 
Another possible role for GelE mediated cleavage of surface 
proteins from the surface of E. faecalis is that it could provide a method to 
evade the immune system. Upon establishment of an infection, when initial 
adherence is no longer required, it may be beneficial for the bacteria to 
remove surface adhesins, which are known to trigger an immune response 
in the host. As mentioned previously, GelE is also known to cleave C3 and 
iC3b, as well as being involved in the degradation of C5a (chemotaxis), 
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disrupting the PMN-mediated killing of E. faecalis, and therefore having a 
role in evading clearance by the immune system (Pinkston et al., 2011). 
A recent study indicates that GelE is loosely associated to the cell 
surface (Bøhle et al., 2011), which indicates that its possible action is 
localized, affecting solely the immediate vicinity of the producing 
enterococcal cell. 
Hyaluronidase (Hyl) 
Hyl is encoded by the chromosomal hyl gene. Along with other 
hydrolytic enzymes, Hyl is involved in the virulence of Enterococcus 
species (Semedo et al., 2003). This degradative enzyme acts on hyaluronic 
acid and is associated with tissue damage. Hyl depolymerizes the 
mucopolysaccharide moiety of connective tissue, thus facilitating spread of 
enterococci, as well as their toxins, through host tissue (Fisher and Phillips, 
2009). 
Superoxide 
Nearly all E. faecalis, but only a few E. faecium isolates, produce 
substantial amounts of extracellular superoxide (Kayser, 2003; Devriese 
and Baele, 2006). Fumarate reductase is likely to be involved in superoxide 
production and may thus be an important source of oxidative stress for the 
host (Bøhle et al., 2011). When E. faecalis isolates from patients with 
endocarditis and bacteraemia were compared with isolates from healthy 
volunteers, superoxide production was, on average, higher among blood 
isolates than in commensal strains (Kayser, 2003). It has been 
demonstrated that superoxide from E. faecalis promotes chromosomal 
instability in mammalian cells, which can lead to colorectal cancer (Bøhle et 
al., 2011). 
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Surface-associated factors 
Apart from the secreted factors, which can also be loosely attached 
to the surface, some virulence factors are tightly bound to the enterococcal 
surface. These surface-associated factors have been involved in adhesion, 
therefore helping further colonization that has been associated to one of the 
first steps towards a possible infection, hence the association to virulence. 
They have also been involved in immune evasion, that can be detrimental 
to the host in case of infection but that is essential when there is the 
establishment of a commensal relationship. 
Enterococcal Surface Protein (Esp) 
Of the cell-surface associated factors, the first one discovered to 
enhance biofilm formation was Esp, which was examined due to its 
homology to the S. aureus protein Bap (biofilm-associated protein) (Garsin 
and Willems, 2010). esp gene is located on a pathogenicity island (PAI) in 
both E. faecalis and E. faecium, and the corresponding proteins are 
expressed in both species at the surface of the bacterium (Sava et al., 
2010).  
In E. faecalis, Esp has been identified as a putative virulence factor 
involved in colonization of the urinary tract. Conflicting results have been 
reported about the role of E. faecalis Esp in biofilm formation, ranging from 
significant loss of biofilm formation in E. faecalis Esp-deficient mutants to 
no apparent effect (Sava et al., 2010), showing that its presence is not 
absolutely required (Garsin and Willems, 2010). 
The genetic repertoire and processes that facilitate multicellular 
cooperative behaviour and biofilm formation in E. faecium are not yet well 
understood (Garsin and Willems, 2010). Recently, more information has 
been presented about the function of E. faecium Esp. Interestingly, in 
contrast to E. faecalis esp gene, which is widely spread among strains, esp 
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gene from E. faecium is predominantly present in hospital-acquired 
isolates, suggesting a role in virulence (Sava et al., 2010). The importance 
of E. faecium Esp in urinary tract infections (UTIs) and endocarditis 
probably results from the fact that these models represent typical biofilm-
associated infection models indicating a specific role of Esp in the 
pathogenesis of E. faecium infections (Sava et al., 2010). 
Aggregation Substance (AS) 
AS is the description used for a group of surface proteins encoded 
on pheromone-inducible conjugative plasmids. Asa1, Asp1, and Acs10 are 
the best studied AS proteins and show over 90 % amino acid sequence 
identity (Sava et al., 2010). 
AS has been regarded as a virulence factor in E. faecalis. They 
have been involved in increased adherence, internalization and survival in 
eukaryotic cells, which can indicate that they might be involved in the 
translocation of E. faecalis through the intestinal epithelia, leading to 
systemic infection. However AS also promotes conjugation by directing 
bacterial aggregation, resulting in close cell contact between donor and 
recipient (Sava et al., 2010).  
Extracellular polymeric substances 
The presence of extracellular polymeric substances are believed to 
be associated with bacterial protection against adverse environmental 
surroundings, such as desiccation or bacteriophages, the sequestration of 
essential cations, and also to be involved in adhesion (Jolly et al., 2002; 
Welman and Maddox, 2003; Mozzi et al., 2009). These substances 
produced by bacterial species are a mixture of various components, 
including polysaccharides, lipopolysaccharides, proteins, peptides, and 
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nucleic acids, in which the polysaccharides constitute the major fraction 
(Suo et al., 2007). 
Cell-surface polysaccharides comprise O-antigens 
lipopolysaccharides (LPSs), lipoteichoic acids (LTAs), capsular 
polysaccharides (CPSs) and exopolysaccharides (EPSs) (Jolly et al., 
2002). EPS are secreted into their surroundings during growth and are 
generally loosely attached to the surface of the microbial cell or excreted 
into the environment. This distinguishes them from the structurally similar 
capsular polysaccharides (CPSs), which do remain permanently linked to 
the surface of the cell (Jolly et al., 2002; Welman and Maddox, 2003).  
The in situ production of these cell-surface polysaccharides plays 
an important role in the manufacture of a diversity of fermented dairy 
products, such as yogurt, drinking yogurt, cheese, cultured cream, and 
milk-based desserts (Jolly et al., 2002; Mozzi et al., 2009). Their presence 
significantly contributes to texture, mouthfeel, taste perception and stability 
of the final products (Jolly et al., 2002). An additional hypothesized 
physiological benefit is that EPSs will remain for longer in the GI tract, thus 
enhancing colonization by probiotic bacteria (Welman and Maddox, 2003). 
Additionally, beneficial effects for the human health have been assigned to 
these EPS, such as cholesterol-lowering, antitumoral or immunomodulating 
activities (Mozzi et al., 2009). 
The capsule, which usually contains various pathogenic antigens as 
virulence factors, plays a critical role in bacterial adhesion and can facilitate 
the evasion of bacteria from host defences (Suo et al., 2007), by preventing 
complement activation and/or killing by phagocytes. E. faecalis was 
previously reported to produce one of four capsule serotypes (A, B, C, or D) 
(Thurlow, Thomas, and Hancock, 2009). The capsule locus in E. faecalis, 
designated cps, contains nine genes (cpsC – cpsK). CpsF encodes a 
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putative glucosyltransferase which is probably responsible for the 
serodiversity between serotype C and D strains, modifying the ratio 
between glucose and galactose in the two types of capsules (Sava et al., 
2010). E. faecalis strains of either serotype C or D are more resistant to 
complement-mediated opsonophagocytosis than unencapsulated strains. 
The capsule has the ability to mask bound C3 from detection on the surface 
of E. faecalis. Similarly, E. faecalis capsule masks LTA from detection, 
which correlates with decreased cytokine production. The altered cytokine 
response to encapsulated pathogens appears to contribute to pathogenicity 
and virulence. The capsule has an important role as a virulence factor of E. 
faecalis and provide several mechanisms by which the presence of the 
capsule influences evasion of the host innate immune response (Thurlow, 
Thomas, Fleming, and Hancock, 2009). However, to date, the chemical 
structures of these capsular polysaccharides have not been published 
(Sava et al., 2010). 
Several studies have demonstrated the presence of an enterococcal 
polysaccharide antigen (Epa) in the E. faecalis cell wall. The epa locus 
consists of 16 open reading frames and is widespread among E. faecalis 
strains with the inside of the bacterial cell wall being its possible localization 
(Sava et al., 2010). This carbohydrate seems to play an important role in 
enterococcal pathogenicity, since disruption of different genes of the epa 
locus results in decreased biofilm formation (Garsin and Willems, 2010) 
and enterocyte translocation, lower resistance to killing by PMNs, higher 
bacterial susceptibility to infection by phages and reduced virulence in 
mouse peritonitis and UTI models (Sava et al., 2010) 
Regarding E. faecium, published information about capsular 
polysaccharides is completely lacking, and it has been suggested there is 
no capsule expression (Sava et al., 2010). 
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Pilin Gene Clusters (PGCs) 
The multi-factorial processes that have been implicated in adhesion 
to multiple types of human cells and in biofilm formation, two processes 
critical in the pathogenesis of many bacterial diseases, also involve the pili 
of Gram-positive bacteria. E. faecalis and E. faecium harbour PGCs, 
comprising genes encoding surface proteins with LPxTG-like motifs and 
sortases, which are required for pilus assembly (Sava et al., 2010).  
E. faecalis harbours two PGCs, designated as the ebp locus 
(endocarditis and biofilm- associated pili) and the bee locus (biofilm 
enhancer in enterococci). The ebp locus is ubiquitous in E. faecalis, and the 
expressed Ebp pili are important factors involved both in initial adherence 
and biofilm formation (Garsin and Willems, 2010; Sava et al., 2010). They 
contribute to the pathogenesis of experimental endocarditis and UTI, which 
are both biofilm-associated infections. In addition, it was found that Ebp pili 
are antigenic in humans during endocarditis. The bee locus is located on a 
conjugative plasmid and was only detected in 5% of the E. faecalis isolates, 
whereas the ebp operon was found in almost all of the isolates (Sava et al., 
2010). 
Like E. faecalis, E. faecium isolates recovered from clinical sites, 
fruits and vegetables, and water and soil are able to produce pili. E. 
faecium harbours four PGCs, designated PGC-1 to -4 (Garsin and Willems, 
2010), that display high similarity with genes of the ebp operon of E. 
faecalis, suggesting a possible role of these pili in interactions with the 
mammalian host (Sava et al., 2010). Although the genetic organization of 
pilin gene clusters, expression and distribution of pili genes among E. 
faecium from various sources was investigated, the role of pili in E. faecium 
pathogenicity was not defined (Garsin and Willems, 2010). 
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Enterococcal Microbial Surface Component Recognizing Adhesive 
Matrix Molecules (MSCRAMMs) 
Colonization of human tissues is assumed to occur via interactions 
between specific proteins in the extracellular matrix and the so-called 
MSCRAMMs (Sava et al., 2010). By sequence homology with other well-
characterized MSCRAMMs, just like the virulence factor Cna in S. aureus 
(Lebreton et al., 2009), several enterococcal MSCRAMMs have been 
identified in E. faecalis and E. faecium. The publicly available genome 
sequences of E. faecalis V583 and E. faecium TX0016 revealed the 
presence of 17 and 15 MSCRAMMs, respectively. So far, seven 
enterococcal MSCRAMMs have been characterized in detail: Ace 
(adhesion of collagen of E. faecalis), Fss1, Fss2, and Fss3 (E. faecalis 
surface protein) of E. faecalis and Acm (adhesin of collagen of E. faecium), 
Scm (second collagen adhesin of E. faecium) and EcbA (E. faecium 
collagen binding protein A) of E. faecium (Sava et al., 2010). 
Most of these MSCRAMMs, from both E. faecalis and E. faecium, 
have been shown to bind to components of the extracellular matrix. In 
animal experiments, they have been associated to the pathogenesis of 
experimental endocarditis (Sava et al., 2010), UTI (Lebreton et al., 2009) or 
biofilm formation (Hendrickx et al., 2009; Garsin and Willems, 2010). 
Adding to that, some of these factors were identified as being antigenic in 
humans during infection, which reinforces the idea of significant expression 
of these proteins in vivo (Lebreton et al., 2009; Sava et al., 2010). Even if 
some MSCRAMMs are only associated with hospital-acquired enterococcal 
isolates other are widely found among clinical and non-clinical isolates 
(Sava et al., 2010). 
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Intracellular factors 
As was previously mentioned, enterococci have a number of 
extracellular and surface factors that give them a fitness advantage when 
they are presented to harsh conditions in the environment or in the 
interaction with a host, as well as helping them in the several steps that can 
lead to infection. The presence of mechanisms that allow countering 
extreme conditions and regulating stress response are essential for fitness 
and survival, and are associated to virulence and pathogenicity of the 
Enterococcus genus. 
The oxidative burst is one of the major mechanisms by which the 
hostʼs phagocytes kill pathogenic bacteria. Therefore, an efficient oxidative 
stress response aiming to increase the cellʼs antioxidant defence may be 
crucial, at least in the early stages, for successful infection (La Carbona et 
al., 2007). 
The opportunistic pathogen E. faecalis is well equipped to respond 
to oxidative stress. It harbours an arsenal of genes such as catalase, 
glutathione reductase, the two subunits of alkyl hydroperoxide reductase, 
manganese superoxide dismutase (MnSOD) and three loci encoding 
peroxidatic activities: a NADH peroxidase, an alkyl hydroperoxide 
reductase and a thiol peroxidase (Tpx) (Verneuil et al., 2005; La Carbona et 
al., 2007), which are involved in the defence not only towards superoxide 
but also towards external exposure to H2O2 and internal generated H2O2 by 
aerobic growth (La Carbona et al., 2007). Some of these genes are under 
direct positive control of the transcriptional regulator HypR, indicating that 
HypR may be an important virulence factor in E. faecalis (Verneuil et al., 
2005). 
In other organisms, virulence genes are controlled by environmental 
stresses and involve secondary RNA polymerase sigma factors and 
  
Chapter 1
31 
specific transcriptional regulators (Michaux et al., 2011). E. faecalis 
genome, like those of Streptococcus pyogenes, Streptococcus 
pneumoniae, and Lactococcus lactis, lacks a general stress response 
regulator homologous to sigmaB of Bacillus subtilis (Le Jeune et al., 2010). 
However, several transcription factors, regulators and extracytoplasmic 
function (ECF) sigma factor have been shown to be involved in virulence 
and stress response in E. faecalis (Michaux et al., 2011). 
The largely studied Fsr system proteins have already been 
mentioned as being necessary for transcriptionally autoregulating the 
expression of the extracellular virulence-related proteases, GelE and SprE 
(Del Papa and Perego, 2011; Pinkston et al., 2011). By strongly influencing 
the regulation of these proteases, the fsr locus is therefore also relevant for 
enterococcal virulence, as revealed by different virulence models (Del Papa 
and Perego, 2011). This FsrABDC QS system is a homologue of the 
AgrABCD virulence system of S. aureus and is not uniquely involved in the 
promotion of biofilm formation, the dispersal of cells in established biofilms 
and as a contributor to the pathogenesis of enterococcal endocarditis due 
to its autoregulation of GelE (Del Papa and Perego, 2011; Pinkston et al., 
2011). The influence of the Fsr system can also be slightly inhibitory to 
biofilm formation. Cell death and genomic DNA release — eDNA, 
dependent on the autolysin, AltA, is necessary for formation of the biofilm 
matrix. GelE activates AltA, whereas SprE acts as an immunity protein and 
prevents GelE from accessing AltA. By regulating SprE, the Fsr system 
adds complexity to the regulation of biofilm formation (Garsin and Willems, 
2010). The Fsr system is also known to influence the expression of 
numerous targets that include other factors, besides GelE, described as 
important for biofilms (BopD), genes predicted to encode surface proteins, 
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and proteins implicated in several metabolic pathways (Bourgogne et al., 
2006). 
Other factors have been identified as being involved in virulence 
and the processes that may lead to infection. Using different infection 
models, the transcription factor SlyA was shown to play a role in the 
virulence of E. faecalis as well as in its persistence inside the host (Michaux 
et al., 2011). The transcriptional regulator Ers (for enterococcal regulator of 
survival) (PrfA like - the major regulator of virulence genes in Listeria 
monocytogenes) has a pleiotropic effect, especially in the cellular 
metabolism, like survival to oxidative stress and in mouse macrophages, 
and virulence of E. faecalis (Verneuil et al., 2005). PerR-like (peroxide 
regulator) regulator is a factor important for E. faecalis virulence in a mouse 
model (Verneuil et al., 2005). PerA (for pathogenicity island-encoded 
regulator), identified in the PAI, is important as a regulator of biofilm 
formation and survival within macrophages and is likely a regulator 
controlling determinants important to pathogenesis, as well as other 
uncharacterized PAI genes (Coburn et al., 2008). The transcriptional 
regulator HypR was clearly shown to be involved in the E. faecalis stress 
response (Benachour et al., 2005). The expression of ClpB, regulated by 
CtsR, appears to play a major role in induced thermotolerance and in 
pathogenesis in E. faecalis (de Oliveira et al., 2011). The transcriptional 
regulator bop (biofilm on plastic surfaces) contributes to the production of 
biofilm, the regulation of the expression of biofilm and prolonged 
bacteraemia in mice in E. faecalis (Hufnagel, Koch, Creti, Baldassarri, and 
Huebner, 2004). The transcriptional regulator ebpR is important for 
transcriptional activation of the E. faecalis endocarditis and biofilm 
associated pilus operon, ebpABC (Bourgogne et al., 2006). In addition to 
the pleiotropic effects displayed by the ECF sigma factor SigV, it also 
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contributes to survival following heat, acid and ethanol treatments and is 
involved in lysozyme resistance of E. faecalis (Le Jeune et al., 2010), just 
like the factors encoded by rsiV (Benachour et al., 2005). 
Emergence of new genetic material 
Enterococcal genomes, like other bacterial genomes, evolve 
through the emergence of new genetic material. This new genetic material 
can arise in bacteria either de novo, by internal genetic mutation, and the 
genic information is then transmitted from parent-to-offspring, or naturally 
transmitted from external sources and organisms, related or not, through 
horizontal gene transfer (HGT). HGT may occur via a variety of naturally 
occurring processes such as genetic conjugation (a unidirectional transfer 
of genetic material during fusion of two cells), genetic transduction (transfer 
of bacterial DNA by phages from an infected bacterium to another 
bacterium) and transformation (uptake of naked DNA by cells). HGT has a 
radically different impact from that of spontaneous mutations, which may be 
responsible for diversification and speciation of microorganisms on an 
evolutionary time-scale. HGT allows bacteria to rapidly acquire, 
immediately upon integration, complex and completely new physiological 
traits. This results in abrupt large-scale alterations in the structure and 
organization of genomes and has been and remains a key driving force in 
bacterial evolution, capable of generating new variants of bacterial strains 
by “genetic quantum leaps” (Dutta and Pan, 2002; Wozniak and Waldor, 
2010). 
During HGT, mobile genetic elements (MGEs), segments of DNA 
that can move within genomes, are transferred. These include plasmids, 
bacteriophages, genomic islands (GEIs), integrons, transposons and 
insertion sequence (IS) elements (Kelly et al., 2009). Many genetic features 
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have already been described as being transferred between the same 
enterococcal species, different species as well as with other genus: 
plasmids (Coburn et al., 2010; Manson et al., 2010; Palmer et al., 2010), 
integrative and conjugative elements (ICEs) (Wozniak and Waldor, 2010), 
the enterococcal PAI (Manson et al., 2010; van Schaik and Willems, 2010; 
Laverde Gomez et al., 2011). Through HGT, antibiotic resistance transfer 
allows other bacteria to acquire antibiotic resistance, metabolic traits 
transfer confers some useful metabolic capabilities to the recipient bacteria 
of the acquired gene, and PAIs transfer, with the virulence gene clusters 
therein, is a common strategy of commensal bacteria to acquire pathogenic 
traits (Dutta and Pan, 2002; Juhas et al., 2009; Laverde Gomez et al., 
2011). 
Sensing and probing the environment 
Enterococci have a number of traits that allow them to respond and 
prevail in the most diverse and varying environmental conditions, both 
inside and outside a host. Their ability to sense changing environmental 
stimuli and orchestrating a response accordingly is of the utmost 
importance in its adaptation to these varying conditions (Hancock and 
Perego, 2004). 
Two-component systems (TCSs) 
Bacteria have different mechanisms available for the regulation of 
stress response. Besides sigma factors and small RNAs, most bacteria 
monitor and adapt to changing conditions through signal transduction 
involving two-component signal transduction systems. TCSs generally 
consist of a sensory histidine kinase (HK) and a cognate response 
regulator (RR). The HK senses the signal and relays the adaptive response 
through the transfer of a phosphoryl group to the RR, which can then act as 
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a transcriptional regulator to modulate gene expression (Hancock and 
Perego, 2004). Most bacterial genomes encode several TCSs and 
enterococcal genomes are not unlike. Taken together, studies on E. 
faecalis TCSs can emphasize that two-component signal transduction 
systems govern important biological parameters of this organism ranging 
from environmental persistence, virulence and biofilm formation, to 
antibiotic resistance and stress response (Teng, Wang, Singh, Murray, and 
Weinstock, 2002; Le Breton et al., 2003; Hancock and Perego, 2004). 
Although all these roles associated to TCSs contribute together to the 
opportunistic character of E. faecalis, little is known about their target 
genes. 
Quorum sensing (QS) 
TCSs allow enterococci to sense environmental stimuli and to 
subsequently coordinate a suitable response. Part of these environmental 
stimuli can be autoinducers (AIs), molecules secreted by a bacterial 
population that accumulate extracellularly and induce genes in that same 
bacterial population. QS is that specific phenomenon: when a sufficient cell 
density has been reached, microorganisms communicate, coordinate and 
switch a set of behaviours among all individuals of the population, by the 
accumulation of AIs over a given threshold concentration (Hense et al., 
2007).  
As the three key determinants of AI concentration (cell density, 
mass-transfer properties and the spatial distribution of cells) can vary 
independently, cells sensing the AI concentration are unable to distinguish 
cell density from mass-transfer properties or spatial distribution. They can 
only assess the combination of these factors. This is why QS and diffusion 
sensing (DS), where cells use AI sensing to measure the mass-transfer 
properties of their environment, can be integrated. The recent notion of 
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efficiency sensing (ES) helps unify the concepts of what cells sense, why 
cells sense and the evolutionary hypotheses of the fitness benefits derived 
from AI sensing (Hense et al., 2007). 
Whether bacteria sense their density to allow them to engage in 
social behaviour that would benefit the group, in QS, or that sensing 
evolved as an autonomous activity of single cells to detect mass transfer 
limitations because of a direct fitness benefit for the individual, in DS, does 
not change the fact that enterococci are able to sense their specific AIs and 
adequately regulate gene expression. 
It was demonstrated that the previously mentioned Fsr system was 
activated by AI concentration through the TCS Ehk15-Err15 (enterococcal 
HK and enterococcal RR) (FsrCA) (Nakayama et al., 2001). The fsr locus is 
comprised of 4 genes, fsrA, fsrB, fsrD, and fsrC, whose products form a 
system that responds to the extracellular accumulation of the gelatinase 
biosynthesis-activating pheromone (GBAP) peptide encoded by the fsrD 
gene that acts as an AI. FsrB acts as a cysteine protease-like processing 
enzyme involved in the processing of the FsrD peptide. Accumulation of 
this peptide in the extracellular space is sensed by the FsrC membrane HK, 
leading to the activation of the RR and transcription factor FsrA. All the 
FsrABDC proteins are necessary for autoregulation at a promoter located 
upstream of fsrB and for the expression of two E. faecalis virulence-related 
proteases, GelE and SprE, from a promoter located upstream of the gelE 
gene (Del Papa and Perego, 2011). This QS mechanism, that involves the 
Fsr system and a TCS, also plays a role in efficient biofilm formation, 
dissemination, and immune system evasion. 
Unrelated to the well-known superfamily of TCS, another two 
component regulatory system, that involves the membrane component 
CylR1 and the DNA binding component CylR2, is necessary for the QS 
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induction of the cytolysin operon, where cytolysin serves as an AI. As 
previously mentioned, the control of the cytolysin is regulated by a 
threshold concentration of the posttranslationally modified subunit CylLS. 
CylLL has been shown to bind strongly to target cell membranes, allowing 
free CylLS to accumulate above a critical induction threshold (Coburn et al., 
2004). This QS system provides a means by which the cytolysin is 
produced in elevated amounts only when a particular target cell is present 
(Clewell, 2007), contributing to the virulence of enterococcal species 
harbouring this trait. 
Beyond controlling gene expression on a global scale and allowing 
communication within species, QS also allows bacteria to communicate 
between species. That communication is achieved via 4,5-dihydroxy-2,3-
pentanedione (DPD), one of the conversion products of S- 
ribosylhomocysteine (SRH) by the enzyme LuxS, which spontaneously 
cyclizes into several furanones in chemical equilibrium, collectively referred 
to as autoinducer-2 (AI-2) (Hense et al., 2007). Specifically, the luxS gene 
that encodes the LuxS enzyme is present in roughly half of all sequenced 
bacterial genomes, AI-2 production has been verified in a large number of 
these species, and AI-2 controls gene expression in a variety of bacteria 
(Waters et al., 2003), being implicated in the regulation of many bacterial 
behaviours including biofilm formation, competence, the production of 
secondary metabolites like antibiotics, and virulence (Pereira et al., 2009). 
All enterococcal genomes publicly available (http://www.ncbi.nlm.nih.gov/ 
and http://www.broadinstitute.org/; related websites last visited: 
2012.01.05) carry genes annotated as luxS genes, which can allow them to 
produce AI-2. While in some cases, AI-2 is clearly acting through a 
canonical QS mechanism, in others no relation to a committed 
communication between species could be ascribed (Pereira et al., 2009). 
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WHEN & WHAT / Is there a straightforward 
enterococcal associated human health risk? 
As seen before, enterococci are widespread among the 
environment, colonizing water, soil, plants and animals, including humans. 
Apart from their typical colonization of skin and mucous membranes, such 
as the GI tract, enterococci have also been linked to human infections. 
What are the enterococcal associated human health benefits and risks and 
when did they emerge? 
The already mentioned definition of a commensal bacteria is relative 
because, within the same host species, a given strain can vary its ability to 
cause disease (Marshall and Ochieng, 2009; Albesharat et al., 2011). The 
blurring of their definition complicates the study of commensal flora. 
Selective pressures, including those from antibiotic use and 
immunosuppressive therapies, further obscure boundaries, leading 
commensals into the realm of pathogens. This crossover phenomenon 
arises because the physical state of hosts also has much to do with 
defining which microorganisms are commensals and which are pathogens 
(Marshall and Ochieng, 2009). The distinction between ʻʻpathogenic 
commensalsʼʼ, that can cause disease when a patient is vulnerable or the 
bacterium gains access to a sterile site, and ʻʻnon-pathogenic 
commensalsʼʼ, which are incapable of causing disease (Albesharat et al., 
2011), allow clarifying the commensal notion. Based on the source of 
isolation, commensals can also be described as those isolates collected 
from asymptomatic individuals and from ʻʻtypicalʼʼ colonization sites, from 
environmental, or from non-human animal sources (Albesharat et al., 
2011). So, a commensal can be defined as an organism that typically does 
not cause disease, although some individual strains within a commensal 
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species may be able to cause disease, and a commensal isolate is defined 
as an isolate that has not been acquired from a diseased animal or person, 
even though that isolate could cause disease in an atypical site, and which 
would not cause disease in humans following typical colonization 
(Albesharat et al., 2011). 
In human disease 
Even though enterococci are considered human commensal, some 
species, like E. faecalis, have been associated to human disease for more 
than a century, but it was not until the past couple of decades that 
members of the genus Enterococcus emerged as common and problematic 
nosocomial pathogens. Not present upon admittance to the hospital or 
other clinical setting, nosocomial infections are acquired by the patient in 
the clinical setting and enterococci, as a whole, are generally not thought of 
as community acquired pathogens, but instead are nosocomial pathogens.  
Mainly E. faecalis, but also E. faecium, have been the species 
associated with hospital acquired infections (Fisher and Phillips, 2009), with 
E. faecium, in recent years, progressively increasing in percentage of 
infection, owing to being resistant to a large number of antibiotics (Willems 
and van Schaik, 2009). With exception of E. faecalis and E. faecium, other 
enterococcal species are rarely associated to human pathogenesis and 
their clinical relevance is often neglected, although there are few reports of 
infections caused by E. durans (Stepanovic et al., 2004), E. hirae (Gilad et 
al., 1998; Poyart et al., 2002; Ribeiro et al., 2008), E. raffinosus (Wilke et 
al., 1997; Sandoe et al., 2001; Savini et al., 2008; Mastroianni, 2009), E. 
gallinarum (Reid et al., 2001; Takayama et al., 2003), E. avium 
(Swaminathan and Ritter, 1999), E. casseliflavus (Reid et al., 2001; Pappas 
et al., 2004; Iaria et al., 2005), E. cecorum (Hsueh et al., 2000) and E. 
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mundtii (Higashide et al., 2005). The lower incidence of other enterococcal 
species may happen because of their possible lower pathogenic potential, 
but misidentification of unusual enterococcal species in medical centres 
due to the commercial identification methods cannot be disregarded, 
requiring accurate identification with molecular methods (Tan et al., 2010). 
Regardless of species, enterococci have been associated with 
several pathological conditions in the hospital environment. The most 
prevalent infections caused by members of this genus are UTIs, 
bacteraemia, intra-abdominal and pelvic infections, wound and tissue 
infections, and endocarditis (Jin et al., 2011). 
The emergence of these microbes as nosocomial pathogens 
coincides with the advent of modern antibiotic therapies. These 
antibacterial agents can interfere with the cell wall, inhibit metabolic 
pathways, and interfere with protein and nucleic acid synthesis (Tenover, 
2006). To prevent the effect of antibiotics, bacteria have developed four 
main mechanisms that allow resistance to occur, knowing that more than 
one may be present in a single bacterium: they can alter the antibiotic 
target site, decrease its uptake by decreased penetration and/or increased 
efflux, enzymatically inactivate or modify it, or create “bypass” pathways 
(Hawkey, 1998).  
Enterococci possess a broad spectrum of antibiotic resistances, 
both intrinsic and acquired. The intrinsic resistance to certain classes of β-
lactam antibiotics (e.g. cephalosporins), low-level resistance to 
aminoglycosides, lincosamides, streptogramins, in the case of E. faecalis, 
and monobactams provided enterococci with a selective advantage in the 
hospital environment (Willems et al., 2011). The intrinsic and acquired 
antibiotic resistance mechanisms of the genus can, upon antibiotic therapy 
with agents inactive against enterococci, lead to an increased enterococcal 
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burden in the gut by elimination of competitors (Jin et al., 2011), or maybe 
even by decreasing the hostʼs killing ability (Albesharat et al., 2011). One of 
the most disturbing resistances seen in enterococci is the acquired 
resistance to vancomycin, which is often regarded as the antibiotic of last 
resort for treating various multi-resistant Gram-positive cocci infections, 
such as enterococcal infections. 
However, antibiotic resistance as such cannot explain the virulence 
of enterococci (Foulquié Moreno et al., 2006), it can only explain their 
resilience upon treatment of infections. Along with antibiotic resistance, the 
presence of virulence-associated factors can contribute to the pathogenic 
potential of these microbes. All the traits that allow the different steps of the 
process of infection to occur contribute to the success of pathogenesis. 
One of the most studied phenomena associated with E. faecalis infections 
is the formation of biofilms. When in biofilms, cells are capable of resisting 
shear forces from blood flow and urine stream (Garsin and Willems, 2010), 
are more resistant to antibiotics than their planktonic counter parts and are 
also considered to be in a conducive location to the dissemination of genes, 
such as antibiotic resistance (Albesharat et al., 2011).  
To fully understand the contributions of virulence factors in disease 
establishment and progression by enterococci, one should also take into 
account that host factors undoubtedly also play an important role. However, 
the interplay between enterococci and the human host is only poorly 
understood (van Schaik and Willems, 2010). Hospitalized patients may 
have a greater incidence of enterococcal infection not only because of the 
associated virulence, but because the hospital itself is a hub (Fisher and 
Phillips, 2009). It was previously thought that infections due to enterococci 
were endogenously acquired from the patientʼs own flora. Analysis of 
enterococcal infections in recent years has shown, however, that most 
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infecting strains appear to be exogenously acquired. These strains can 
come from other patients, from the hospital personnel harbouring these 
strains in their own GI tract, or from environmental sources in the hospital 
(Jin et al., 2011), but also from patientsʼ mobile phones, patientsʼ 
companions, and visitors (Tekereko!lu et al., 2011). 
However, even in persons with impaired immunoresistance, 
enterococci alone are often unable to cause disease. Enterococci 
frequently are isolated from infectious processes as part of a polymicrobial 
flora. Elimination of one or several partners of this polymicrobial flora other 
than enterococci often is enough to cure the infection (Jin et al., 2011). 
Apparently, in the healthy host, deficiency of one part of the immune 
system is counterbalanced by other components of the immune system 
(Sava et al., 2010). 
In human health 
Despite being associated with disease as nosocomial pathogens, 
enterococci can have, not only a commensal relationship, but also a 
mutualistic one for the human host, therefore being beneficial. 
The human GI tract is colonized by microorganisms from the oral 
cavity to the rectum, comprising nearly 800 species. Bacteria in the gut 
achieve the highest cell densities recorded for any ecosystem, which 
makes it one of the most densely populated microbial ecosystems on earth. 
This population evolves over time, is highly stable within one individual over 
time, and a unique population is found in each individual (Albesharat et al., 
2011).  
Microbial colonization in humans varies along the length of the 
gastrointestinal tract, with a low of 101-103 bacteria/mL in the stomach and 
the duodenum, progressing to 104-107 bacteria/mL in the jejunum and 
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ileum, and culminating in 1011-1012 bacteria/mL in the colon (Sekirov and 
Finlay, 2009). Obligate anaerobes make up most of the colonic microbiota, 
with facultative anaerobes about ∼1000-fold fewer (Sekirov and Finlay, 
2009). Enterococci are members of the human GI tract consortium, 
comprising up to 1% of the adult microbiota (Cox and Gilmore, 2007). E. 
faecalis and E. faecium are the most common species in the human GI 
tract. The numbers of E. faecalis in human faeces range from 105 to 107 per 
gram, and those of E. faecium from 104 to 105 per gram (Fisher and 
Phillips, 2009). 
The gut microbiota constitutes a complex ecosystem involved in 
physiologic functions critical for human life (Sanz, 2011). They provide 
additional metabolic capacities to their host and regulate expression of 
genes involved in lipid and carbohydrate metabolism, which thereby 
influences the nutrient supply, energy balance, body weight (Sanz, 2011), 
as well as achieving an immunological function. The gut microbiota is a 
critical stimulus for the adequate maturation of the immune system, which 
contributes to reducing infections and aberrant immune responses (Sanz, 
2011). Intestinal microbiota contribute to many aspects of host defence 
against invading pathogens both through direct microbial antagonism and 
promotion of maturation of the intestinal immune system. 
Aside from the advantageous presence of bacteria, such as 
enterococci, for human health, this genus can also be a health-promoting 
agent when specifically consumed in probiotic preparations. A probiotic can 
be described as a preparation or a product containing viable and defined 
microorganisms, which, when administered in adequate amounts, alter the 
microbiota by implantation or colonization, in a compartment of the host, 
and that exert beneficial health effects in this host (Foulquié Moreno et al., 
2006; Vouloumanou et al., 2009). Some of these strains have been chosen 
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based on selection criteria that are believed to be important for their 
efficacy such as origin of strain, in vitro adherence to intestinal cells and 
survival during passage through the GI tract (Soccol et al., 2010). A group 
of requirements have been identified for a microorganism to be defined as 
an effective probiotic. These include the ability to (a) adhere to cells; (b) 
exclude or reduce pathogenic adherence; (c) persist and multiply; (d) 
produce acids, hydrogen peroxide, and bacteriocins antagonistic to 
pathogen growth; (e) be safe, non-invasive, noncarcinogenic, and non-
pathogenic; and (f) coaggregate to form a normal balanced flora (Foulquié 
Moreno et al., 2006).  
Strains that are used as probiotics for man have been isolated from 
the human GI tract and usually belong to species of the genera 
Lactobacillus and Bifidobacterium. However, yeasts and strains belonging 
to species of other lactic acid bacteria (LAB), among them enterococci, 
have been used in the past as probiotics too, such as E. faecium, E. 
faecalis (Foulquié Moreno et al., 2006; Soccol et al., 2010). Several well 
studied enterococcal strains, such as E. faecium SF 68, E. faecium CRL 
183, E. faecium PR88, E. faecium strain ECOFLOR and E. faecalis strain 
Symbioflor 1, have been used for their hypocholesterolemic and anti-
carcinogenic effects on individuals, the production of enterocins active 
towards L. monocytogenes, to alleviate the symptoms of irritable bowel 
syndrome and recurrent chronic sinusitis or bronchitis, and in the 
prevention of antibiotic-associated diarrhoea and in the treatment of 
diarrhoea in children (Foulquié Moreno et al., 2006; Domann et al., 2007; 
Ogier and Serror, 2008). The action attributed to these ingested enterococci 
is mutualistic just like other enterococcal strains already present in the 
human GI tract might also be. 
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At the time this thesis started, researchers were starting to realize 
that genes found to be associated with increased virulence potential in 
enterococcal clinical isolates were also present in isolates from other 
environments, in particular where enterococci play beneficial roles, namely 
food. Therefore, the quest for dissemination of virulence factors among 
food isolates was no longer important, but rather other issues started to 
become relevant. What makes a strain become virulent? Is it enough to 
carry virulence factors? Can food strains be virulent? Is the mere presence 
/ detection of genes enough to predict a phenotype associated with those 
genes? Are the traits (phenotype and genotype) detected in a strain 
enough to predict the outcome of an isolate facing host defences? Is the 
QS molecule AI-2, a universal communication molecule, eliciting any 
virulence potential in E. faecalis, thus contributing to the complex 
development of polymicrobial communities where E. faecalis naturally 
inhabit? These questions were addressed in the thesis and the generated 
knowledge will contribute to a better safety assessment of enterococcal 
isolates. 
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Enterococci are Gram-positive lactic acid bacteria, which have been 
known since the end of the 19th century to be associated with humans both 
as natural colonizers and as infectious agents. At the beginning of the 20th 
century, these bacteria were also recognized as being able to clot milk. The 
relevance and the importance of these bacteria are concerned mostly with 
two particular aspects, which have certainly generated discussion among 
researchers and have encouraged them to clarify the virulence 
mechanisms involved in the pathogenesis of infections caused by 
enterococci. Firstly, enterococci are human commensals that are used in 
the production of some fermented foods, but are also important nosocomial 
pathogens. Secondly, their virulence is still debated and puzzling, not only 
because both infectious and non-infectious strains carry the same putative 
virulence traits, but also because the bacterial factors mediating virulence 
may be diverse between different strains and species (Bourgogne et al., 
2008). 
The cytolysin (haemolysin/bacteriocin) system is one of the best-
studied virulence traits in Enterococcus. It is encoded by an operon 
beginning with the cylLL gene and ending at the cylI gene (Figure 2.1A). 
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This cytolysin contributes to virulence in infection models (Clewell, 2007). It 
is therefore important, for enterococcal isolates from both clinical 
specimens and food sources, to screen for the production and genetic 
carriage of this virulence factor. Although several phenotypic techniques for 
the detection of haemolytic activity have been described (Park et al., 2007), 
the gold standard method for the production of haemolysin has been for a 
long time the presence or absence of clear zones (β-haemolysis) 
surrounding colonies on blood agar plates (Balashova et al., 2006). This 
method, however, is influenced by factors such as medium composition, 
the species of red blood cells used, the presence of oxygen and the 
duration of incubation. In fact, no single standardized method has been 
described. 
The fact that eight described cytolysin genes are considered 
essential for the production of a functional cytolysin makes the screening 
for both divergent operons of the cyl locus important (Figure 2.1B). The 
screening for a single gene or part, or parts, of the entire cytolysin 
determinant will only indicate a strainʼs potential for production of the 
haemolysin/bacteriocin activity. 
A thorough search in the literature revealed that not only are the 
phenotypic assays not performed under the same conditions, but also that, 
in the majority of the experiments, only a few cyl genes are screened for, 
often leading to incongruent results between the genotype and phenotype 
of strains (Shepard and Gilmore, 2002; Creti et al., 2004; Seno et al., 2005; 
McBride et al., 2007; and further references therein). Such apparent 
incongruence needs to be resolved in order to clearly determine whether 
experimental design accounts for these or whether phenotypic expression 
of haemolysin/bacteriocin is lacking where the genotypic potential for 
cytolysin production exists. We believe that unambiguous procedures for 
  
Chapter 2
51 
both the genetic and the phenotypic screening of enterococcal isolates are 
essential and should be the starting point for clarifying the apparent 
incongruence suggested by the literature. 
 
A 
 
B 
 
Figure 2.1. (A) Organization of the cyl locus and location of the primers Cf and Cr 
used for the PCR. (B) The E. faecalis cytolysin senses and destroys target cells 
(Roux et al., 2009). The cylLL and cylLS genes encode precursors of two small 
lantibiotic-like peptides, which are subsequently modified by the cylM gene product. 
The cylB gene product is an ATP-binding cassette transporter that facilitates the 
transport of the peptides out of the cell and is involved in additional processing. 
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The cylA gene product extracellularly processes the peptides and activates them, 
allowing them to combine to produce the cytolysin. The mechanism signalling the 
upregulation of the operon involves two regulator proteins corresponding to the 
cylR1 and cylR2 gene products from a divergently transcribed operon. An immunity 
function is present and is provided by a membrane protein encoded by the cylI 
gene (Clewell, 2007). Cytolysin expression is regulated by CylLSʼʼ through a 
quorum sensing-like mechanism. In the absence of target cells, the mature subunit 
CylLLʼʼ interacts with CylLSʼʼ to form an inactive oligomeric complex (1) that is not 
able to induce expression of the cytolysin operon. In the presence of target cells, 
CylLLʼʼ binds them preferentially, creating a transient pool of free CylLSʼʼ (2) to 
induce high- level cytolysin expression prior to the slow reaction of CylLSʼʼ joining 
the pore complex (Roux et al., 2009). 
 
Knowing that cytolysin is produced by a complex process that 
requires the products of eight genes, a primer pair was designed (Figure 
2.1A) based on the sequence of the cytolysin locus of Enterococcus 
faecalis strain MMH594 from the cylR2 gene to the cylI gene (GenBank 
accession no. AY032999). In this manner, the two divergent operons of the 
cytolysin locus were amplified, enabling a genotypic screening that would 
represent the complete cyl locus (Cf, GGT TGC CAT TGA AAA ATA TCT 
TCT AGT GGA GTA TCC AGG, from bp 194 to 156 of the cylR2 gene; Cr, 
GTG ATT GAT TGG CTT ATT TCA TCA TCA TCA CTT TTG AGC, from bp 
902 to 863 of the cylI gene). The PCR was performed using an Expand 
Long Template PCR system (Roche) and the conditions recommended by 
the manufacturer. The thermal cycling parameters for the 8364 bp PCR 
product consisted of one cycle at 94 ºC for 2 min and 10 cycles at 94 ºC for 
10 s, 50 ºC for 30 s, and 68 ºC for 10 min. This was followed by 20 cycles 
at 94 ºC for 10 s, 50 ºC for 30 s, and 68 ºC for 10 min (with the elongation 
time increasing by 10 s per cycle) and a final cycle at 68 ºC for 7 min. The 
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PCR screening for the complete cyl locus was performed on 55 strains from 
nosocomial infections and from food (milk and cheese): 36 E. faecalis, 7 
Enterococcus faecium, 4 Enterococcus hirae and 8 Enterococcus durans. 
The phenotypic screening of the enterococcal strains for cytolysin 
production was performed on Columbia blood agar supplemented with 5 % 
(v/v) horse blood (Becton Dickinson) and incubated at 37 ºC for 24 or 48 h, 
under anaerobic conditions (GasPak EZ Gas Generating Container 
Systems; Becton Dickinson). 
The results are presented in Table 2.1. No differences in haemolytic 
activity were seen between the durations of incubation (24 and 48 h) at 
37 ºC. All strains were also tested on BHI agar supplemented with 5 % (v/v) 
human blood, incubated at 37 ºC for 24 or 48 h under identical anaerobic 
conditions. No differences were seen between the results obtained for 
blood plates with human or horse erythrocytes. Nonetheless, the 
haemolytic clearing zones were more evident on horse blood (data not 
shown), making horse erythrocytes more convenient for the haemolysin 
assay and allowing an assay with a higher sensitivity. All 55 strains tested 
showed complete agreement between genotypic and phenotypic assays. 
This correlation was observed for the four enterococcal species tested, 
namely E. faecalis, E. faecium, E. durans and E. hirae. 
Based on our genotypic and phenotypic screening methodology, a 
much higher correlation was obtained compared to any previously 
described screening (Shepard and Gilmore, 2002; Creti et al., 2004; Seno 
et al., 2005; McBride et al., 2007; and further references therein). The PCR 
screening for the complete cyl locus described herein gives a measure of 
the gene reservoir of the strain, while the phenotypic assay is still the only 
test that allows demonstration of active cytolysin production. As 
environmental factors could strongly influence gene expression (Finlay and 
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Falkow, 1997), it is necessary to take into account that the in vitro 
conditions used to test for phenotypic characters are different from those 
found in vivo in the human host. For these reasons, enterococci should be 
evaluated not only for the in vitro expression of virulence traits, but also 
using molecular assays for evidence of silent genes that could potentially 
be activated, thereby changing these bacteria into potential pathogens or 
augmenting their pathogenicity (Sabia et al., 2008). In the case of negative 
phenotype results, gene products of another strain or species could 
complement the lack of expression of an inactive gene. In conclusion, the 
incongruence previously evidenced between phenotypic and genotypic 
assays for the haemolysin/bacteriocin of enterococcal species is probably 
due to the experimental design rather than being attributable to any 
particular genetic phenomenon. 
 
Table 2.1. Results from the genetic and phenotypic screening of the cytolysin 
system. 
Species Total no. of strains Origin (clinical / food) PCR* Haemolysis† 
E. faecalis 24 20/4 + β 
 12 0/12 - γ 
E. faecium 1 0/1 + β 
 6 2/4 - γ 
E. durans 1 0/1 + β 
 7 0/7 - γ 
E. hirae 4 0/4 - γ 
* +/–, The complete cyl operon was/was not detected by PCR. 
† γ represents the absence of haemolysis; β represents the presence of 
haemolysis. 
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Abstract 
Despite the existence of various virulence factors in the 
Enterococcus genus, enterococcal virulence is still a debated issue. A main 
consideration is the detection of the same virulence genes in strains 
isolated from nosocomial or community-acquired infections, and from food 
products. The goal of this study was to evaluate the roles of two well-
characterized enterococcal virulence factors, Fsr and gelatinase, in the 
potential virulence of Enterococcus faecalis food strains. Virulence of 
unrelated Enterococcus isolates, including dairy strains carrying fsr and 
gelE operons, was compared in the Galleria mellonella insect model. E. 
faecalis dairy strains were able to kill larvae and were as virulent as strain 
OG1RF, one of the most widely used for virulence studies. In contrast, 
Enterococcus durans and Enterococcus faecium strains were avirulent or 
poorly virulent for G. mellonella. To evaluate the role of fsrB and gelE in 
virulence of E. faecalis dairy strains, both genes were deleted 
independently in two strains. The ΔfsrB and ΔgelE deletion mutants both 
produced a gelatinase-negative phenotype. Although both mutations 
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significantly attenuated virulence in G. mellonella, the ΔfsrB strains were 
more strongly attenuated. These results agree with previous findings 
suggesting the involvement of fsrB in the control of other cell functions 
relevant to virulence. Our work demonstrates that the presence of 
functional fsrB, and to a lesser extent gelE, in dairy enterococci should be 
considered with caution. 
Introduction 
Enterococcus is a peculiar and controversial genus of Gram- 
positive lactic acid bacteria. It includes commensal species that inhabit the 
gastrointestinal tracts of humans and animals, which can be used as starter 
cultures in food fermentations, as animal health supplements and/or as 
probiotics. However, they are also capable of causing opportunistic 
infections, including bacteraemia, endocarditis, meningitis, and wound, 
urinary tract and nosocomial bloodstream infections. Owing to their 
robustness, these bacteria are able to contaminate and maintain viability in 
diverse environments such as soil, sand, water, plants and food (Mundt, 
1986). In the particular case of fermented food products, enterococci 
belong to the non-starter flora, although they have been proposed as 
starters for the production of certain cheeses and other fermented milk 
products (Aarestrup et al., 2002). They are of particular relevance for 
traditionally made cheeses in south European countries, where they play an 
important role in the ripening process, through proteolysis, lipolysis and 
citrate metabolism, therefore contributing to the organoleptic characteristics 
of the product. 
Enterococcus faecalis is the predominant species in human/ animal-
associated environments, and therefore the most studied species of this 
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genus (Tannock and Cook, 2002). E. faecalis, together with Enterococcus 
faecium, are also the most frequently found species in dairy food products, 
with varying prevalence as a function of the country and cheese type 
(Aarestrup et al., 2002). E. faecalis is also responsible for up to 80 % of 
enterococcal-associated nosocomial infections, followed by E. faecium. 
One explanation for the over-representation of E. faecalis among clinical 
isolates may relate to its natural abundance, or to the presence of virulence 
factors (Hancock and Gilmore, 2000). Although harmless in healthy 
individuals, enterococcal clinical isolates become pathogenic in patients in 
intensive care units and in hospitalized patients with impaired immune 
systems. This has been associated with a variety of virulence factors 
carried by E. faecalis (Ogier and Serror, 2008). 
One of the most studied E. faecalis virulence factors is gelatinase, a 
metalloprotease able to degrade several substrates, such as gelatine, 
casein, haemoglobin and other bioactive peptides, including E. faecalis sex 
pheromones (Kayaoglu and Ørstavik, 2004). Gelatinase is encoded by 
gelE, which is in an operon with sprE, which encodes a serine protease 
(Qin et al., 2000). Its phenotypic expression requires the regulatory system 
encoded by the fsrABC operon (Qin et al., 2000; Lopes et al., 2006), 
recently renamed fsrABDC (Nakayama et al., 2006). fsr is homologous to 
the agr quorum sensing system of Staphylococcus aureus, and has also 
been implicated in virulence of E. faecalis independently of gelE 
(Bourgogne et al., 2006). The role of gelE and fsr loci in E. faecalis 
virulence has been demonstrated in different mammalian infection models 
(Mohamed and Murray, 2006), in the Caenorhabditis elegans nematode 
model (Sifri et al., 2002) and in the Arabidopsis thaliana plant model (Jha et 
al., 2005). More recently, gelatinase has been implicated in evasion of the 
immune system of the insect Galleria mellonella, suggesting that gelatinase 
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may participate in virulence in this system (Park et al., 2007). Screening of 
both gelE and fsr in E. faecalis isolates from different origins revealed their 
dissemination in fermented milk products (Semedo et al., 2003; Lepage et 
al., 2006; Lopes et al., 2006). However, the roles for Fsr and gelatinase in 
the potential virulence of E. faecalis food strains have never been 
established. In the present study, two gelatinase-positive E. faecalis dairy 
strains carrying gelE and the complete fsr operon, and their respective 
isogenic gelE and fsrB deletion mutants, were tested for virulence in the G. 
mellonella infection model. 
Materials and Methods 
Bacterial strains, plasmids, and culture conditions 
Bacterial strains used in this study are listed in Table 3.1. 
Enterococci were grown in M17 broth supplemented with 0.5 % (w/v) 
glucose (M17BGlu) or M17 agar supplemented with 0.5 % glucose 
(M17AGlu) at 37 ºC without aeration. Escherichia coli strains were grown 
aerobically in Luria–Bertani broth or on LB agar at 37 ºC. Antibiotics were 
used at the following concentrations: erythromycin, 30 mg/mL for E. 
faecalis and 150 mg/mL for E. coli; ampicillin, 80 mg/mL. 
General DNA techniques 
General molecular biology techniques were performed by standard 
methods (Sambrook et al., 1989). Restriction enzymes, polymerases and 
T4 DNA ligase were used according to manufacturersʼ instructions. PCR 
amplification was performed using a Biometra or Eppendorf thermocycler. 
When necessary, PCR products and DNA restriction fragments were 
Chapter 3 
 65 
purified with QIAquick purification kits (Qiagen) or Montage Life Science 
kits (Millipore). Plasmids were purified using the QIAprep Spin Miniprep kit 
(Qiagen). Electrotransformation of E. coli and E. faecalis was carried out as 
described by Dower et al. (Dower et al., 1988) and Dunny et al. (Dunny et 
al., 1991), using a Gene Pulser apparatus (Bio-Rad). Plasmid inserts were 
sequenced at Baseclear. 
Table 3.1. Strains used in this study 
Strains Relevant characteristics Reference or source 
E. coli   
DH5α F- Φ80dlacZΔM15 Δ(lacZYA-argF)U169 deoR 
recA1 endA1 hsdR17(rK- mK+) phoA supE44 λ- thi-
1 gyrA96 relA1 
(Grant et al., 1990) 
TG1 repA supE hsdD5 thi (Δlac-proAB) F- (traD36 proAB-
lacZΔM15) repA 
(Law et al., 1995) 
 
E. faecalis 
  
OG1RF Fusr Rifr, plasmid free wild-type strain, Gel+ (Dunny et al., 1978) 
QA29b Wild-type E. faecalis; isolated from cheese, Gel+ This study 
LSE4a Wild-type E. faecalis; isolated from milk, Gel+ This study 
LN68 Wild-type E. faecalis; isolated from milk, Gel- (Lopes et al., 2006) 
TX5264 gelE in-frame deletion in OG1RF, Gel- (Sifri et al., 2002) 
TX5266 fsrB in-frame deletion in OG1RF, Gel- (Qin et al., 2001) 
QA29bΔfsrB fsrB in-frame deletion in QA29b, Gel- This study 
QA29bΔgelE gelE in-frame deletion in QA29b, Gel- This study 
LSE4aΔfsrB fsrB in-frame deletion in LS4E, Gel- This study 
LSE4aΔgelE gelE in-frame deletion in LS4E, Gel- This study 
 
E. faecium 
  
QSE32 Wild-type; isolated from cheese, Gel+ (Alves et al., 2004) 
 
E. durans 
  
QN1 Wild-type; isolated from milk, Gel- (Ribeiro et al., 2007) 
 
Construction of in-frame gelE and fsrB deletion mutants of 
strains QA29b and LSE4a 
 Markerless gelE and fsrB deletion mutants of E. faecalis were 
constructed essentially as described by Brinster et al. (Brinster, Furlan, and 
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Serror, 2007). Briefly, 5ʼ and 3ʼ flanking regions of fsrB and gelE were 
amplified from chromosomal DNA of each strain by PCR with primers OEF-
232, OEF-233, OEF-234 and OEF-235, and OEF- 236, OEF-237, OEF-238 
and OEF-239, respectively (Table 3.2). The two cognate PCR fragments 
were fused by PCR using the external primers OEF-232 and OEF-235, and 
OEF-236 and OEF-239 for fsrB and gelE, respectively, and the resulting 
product was cloned into pGEM-T (Promega). The inserted PCR fragment 
was removed from its cloning vector by restriction enzymes and 
subsequently cloned into pG+host9 plasmid (Maguin et al., 1996), which 
was then electroporated into E. faecalis. The fsrB and gelE single- and 
double- crossover mutants were selected as described by Brinster et al. 
(Brinster, Furlan, and Serror, 2007). Successful targeted mutations of fsrB 
and gelE in strains LSE4a and QA29b were first identified by PCR 
screening and were confirmed by Southern blot analysis. 
Gelatinase activity assay 
The phenotypic assay of gelatinase activity was performed as 
described by Lopes et al. (Lopes et al., 2006). Briefly, Enterococcus strains 
were grown on agar plates containing 3 % (w/v) gelatine (Oxoid) and 
flooded with a saturated solution of ammonium sulphate (Merck). A 
transparent halo around cells indicated gelatinase activity. 
Table 3.2. Primers used in this study 
Primer 
name 
Sequence (5ʼ-3ʼ)* Position of the 
primer 5ʼ end 
Reference 
OEF-232 GAAAGGGATGAGTGAACAAATG bp 839 upstream of 
the fsrB start codon  
(Sifri et al., 
2002) 
OEF-233 CTTTGTCCATTGTGTTTTTCCTG bp 78 in fsrB  (Sifri et al., 
2002) 
OEF-234 CAGGAAAAACACAATGGACAAAGT
GGATGGGACAAACTGAAAAACC 
bp 54 before the fsrB 
stop codon 
This study 
OEF-235 TAGCCAACAAACGAATCACAACC bp 1020 after the (Sifri et al., 
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fsrB stop codon  2002) 
OEF-236 CTAAAAGTGATTGTTGATGTGC bp 639 upstream of 
the gelE start codon  
(Qin et al., 
2001) 
OEF-237 ATCAACAGTAACGCCTTCC bp 258 in gelE  (Qin et al., 
2001) 
OEF-238 GGAAGGCGTTACTGTTGATATTCA
GGTAAACCAACCAAGTG  
bp 45 upstream of 
the gelE stop codon 
This study 
OEF-239 GATTATTTGCCTTCTTTTCAGC  bp 1047 after gelE 
stop codon 
(Qin et al., 
2001) 
sprE_2 TCAAACAAACGAAACTGGC  1 761 697† This study 
sprE39 TGCCTTCTTTTCAGC  1 761 921 This study 
sprE_3 CATTCTTAAAACTTTCAGCCAC  1 762 591 This study 
gelE39 CAAGCTAAAACCGGC  1 762 832 This study 
msprE TAACTTTGATCGCCGG  1 762 858  This study 
gelE TCATTCATTGACCAG  1 762 961 This study 
sprE59 TGAATCTGTTCTGGTC  1 762 986  This study 
msprE_3 AAAGTTTGAATCTTCAGATACCC  1 763 120  This study 
msprE_2 AAAGTTTGAATCTTCAGATACCC  1 763 120  This study 
gelE_3 CAACACTCTGAGTATCCGCACC  1 763 362  This study 
mgelE_2 AACGGATAACACAGGGG  1 763 829  This study 
gelE_2 GTGTAAAGCAATTCCCG  1 763 831  This study 
mgelE_3 TCTTCGCCAACTGGTGACC  1 764 008  This study 
fsrC39 TTGCTTTATCCTCCC  1 764 545  This study 
mgelE AATATTTACGCAGGG  1 764 605  This study 
gelE59 TTGAGTTATGAGGGG  1 764 700  This study 
fsrC_3 TTTCTTTTTACATATAACAATCCCC  1 764 840  This study 
mfsrC_2 TGAAGAAACGATTGCACCAACC  1 765 263  This study 
fsrC_2 TTTATAATCATGACGAAACATCGC  1 765 328  This study 
mfsrC_3 TTTTTGTGTTTTTGATTTCGCC  1 765 573  This study 
fsrB39 AACATTAATGCCGC  1 765 917  This study 
mfsrC TTTGTTCGTTTGCGGC  1 765 942  This study 
fsrB GTCCAAATATATTGGGC  1 766 115  This study 
fsrC59 GACAATGGATGGGAC  1 766 118  This study 
fsrA3I TTCGCTTAACGTCCC  1 766 635  This study 
mfsrB TTGAAGAGGAGGGCG  1 766 814  This study 
fsrB59 TTACTTAGGGAGGG  1 766 893  This study 
fsrA_2 CTAGGAAAAAGATATTTAGTTGGG
C  
1 767 442  This study 
mfsrA ATGAGTGAACAAATGGC  1 767 638  This study 
fsrA59 GTTTTTGTTTGCAGG  1 767 788  This study 
mfsrA_2 CAAGAACAGTTTGGCGGTTG 1 767 908 This study 
*Sequences added for fusion PCR are underlined. 
†Position of the primer 5ʼ end in the V583 genome. 
 
G. mellonella mortality assay 
G. mellonella eggs were hatched at 25 ºC, and the larvae were 
reared on beeʼs wax and pollen (Naturalim) until the last instars which were 
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used for the infection experiments. Enterococcus strains were grown in 
M17BGlu and collected by centrifugation 1 h after they had reached 
stationary phase. Bacterial cells were washed with 0.9 % saline solution 
and stored as a dry, frozen pellet at -80 ºC. Before inoculation, the frozen 
bacterial pellet was suspended in 1 mL saline solution and serial dilutions 
were plated on M17AGlu plates in order to determine the bacterial count of 
the pellet. 
Groups of 20–30 G. mellonella larvae, starved for 24 h and 
weighing about 200 mg, were injected at the base of the last proleg with 
10 mL each bacterial inoculum (~2 × 108 cells/mL) using a microinjector 
(KDS 100; KD Scientific) with a 1 mL syringe and 0.45 × 12 mm needles 
(Terumo). A control group of larvae received saline solution only. The size 
of the inoculum was confirmed by determining the number of CFU on 
M17AGlu. Five infected larvae were kept per Petri dish, without food, at 
37 ºC and survival was monitored every 24 h for 2–5 days, depending on 
the experiment. Experiments were repeated at least three times. The 
mortality rate was compared using a two-tailed unpaired t-test at the 95 % 
confidence interval. Survival curves were constructed by the Kaplan–Meier 
method and compared by log-rank analysis (GraphPad Prism, version 4.0; 
GraphPad Software). P-values of < 0.05 were considered statistically 
significant. 
Sequence analysis of the fsr–gelE region of E. faecium QSE32 
PCR amplification of overlapping fragments of the fsr–gelE region 
was carried out using Expand High Fidelity DNA polymerase (Roche) and 
the primers indicated in Table 3.2. Sequencing was performed at 
Baseclear. The sequence was analysed using Vector NTI 10.3.0 
(Invitrogen) and the final DNA sequence, and the deduced protein 
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sequence were analysed using Vector NTI 10.3.0 (Invitrogen) and BLAST 
from the NCBI website (http://blast.ncbi.nlm.nih.gov/). 
Results 
Killing of G. mellonella by isolates of E. faecalis and other 
enterococcal strains 
Increasing interest in using G. mellonella as a surrogate model to 
study virulence of various microorganisms led us to compare virulence of 
enterococcal strains. We determined whether strains of enterococci other 
than E. faecalis GM could kill G. mellonella (Park et al., 2007). Mortality 
rates at 48 h post-infection are presented in Figure 3.1. All E. faecalis 
strains tested (LN68, V583, LSE4a, OG1RF and QA29b) were able to kill 
between 60 and 98 % of G. mellonella larvae with inocula of about 2 × 106 
CFU. The most virulent E. faecalis strains for G. mellonella were the clinical 
strain V583 and milk isolates LN68 and LSE4a. Maximum killing by LN68 
was reached within 24 h (data not shown), indicating that this isolate was 
more rapidly lethal for G. mellonella. The clinical strain OG1RF and the 
cheese isolate QA29b were significantly less virulent with ~72 and ~60 % 
killing after 48 h, respectively. Interestingly, E. durans strain QN1 and E. 
faecium strain QSE32 did not kill G. mellonella larvae significantly. These 
data show that E. faecalis strains from both clinical and food origin have the 
ability to kill G. mellonella larvae, whereas E. durans and E. faecium 
species seem to be avirulent or of low virulence for G. mellonella under the 
conditions used. 
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Figure 3.1. Killing of G. mellonella larvae by various enterococci isolates. 
Percentage mortality of G. mellonella larvae at 48 h post-infection with E. faecalis 
strains LN68 (2.07 × 106 ± 0.5 × 106 CFU), V583 (1.67 × 106 ± 0.06 × 106 CFU), 
LSE4a (2.45 × 106 ± 0.13 × 106 CFU), OG1RF (2.0 × 106 ± 0.2 × 106 CFU) and 
QA29b (2.07 × 106 ± 0.11 × 106 CFU), E. durans strain QN1 
(1.94 × 106 ± 0.19 × 106 CFU) and E. faecium strain QSE32 
(1.8 × 106 ± 0.1 × 106 CFU). Larvae were infected with ~2 × 106 bacteria as 
indicated in parentheses. Data were obtained from three independent experiments 
and are expressed as the mean values ± SD. Asterisks indicate a significant 
difference (** P < 0.005, *** P < 0.0005) relative to the LN68 strain. 
 
Gelatinase and Fsr affect E. faecalis virulence in G. mellonella 
We asked whether the G. mellonella model could discriminate 
between the roles of gelE and fsrB in virulence, using OG1RF and isogenic 
strains TX5264 and TX5266 (kindly provided by B. Murray) deleted for gelE 
and fsrB, respectively. Larvae were infected with ~2 × 106 CFU OG1RF, 
TX5264 and TX5266. As shown in Figure 3.2, the three strains have similar 
killing rates of G. mellonella at 48 h. However, killing was significantly 
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delayed for larvae injected with the ΔgelE strain (TX5264); 50 % of the 
larvae were dead after 24 h, compared to 80 % of those injected with 
OG1RF or TX5266 (P < 0.05). This result indicates that gelE, but not fsrB, 
contributes to OG1RF virulence in the G. mellonella infection model. 
To study the role of gelE and fsrB in the potential virulence of E. 
faecalis food isolates, we collected strains QA29b and LSE4a in two distant 
areas of cheese production in Portugal (Semedo et al., 2003; Lopes et al., 
2006). According to PFGE and MLST analysis, these two isolates are not 
genetically related (data not shown). Besides the fsrABDC and gelE-sprE 
operons, both strains carried the virulence genes agg, esp and efaAfs, 
none of which was haemolytic (results not shown). We successfully 
generated independent in-frame gelE and fsrB deletion mutants by allelic 
exchange in E. faecalis QA29b and LSE4a, as described by B. Murray and 
co-workers (Qin et al., 2001; Sifri et al., 2002). As expected, the resulting 
ΔfsrB and ΔgelE deletion mutants failed to produce detectable gelatinase in 
a standard plate assay (data not shown). Next, their virulence was 
examined using the G. mellonella infection model. As for OG1RF, 
inactivation of the gelE gene in the two strains significantly decreased 
killing of G. mellonella larvae; 65 and 32 % of larvae infected with the gelE 
mutants were dead after 48 h, compared to 88 and 60 % of those infected 
with LSE4a and QA29b, respectively (P < 0.05). Moreover, inactivation of 
fsrB in LSE4a and QA29b clearly reduced virulence compared to the 
isogenic wild-type (WT) strains (Figure 3.3). After 48 h post-infection, the 
QA29b ΔfsrB mutant killed 15 % of the G. mellonella larvae, versus 60 % 
killing by the isogenic WT strain. Thus, in contrast to results in OG1RF, fsrB 
appears to be implicated in infection by certain E. faecalis isolates. 
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Figure 3.2. Role of E. faecalis gelatinase in killing of G. mellonella larvae. Survival 
of G. mellonella after injection of E. faecalis strains OG1RF (2.1 × 106 CFU per 
larva), ΔgelE (TX5264, 1.89 × 106 CFU per larva) and ΔfsrB (TX5266, 
1.71 × 106 CFU per larva). Larva infection doses are indicated in parentheses. !, 
OG1RF;  !, ΔgelE; ", ΔfsrB. One representative experiment of three independent 
experiments is shown. 
 
 
Figure 3.3. Effects of gelE and fsrB inactivation on killing of G. mellonella. 
Percentage mortality of G. mellonella larvae at 48 h post-infection with E. faecalis 
strains LSE4a (2.45 × 106 ± 0.14 × 106 CFU), LSE4aΔgelE 
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(1.91 × 106 ± 0.02 × 106 CFU) and LSE4aΔfsrB (1.94 × 106 ± 0.49 × 106 CFU), 
QA29b (2.07 × 106 ± 0.11 × 106 CFU), QA29bΔgelE (2.32 × 106 ± 0.42 × 106 CFU) 
and QA29bΔfsrB (2.32 × 106 ± 0.29 × 106 CFU). Larvae were infected with 
~2 × 106 bacteria as indicated in parentheses. Data were obtained from three 
independent experiments and are expressed as mean values ± SD. Asterisks 
indicate a significant difference (* P < 0.05, ** P < 0.005) relative to the wild-type 
strain. 
 
Sequence analysis of the E. faecium QSE32 fsr–gelE region 
To check whether the low virulence of the E. faecium QS32 strain in 
G. mellonella could result from the absence of a functional Fsr system, we 
sequenced the entire fsr–gelE region of this strain. The gene organization 
was identical to E. faecalis V583, and the sequence shared 98 % identity at 
both the nucleotide and amino acid sequence level with gelE of E. faecalis 
V583 (data not shown). Therefore, we concluded that the Fsr system of E. 
faecium QS32 is most probably functional and that gelE conferred 
gelatinase activity. The low virulence of E. faecium QS32 seems to be 
independent of the functionality of the fsr–gelE region. 
Discussion 
Simple invertebrates, the nematode C. elegans and insects 
Drosophila melanogaster and G. mellonella have recently attracted interest 
as models for screening of virulence factors of pathogenic microbes, 
including E. faecalis, or for elucidating their effects in the host (Maadani et 
al., 2007; Park et al., 2007; Schneider et al., 2007). Although adaptive 
immunity is unique to vertebrates, the innate immune response seems to 
  
  
74 
be well conserved between vertebrates and invertebrates. In contrast to the 
nematode, which lacks the cellular immune response involved in 
phagocytosis of bacteria (Fares and Greenwald, 2001), insects have both 
cellular and humoral responses, making them attractive models to study 
bacteria–host interactions (Vallet-Gely et al., 2008). Although the G. 
mellonella infection model has been efficiently used to identify virulence 
factors in Gram-negative bacteria and in fungi (Xu et al., 1991; Cotter et al., 
2000; Brennan et al., 2002; Choi et al., 2002; Mylonakis et al., 2005; Schell 
et al., 2008), this model has been mainly used to characterize virulence 
factors in Bacillus cereus and Bacillus thuringiensis. These bacteria are 
virulent to G. mellonella by oral infection (Salamitou et al., 2000; Fedhila et 
al., 2006) and by injection into the haemocoel (Bouillaut et al., 2005). A 
recent study demonstrated killing of G. mellonella larvae by at least one E. 
faecalis strain isolated from larval cadavers (Park et al., 2007). In the 
present study, we used the G. mellonella model to compare virulence of 
several Enterococcus strains from food and clinical origins. Using this 
simple infection model, we demonstrated the efficacy of the G. mellonella 
model, and establish for the first time that gelatinase and Fsr virulence 
factors of E. faecalis contribute to the virulence of food isolates. 
E. durans and E. faecium strains were relatively avirulent or of low 
virulence, killing only 0–3 % of larvae, whereas E. faecalis strains had 
killing rates of 60–98 %. Although we used different strains of E. faecalis 
and E. faecium in this study, our results with G. mellonella correlate well 
with the C. elegans model, for which E. faecium strains were less virulent 
than E. faecalis strains (Garsin et al., 2001). 
Attenuated virulence of gelE-deficient E. faecalis strains in the G. 
mellonella infection model is consistent with results in mammal and 
nematode models (Qin et al., 2000; Sifri et al., 2002; Engelbert et al., 2004). 
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This result correlates with the recent finding that gelatinase degrades 
cecropin, an antimicrobial peptide important for the immune system in the 
haemolymph of larvae of G. mellonella (Park et al., 2007). 
Since inactivation of gelE does not abolish E. faecalis virulence, 
other factors might be involved in G. mellonella virulence. Although SprE 
protease is still expressed in gelE-inactivated strains, it does not seem to 
have insecticidal activity (Park et al., 2007). Based on the high genome 
diversity between E. faecalis isolates (Lepage et al., 2006; Bourgogne et 
al., 2008), it is likely that the strains used in this study carry other factors 
involved in virulence in G. mellonella or differentially express them. 
Interestingly, the OG1RF genome encodes a putative extracellular protease 
(OG1RF_0194), which remains to be characterized (Bourgogne et al., 
2008). 
The major regulatory system of gelatinase, the fsr operon, is among 
the most probable candidates to be involved in virulence in G. mellonella. 
While no significant difference in virulence was observed between larvae 
inoculated with the OG1RF and the fsrB isogenic mutant, we found that 
fsrB contributes to virulence in G. mellonella in the two food isolates 
studied. The result with OG1RFΔfsrB is in agreement with a previous study 
in which fsrB inactivation in OG1RF did not modify virulence in a rat 
endocarditis model (Singh et al., 2005). The authors proposed that residual 
production of gelatinase was sufficient to allow induction of endocarditis. In 
this case, however, residual gelatinase production would have had to be 
strongly induced in vivo, especially as virulence was evaluated at just 24 h 
post-infection. As proposed above, fsrB may directly or indirectly regulate 
other factors important for virulence in OG1RF. Since inactivation of fsrB in 
LSE4a and QA29b food isolates appears to be more relevant for virulence, 
we propose that OG1RF has additional factors that contribute to its 
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pathogenic potential, as suggested by its intrinsic virulence in a mouse 
peritonitis model (Bourgogne et al., 2008), or that these food isolates lack 
factors important for virulence in such a model. Taken together, present 
results and previous work suggest that the genetic background of the strain 
may be as important as the infection or host model used to assess 
virulence. Singh et al. (Singh et al., 2005) used an endocarditis model to 
demonstrate that a gelE sprE double mutant significantly decreased the 
evolution of endocarditis compared to infection by WT OG1RF; the fsrB 
mutant was not significantly attenuated compared to wild-type OG1RF. 
Using different models, i.e. rabbit endophthalmitis, mouse peritonitis, C. 
elegans and G. mellonella (this study), the fsrB mutant strain of OG1RF 
was more attenuated than the double protease mutant (Sifri et al., 2002; 
Engelbert et al., 2004). An important conclusion of this work is that the role 
of virulence genes studied in one model cannot always be extrapolated to 
other models. 
Transfer of virulence or antibiotic resistance genes has been 
observed in vitro (Eaton and Gasson, 2001) and in vivo (Mater et al., 2005; 
Lester et al., 2006). Although our finding does not preclude that 
enterococcal food isolates will be virulent in other infection or animal 
models or pathogenic for humans, it indicates the in vivo activity of the 
gelatinase and Fsr present in food isolates, and calls for surveillance in 
monitoring virulence traits in food strains which represent a potential 
reservoir for virulence genes. 
In summary, we used the G. mellonella infection model as a 
surrogate virulence model to compare virulence of three Enterococcus 
species, and E. faecalis isolates and isogenic deletion mutants. Our data 
show that fsrB and to a lesser extent gelE significantly contribute to the 
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virulence of E. faecalis food isolates. This simple animal model may provide 
insights for risk assessment of food isolates. 
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Abstract 
Enterococcus faecalis is a nosocomial opportunistic pathogen, but 
is also found in fermented food products where it plays a fundamental role 
in the fermentation process. Previously, we have described the non-starter 
E. faecalis cheese isolate QA29b as harbouring virulence genes and 
proven to be virulent in Galleria mellonella virulence model. In this study, 
we further characterized this food strain concerning traits relevant for the 
host-pathogen relationship. QA29b was found to belong to sequence type 
(ST) 72, a common ST among food isolates, and thus we consider it as a 
good representative of food E. faecalis strains. It demonstrated high ability 
to form biofilms, to adhere to epithelial cells and was readily eliminated by 
J774.A1 macrophage cells. Despite carrying the cps locus associated with 
the capsular polysaccharide CPS 2 type, cps genes were not expressed, 
likely due to an IS6770 insertion sequence existing in the cpsC-cpsK 
promoter region. This work constitutes the first study of traits important for 
interaction, colonization and infection in the host performed on a good 
representative of E. faecalis food isolates. Reported results stress the need 
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for a reliable serotyping assay of E. faecalis, as cps genotyping may not be 
reliable. Overall, QA29b characterization shows that despite its virulence 
potential in an insect model, this food strain is readily eliminated by 
mammalian macrophages. Thus, fine tuned approaches combining cellular 
and mammalian models are needed to address and elucidate the 
multifactorial aspect of virulence potential associated with food isolates. 
Introduction 
Enterococci are at the crossroad of food safety and while they are 
used as markers associated with faecal contamination they also have been 
ascribed a beneficial role in foods. In cheese, the presence of enterococcal 
flora affects taste, aroma, colour, structure, as well as the overall sensory 
profile (Giraffa, 2003), therefore contributing to the organoleptic 
characteristics of the full-ripened product (Gaspar et al., 2009). Bacteria 
from this genus belong to the non-starter flora (Aarestrup et al., 2002) that 
originates from raw milk and the environment, they proliferate among other 
bacteria which occur in the same environment, resist the manufacturing 
processes involved in cheese making and can therefore be found in the 
final product (Fortina et al., 2008). Using food as a vehicle, and having the 
ability to survive the harsh conditions in the stomach, enterococci gain 
access to the gastrointestinal tract (Magalhaes et al., 2007), and therefore 
interact with the host and the microbiota already present. 
While harmless in healthy individuals, some enterococcal isolates 
may become pathogenic in hospitalized patients in intensive care units and 
with impaired immune systems. They are capable of causing opportunistic 
infections, including bacteraemia, endocarditis, meningitis, and wound, 
urinary tract and nosocomial bloodstream infections. This has been 
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associated with a variety of virulence factors carried by enterococci 
(Gaspar et al., 2009), particularly by Enterococcus faecalis. About a dozen 
of these putative virulence traits have been reported from virulence 
analyses in various animal models. They are involved in attachment both to 
host cells and to extracellular matrix proteins (AS, Esp, EfaA), in resistance 
to macrophages (AS, HypR), in cell and tissue damage (Cyl, GelE, SprE) 
and in immune system evasion (capsular polysaccharides) (Ogier and 
Serror, 2008). Encapsulated strains of serotype C or D are more resistant 
to complement-mediated opsonophagocytosis (Hufnagel et al., 2005; 
Thurlow, Thomas, Fleming, and Hancock, 2009). Serodiversity between 
serotype C and D isolates is attributed to the presence or absence of the 
putative glycosyltransferase encoded by cpsF gene of the nine-genes 
capsule-encoding cps locus (cpsC-cpsK), respectively (Hufnagel, Hancock, 
Koch, Theilacker, Gilmore, and Huebner, 2004; Thurlow, Thomas, and 
Hancock, 2009). The cognate loci with or without cpsF correspond to cps 
type 2 (cps2) and type 5 (cps5), respectively. Recent studies, indicate that 
cps2 isolates are associated with an enrichment of virulence traits 
suggesting that cps2 isolates may be more prone to survive and/or colonize 
hospitalized patients (McBride et al., 2007). In particular, ST6 E. faecalis 
isolates of the high-risk enterococcal clonal complex (CC) 2 predominate 
among hospital acquired isolates; they seem to be uniformly of CPS2 type 
(McBride et al., 2007). That is the case of E. faecalis V583 isolated from a 
patient suffering from a persistent bloodstream infection. It was the first 
vancomycin-resistant clinical isolate reported in the United States (Sahm et 
al., 1989). This isolate is a good reference as clinical strain causing human 
infections. 
Numerous studies report that enterococcal food strains carry and 
express virulence determinants (Franz et al., 2003; Foulquié Moreno et al., 
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2006; Ogier and Serror, 2008). We have recently described the non-starter 
E. faecalis QA29b strain isolated from raw milk traditional Portuguese 
eweʼs cheese as being able to express some virulence traits in G. 
mellonella insect model (Gaspar et al., 2009) and the Caenorhabditis 
elegans nematode model (unpublished data). Even if the presence of non-
starter enterococcal flora is advantageous for the processes of 
fermentation, preservation and maturation of food products, the association 
of this genus with nosocomial infections indicates the requirement of a risk 
assessment for the presence of these strains in food.  
In this study we were interested in further characterizing the non-
starter E. faecalis food isolate QA29b, regarding gene content and traits 
involved in host recognition, adhesion and survival, using vancomycin-
resistant E. faecalis CC2 clinical isolate V583, and itʼs cured derivative 
VE14089, as a reference.  
Material and Methods 
Bacterial strains and culture conditions 
Bacterial strains used in this study are listed in Table 4.1. VE14089 
strain is a derivative of V583 strain and was used in assays with animal 
cells, instead of V583, because it is gentamicin sensitive. 
For biofilm assay experiments strains were grown for 16 h in 2×YT 
(BD, Franklin Lakes, NJ) supplemented with 0.5 % glucose (2×YTGlu) 
broth, at 37 °C, and the culture was subsequently diluted 1:100 (v/v) in pre-
warmed to 37 ºC 2×YT broth. For reverse transcription PCR (RT-PCR) 
experiments the strains were inoculated in 5 mL 2×YTGlu broth and grown 
for 16 h without shaking at 37 ºC. The culture was then diluted 100 times in 
pre-warmed to 37 ºC 2×YTGlu medium and incubated at 37 ºC until 
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reaching mid exponential phase (optical density (OD) at 600 nm of 
approximately 0.5). A sample from this culture was washed twice in 
phosphate-buffered saline (PBS) (pH 7.4) (Gibco, Life Technologies, 
Carlsbad, CA) and resuspended in one tenth of its initial volume. The 
washed bacterial culture was diluted 50 times and incubated for 1 h at 
37 ºC in two different conditions: 2×YT and 2×YTGlu. 
Table 4.1. E. faecalis strains used in this study. 
Strains Relevant characteristics Reference or source 
QA29b Isolated from a Portuguese cheese; fsrABDC+, 
gelEsprE+, agg+, esp+ and efaAfs+; Cyl-, Gel+ 
(Gaspar et al., 2009) 
V583 Sequenced strain containing PAI and plasmids 
pTEF1, pTEF2, and pTEF3 
(Sahm et al., 1989) 
VE14089 Plasmid-free derivative of V583; EryS, GenS (Rigottier-Gois et al., 2011) 
 
Multi-locus sequence typing (MLST) 
MLST was performed by amplifying and sequencing the internal 
regions of seven housekeeping genes gdh, gyd, pstS, gki, aroE, xpt and 
yqiL, as described (http://efaecalis.mlst.net). The allele number for each 
gene was assigned based on the E. faecalis MLST database. The 
combination of the allelic sequences for the seven genes yielded the allelic 
profile and the corresponding ST for QA29b isolate. 
Macroarray 
The macroarray was constructed, performed and analysed as 
described by Lepage et al. (Lepage et al., 2006). A set of 308 additional 
probes were added to the previously 202 described probes, making a total 
of 506 and 4 chromosomal gene probes from V583 and MMH594, 
respectively, that were used for the screening of QA29b genome. MMH594 
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is an E. faecalis blood isolate carrying the E. faecalis pathogenicity island 
(Huycke and Gilmore, 1995; Shankar et al., 2002). 
CPS type polymorphism determination by PCR 
The CPS type polymorphism was determined by PCR, in a total 
volume of 20 μL with 100 ng of genomic DNA, extracted as previously 
described (Fouet and Sonenshein, 1990), and using primers cpsE1 (5ʼ - 
GTGTTGTCATGCCGATTCACAATGC - 3ʼ) and cpsG2 (5ʼ - 
CTGCTGGACCACCAACAAAATTCG - 3ʼ). The PCR was performed using 
a thermostable DyNAzyme™ II DNA Polymerase (Finnzymes, Vantaa, 
Finland) and the conditions recommended by the manufacturer. The 
thermal cycling parameters were adapted in order to amplify the 4069 bp 
PCR product.  
Adherence assay 
The ability of E. faecalis strains VE14089 and QA29b to adhere to 
Caco-2 cells was determined as previously described (Olier et al., 2003), 
with minor modification. On 24-well tissue-culture plates, an almost 
confluent monolayer of Caco-2 cells was infected with an E. faecalis 
bacterial suspension, with a corresponding multiplicity of infection (MOI) of 
~50. Adhesion of E. faecalis cells to Caco-2 cells was allowed to occur for 
2 h at 37 °C. Cells were then washed with PBS and adherent bacteria were 
harvested after lysis of the cell monolayers with Triton X-100 and suitable 
dilutions of the lysates were plated. The plates were subsequently 
incubated for 24-48 h at 37 ºC and colony forming unit (CFU) values for 
viable bacteria were determined. 
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Adherence assays were done in duplicate, and the overall 
significance of the differences was determined by a two-tailed unpaired t-
test. 
Biofilm assay on polystyrene microtiter plates 
Biofilm formation on polystyrene was quantified with crystal violet 
staining method as previously described (Thomas et al., 2009). 200 μL of 
the diluted cell suspension was used to inoculate sterile 96-well polystyrene 
microtiter plates (Sarstedt, Nümbrecht, Germany). Biofilms were processed 
after 24 h incubation at 37 ºC, as described above. Each assay was 
performed in quintuplicate, repeated three times, and the overall 
significance of the differences was determined by a two-tailed unpaired t-
test. All experiments included a blank well (medium without any inoculum). 
Macrophage Survival Assay 
The macrophage survival assay was mainly performed as described 
by Bennett et al. (Bennett et al., 2007) with some modifications. Confluent 
J774.A1 (mouse monocytes - macrophages) monolayers were infected with 
an overnight bacterial culture. Approximately 4 × 106 bacteria were added 
to J774.A1 monolayers, to yield a MOI of approximately 10, and were 
incubated at 37 °C in 5 % CO2 atmosphere for 1 h to allow bacterial 
adherence and entry, after which gentamicin (250 μg/mL) was added to the 
cultures to kill extracellular bacteria. At various time points after infection, 
1 % Triton X-100 in PBS was used to lyse cells. Lysates were then serially 
diluted and inoculated on BHI plates to enumerate viable intracellular 
bacteria. The assays were performed 5 times and results are reported as 
intracellular Survival Index (SI), i.e. the per cent (mean) of the internalized 
CFUs at each analysed time post-infection that survived after phagocytosis. 
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RT-PCR of cps locus 
For each studied condition, culture samples for RNA isolation were 
collected and processed accordingly. Immediate RNA sample stabilization 
and protection was achieved using the RNAprotect Bacteria Reagent 
(Qiagen, Hilden, Germany), total RNA purification was performed using the 
RNeasy Mini Kit (Qiagen, Hilden, Germany), DNA digestions were 
executed after RNA isolation using DNase I recombinant, RNase-free 
(Roche Applied Science, Penzberg, Germany), and final RNA clean-up and 
concentration was carried out with RNeasy MinElute Cleanup Kit (Qiagen, 
Hilden, Germany), all according to the manufacturerʼs instructions. The 
integrity and overall quality of the total RNA preparations was evaluated by 
native agarose gel electrophoresis and their corresponding RNA 
concentration was measured using a NanoDrop spectrophotometer 
(NanoDrop Technologies, Inc.). 
cDNA was synthesized using Transcriptor High Fidelity cDNA 
Synthesis Kit (Roche Applied Science, Penzberg, Germany) according to 
the standard procedure for qualitative RT-PCR from the manufacturer's 
instructions. Specificity and efficiency for the primer pair (5ʼ-
GATGTTGTCCGTTGTAATTGG-3ʼ) (5ʼ-CCACATTTCTTGCGTGTCC-3ʼ) 
were confirmed by amplifying an internal gene fragment of 852 bp of the 
cpsE gene (ef2491) on genomic DNA. cDNA solutions were added to PCR 
reactions, which were performed using a thermostable DyNAzyme™ II DNA 
Polymerase (Finnzymes, Vantaa, Finland), using conditions recommended 
by the manufacturer. The previously described MLST housekeeping gene 
gdh and gyd were used as positive control (http://efaecalis.mlst.net). 
For each condition, the qualitative RT-PCR tests were 
independently performed twice and showed similar results. 
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Sequencing 
The region between cdsA and cpsC genes, which encompasses the 
cpsC-cpsK promoter, was amplified from QA29b DNA, using the primer pair 
(5ʼ- CTGAGCTCTTGGCATCAACC-3ʼ) (5ʼ-TATGGCGTGAAAGACTCTGG-
3ʼ). Based on V583 genome sequence, the expected size for this amplicon 
was 865 bp. For QA29b we obtained an amplicon with 1933 bp, which we 
sequenced (STAB Vida, Portugal) using primer walking. Sequence is 
deposited in GenBank under the accession number JX119099. 
Results 
MLST typing, gene content and cps typing 
The combination of the allelic sequences for the seven 
housekeeping genes in QA29b yielded the allelic profile, which 
corresponded to the ST72. This ST is closely related with 162, 168 and 
196, differing only by one allele type, and belonging to the CC72. MLST 
typing of QA29b thus shows that it is clonally distinct from V583, which 
belongs to the ST6 and to the CC2 (differing in all alleles of the seven 
housekeeping genes). 
Gene content of QA29b was evaluated by comparative genome 
hybridization (CGH) using a macroarray, which covered approximately 
16 % of the whole V583 chromosomal genome with gene probes scattered 
around the chromosome (Figure 4.1). More than 30 % of the V583 
chromosomal genes probed were missing from QA29b genome. They 
included 51 genes that were recently reported as CC2-enriched (Solheim et 
al., 2011). With the exception of prophage 4 genes, which were present in 
QA29b, 80 % of the absent genes were localized in mobile genetic 
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elements predicted in V583 genome (Lepage et al., 2006). Of the 115 core 
variable genes probed as defined by Solheim et al. (Solheim et al., 2009), 
30 were absent in QA29b. They comprised genes ef2164, ef2166, ef2168, 
ef2169, ef2172, ef2174, ef2175, ef2176 located downstream of the 
enterococcal polysaccharide antigen gene (epa) cluster, the 
rhamnopolysaccharide biosynthesis operon, which encode predicted 
functions involved in polysaccharides biosynthesis. 
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Figure 4.1. CGH analysis of QA29b strain. The genes are ordered according to the 
organization of the V583 genome. Black and white bars indicate present and 
absent genes, respectively. The mobile genomic elements and regions are 
indicated at the top. Genes located in the cps locus and epa region are displayed 
on the left. 
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CGH data indicated that QA29b carries the full-length cps locus 
(ef2487 to ef2492). This result was confirmed by PCR using primers cpsE1 
and cpsG2 that were designed to amplify the region between cpsE (ef2491) 
and cpsG (ef2489), to detect the presence of cpsF (ef2490), which 
distinguishes cps2 and cps5 loci. Detection of an amplification product of 
4069 bp for QA29b strain and V583 used as positive control confirmed the 
presence of cpsE and cpsG genes along with cpsF gene. Accordingly to 
this result QA29b carries a cps 2 locus associated with serotype C (Thurlow 
et al., 2009). 
Biofilm assay on polystyrene microtiter plates 
Ability to form biofilm on a polystyrene surface was quantified 
(Figure 4.2). For the same conditions used to quantify the biofilm production 
of the E. faecalis clinical strain, QA29b exhibited an increased ability to 
form biofilm. The observed differences between the two strains were not a 
result of growth differences as both strains displayed similar growth curves 
(data not shown). 
Adherence assay 
Since enterococci are normal commensals of the gastrointestinal 
tract, the ability to adhere to Caco-2 cells (a human colon carcinoma cell 
line) was investigated. For this purpose, we compared adhesion of strain 
QA29b and strain VE14089, a plasmid-cured derivative of V583 clinical 
strain that allows gentamicin protection assay. Figure 4.3 shows that 
attachment of QA29b to Caco-2 cells was three times higher than the 
clinical isolate derivative VE14089. 
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Figure 4.2. Biofilm formation on polystyrene. The quantification of biofilm formation 
was assayed as a function of crystal violet stain (measured at 595 nm) retained by 
the biofilm biomass grown for 24 h. Data are mean of two independent hexuplicate 
trials, and error bars indicate standard deviations. *, significant P values of less 
than 0.05 relative to V583, determined using a two-tailed unpaired t-test. 
 
Figure 4.3. QA29b and VE14089 adhesion to Caco-2 cells. The results are 
presented as per cent adhesion ± standard deviation. *, significant P values of less 
than 0.05 relative to VE14089, determined using a two-tailed unpaired t-test. 
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Macrophage Survival Assay 
Phagocytosis and survival of QA29b were evaluated in murine 
J774-A1 macrophage-like cell line. As shown in Table 4.2, uptake of 
bacteria of strain VE14089 was almost 4 fold lower than uptake of QA29b 
at a comparable multiplicity of infection. This result indicates that bacteria of 
strain QA29b are more efficiently internalized by macrophages. A time 
course study of bacterial survival inside macrophages (Figure 4.4) showed 
a significant decrease of QA29b viability compared to VE14089. Altogether 
these data show that QA29b is more efficiently internalized by murine 
macrophages and has a higher susceptibility to macrophage bactericidal 
activity than the clinical strain. 
 
Figure 4.4. Time course of intracellular survival of QA29b and VE14089 strains 
within murine J774A.1 macrophages. Results correspond to the per cent means ± 
standard deviations of intracellular Survival Index (SI) determined at 0, 4, 8 and 
24 h post-killing of external bacteria (grey bars: VE14089; white bars: QA29b). 0 h 
post-killing corresponds to 2 h post-infection, so time points mentioned in the figure 
correspond to 2, 6, 10 and 26 h post-infection; asterisks indicate a significant 
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difference (* P < 0.05, ** P < 0.005) relative to VE14089 for each time point, 
determined using a two-tailed unpaired t-test. 
 
Table 4.2. Macrophage Survival Assay: MOI, uptake percentage at 0 h of infection, 
and standard deviation values. 
Strain MOI (± SD) % Uptake (± SD) 
QA29b 12.0 (± 0.4) 24.1 (± 3.8) 
VE14089 14.3 (± 0.8) 6.3 (± 0.9) 
 
Expression of the cps locus 
As described by (Hancock et al., 2003), the expression of the large 
transcript that encompasses the cpsC to -K genes, is controlled by one 
promoter. The screening for the presence of an internal fragment of the 
cpsE gene would therefore allow the detection of the presence of the 
transcript, which codes for the cps locus. The cps transcript was detected 
for V583 strain, regardless of the growth conditions. In contrast to the 
clinical isolate, no amplification product was detected in the dairy strain 
QA29b in any of the tested conditions (data not shown). This indicates that 
for the two different media used no detectable amount of the cps transcript 
was present, suggesting the absence of a capsule formed from the 
expression of cps locus. Indeed, sequencing of the cpsC-cpsK promoter 
region revealed a 1068bp insertion, identified by BLAST as an IS6770 of 
the IS30 family (Thorisdottir et al., 1994). This insertion was located 
between the RBS and the predicted -10 and -35 positions (Hancock et al., 
2003), and explains the fact that we did not detect expression of the cps 
genes in QA29b strain. 
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Discussion 
E. faecalis QA29b is a previously studied non-starter lactic acid 
bacteria, which harbours several known virulence traits, and was proven to 
be virulent in non-mammalian virulence models. In the present study, 
QA29b was further characterized genetically and regarding traits involved 
in the interaction with the host in order to enable the risk assessment 
associated with its presence in food. QA29b belongs to CC72, which, 
according to the MLST database, includes other dairy food isolates. 
Although few CC72 hospital-associated isolates were reported they are not 
the most prevalent (Willems et al., 2011). Large-scale genomic comparison 
with V583 chromosomal genes, used as a clinical reference strain, 
established that QA29b lacks many of the genetic mobile elements of 
V583, including the pathogenicity island. Moreover, QA29b lacks also most 
of the CC2-enriched genes probed. Compared to the reference strain, 
QA29b had increased ability to form biofilm, to adhere to epithelial cells and 
to be engulfed by macrophages. Inversely, QA29b is unable to survive in 
J774.A1 macrophages and shows no expression of the cps genes. 
The most abundant E. faecalis exopolysaccharides are the 
enterococcal polysaccharide antigen (EPA) and the serotype-determining 
CPS. They both seem to play an important role in enterococcal 
pathogenicity. Disruption of the epa locus decreased biofilm formation, 
survival in polymorphonuclear leukocytes, translocation across human-
derived enterocytes and reduced virulence (Xu et al., 1998; Teng, Jacques-
Palaz, Weinstock, and Murray, 2002; Zeng et al., 2004; Mohamed and 
Huang, 2007; Singh et al., 2009). E. faecalis CPS contributes to resistance 
to complement-mediated opsonophagocytosis (Thurlow, Thomas, Fleming, 
and Hancock, 2009), but there is no knowledge on its effect upon survival 
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inside macrophages. Comparative genomics indicates that QA29b lacks 
V583 genes located downstream the epa operon, which could contribute to 
EPA biosynthesis (Rigottier-Gois et al., 2011). In contrast, like V583, 
QA29b carries the full-length cps2 locus. According to Thurlow et al. 
(Thurlow, Thomas, and Hancock, 2009) who established a correlation 
between E. faecalis serotypes and the cps locus polymorphism, QA29b is 
expected to belong to serotype C. However, in contrast to V583, QA29b 
isolate did not express detectable amounts of the transcripts corresponding 
to the cps cluster in the conditions tested, raising the question of its 
serotype and moreover of the CPS-related traits. Indeed, lack of CPS could 
explain efficient internalization of QA29b by macrophages, adhesion to 
epithelial cells and increased biofilm formation. Like proposed for 
opsonophagocytosis (Thurlow, Thomas, Fleming, and Hancock, 2009), 
absence of the capsule could make other bacterial cell surface ligands 
more accessible for recognition by either macrophages or epithelial cells. 
This is in agreement with the findings of Soriani et al. (Soriani et al., 2006) 
that state that in group B Streptococcus infections of Caco-2 cells, the 
absence of capsule led to better adhesion to cells and, consequently, to an 
increased capacity to invade them. Previous studies showed that the 
expression of the cps locus is regulated in order to modulate the presence 
of polysaccharide antigens during colonization or infection (Corcionivoschi 
et al., 2009; Vebø et al., 2009). Absence of expression of the cps locus 
could allow optimal adherence to host cells. 
E. faecalis isolates were reported resistant to killing by mouse 
peritoneal macrophages (Gentry-Weeks et al., 1999; Verneuil et al., 2005). 
However, QA29b strain was particularly sensitive to killing by J774.A1 
macrophages. Although the role of the cps locus in E. faecalis survival 
inside macrophages has not been investigated, it would be tempting to 
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speculate that absence of expression of cps locus could contribute to 
QA29b sensitivity to macrophages. E. faecalis survival mechanisms inside 
macrophages have not been elucidated; however oxidative stress response 
and EPA synthesis appear to be important (Brinster, Posteraro, Bierne, 
Alberti, Makhzami, Sanguinetti, and Serror, 2007). They both could 
contribute to QA29b sensitivity to macrophages. 
The results of this work illustrate for the first time that the mere 
presence of cps genes, associated with virulence, is not sufficient to predict 
the corresponding phenotype. Although this fact has been previously 
established on other genes (Shepard and Gilmore, 2002; Hew et al., 2007; 
Carlos et al., 2010), our results on the cps locus highlight the need to 
improve and deepen the knowledge on enterococci serotypes, as CPS 2 
type may not necessarily be expressed in a cps 2 genotype. It would be 
interesting to determine if silencing of cps 2 genes also applies in clinical 
isolates. Overall, even if the presence of virulence-associated genes in food 
isolates has to be evaluated, their expression and cognate phenotypic traits 
have to be considered for accurate safety assessment. Moreover, the two 
strains studied in this work have different genetic backgrounds. If, on the 
one hand, this may explain phenotypic differences, on the other hand, it 
highlights the importance of gathering more genetic and functional data on 
genetically related strains from different origins. 
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Abstract 
Interspecies communication may influence community structure and 
function. That is likely true in the gut, which contains a complex collection of 
bacterial species. Autoinducer-2 (AI-2)-mediated quorum sensing (QS) has 
been extensively studied in relation to the regulation of microbial behaviour 
and has been recognized as an interspecies communication molecule. Its 
synthase, LuxS, is an enzyme in the activated methyl cycle (AMC) that 
catalyses the conversion of S-ribosylhomocysteine (SRH) to homocysteine. 
The by-product of the reaction catalysed by LuxS is (S)-4,5-dihydroxy-2,3-
pentanedione (DPD), which spontaneously forms the furanones known 
collectively as AI-2. Despite belonging to the normal microbiota of the 
gastrointestinal (GI) tract of hosts ranging from mammals to insects, 
Enterococcus faecalis remains an important opportunistic pathogen and 
represents one of the main causes of nosocomial infections in the USA and 
Europe. E. faecalis VE14089, a plasmid-cured derivative of E. faecalis 
V583, harbours the luxS gene. This work was thus designed to check for 
the ability of VE14089 to produce AI-2, understand the role of both AI-2 and 
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LuxS in the biology of E. faecalis, and evaluate its ability to relate with the 
host. The role of LuxS in E. faecalis VE14089 has been examined by 
phenotypic experiments and transcriptomic profiling. VE14089 was found to 
produce AI-2 through the activity of LuxS protein. When compared with the 
wild type (WT), the luxS mutant had no apparent phenotype regarding 
growth, biofilm formation, adhesion to Caco-2 cells, resistance to oxidative 
stress and survival in a macrophage survival assay. However, microarray 
comparison of gene expression revealed that the luxS mutation caused 
pleiotropic effects in gene expression, which could not be complemented by 
extracellular AI-2 addition. These global differences in gene expression 
affected several gene functional roles, namely energy, DNA, fatty acid and 
intermediary metabolites metabolism, transport and regulatory functions, 
cell envelope, and hypothetical and unknown function proteins. This study 
shows that differential gene expression related to the luxS mutation cannot 
be ascribed to quorum sensing (QS) and that the role of LuxS appears to 
be limited to metabolism. 
Introduction 
Despite a dozen putative virulence factors having been reported 
from virulence analyses in various animal models, they are not exclusive to 
clinical strains and, per se, are not accountable for understanding the 
opportunistic behaviour of Enterococcus faecalis. 
E. faecalis belong to the normal microbiota of the GI tract of hosts 
ranging from mammals to insects (Brinster, Posteraro, Bierne, Alberti, 
Makhzami, Sanguinetti, and Serror, 2007). They are also found in a variety 
of food products, namely milk and cheese produced in the south of Europe 
(Ogier and Serror, 2008). However, E. faecalis remains an important 
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opportunistic pathogen and represents one of the main causes of 
nosocomial infections in the USA and Europe. Especially for 
immunocompromised patients, these infections include endocarditis, 
meningitis, pneumonia, peritonitis, visceral abscesses, urinary infections or 
septicaemia (Lebreton et al., 2009). 
Pathogenic bacteria produce virulence factors when they sense they 
are in a location in which the energy required for pathogenesis is 
warranted. One environmental factor monitored by pathogens is population 
density, either of its own population or of the population of a host's 
endogenous flora (Parker and Sperandio, 2009). 
Intercellular communication is not the exception but, rather, the 
norm in the bacterial world. The process of sensing population density, 
called QS, is fundamental to coordinate certain behaviours of microbes. 
As a population of QS bacteria grows, a proportional increase in the 
extracellular concentration of the signalling molecule occurs. When a 
threshold concentration is reached, the group detects the signalling 
molecule and responds to it with a population-wide alteration in gene 
expression. Processes controlled by QS are usually the ones that are 
unproductive when undertaken by an individual bacterium but become 
effective when undertaken by the group (Bassler and Losick, 2006). QS has 
been shown to regulate a variety of functions, including symbiosis, 
virulence, competence, motility, sporulation, mating, conjugation, antibiotic 
production, and biofilm formation (Zhu and Pei, 2008). 
The small molecules that are produced, released and detected, and 
which mediate QS are called autoinducers (Zhu and Pei, 2008). Most 
autoinducers are species specific; however, one autoinducer, AI-2, and its 
synthase, LuxS, have been identified in many bacteria, (Pereira et al., 
2008) and implicated in the regulation of many bacterial behaviours 
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including biofilm formation, competence, the production of secondary 
metabolites like antibiotics, and virulence. While in some cases, AI-2 is 
clearly acting through a canonical QS mechanism, in others a possibly 
primary and sometimes sole role in central metabolism has been proposed 
(Pereira et al., 2009). 
LuxS protein is an integral metabolic component of the AMC (Figure 
5.8). The AMC is a key metabolic pathway that generates S-
adenosylmethionine (SAM) as an intermediate product. SAM bears a 
methyl group with a relatively high transfer potential, and is used by 
numerous methyltransferases to carry out cellular processes including 
nucleic acid and protein methylation, and detoxification of reactive 
metabolites. The product of the methyltransferase reaction is S-
adenosylhomocysteine (SAH), and in the complete AMC, SAM is 
regenerated from SAH via homocysteine and methionine, ready for another 
round of methylation/transmethylation. The role of LuxS in the AMC is to 
catalyse the cleavage of SRH to yield homocysteine and a by-product DPD. 
DPD is the precursor of the family of related, inter-converting molecules 
collectively termed ʻAI-2ʼ (Doherty et al., 2010). A gene, annotated as luxS, 
is also present in the genome of E. faecalis V583, the first vancomycin-
resistant clinical isolate reported in the United States (Sahm et al., 1989) to 
be fully sequenced. 
In this study we investigated the production of AI-2 in E. faecalis, 
determined E. faecalis ability to sense the extracellular presence of AI-2, 
and explored the role of LuxS in the bacterial cell and in its interaction with 
the host.  
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Materials and Methods 
Bacterial strains and general culture conditions 
Bacterial strains used in this study are listed in Table 5.1. 
Enterococci were grown in M17 broth (BD, Franklin Lakes, NJ) 
supplemented with 0.5 % (w/v) glucose (M17Glu) or M17Glu agar at 37 ºC, 
unless stated otherwise. Escherichia coli strains were grown in Luria–
Bertani (LB) broth or on LB agar at 37 ºC. Antibiotics were used at the 
following concentrations: erythromycin, 30 μg/mL for E. faecalis and 
150 μg/ml for E. coli; ampicillin, 80 mg/ml. 
Table 5.1. Strains used in this study 
Strains Relevant Characteristics Reference or Source 
E. coli 
 
  
DH5α F- Φ80dlacZΔM15 Δ(lacZYA-argF)U169 deoR 
recA1 endA1 hsdR17(rK- mK+) phoA supE44 λ- 
thi-1 gyrA96 relA1 
(Grant et al., 1990) 
TG1 repA supE hsdD5 thi (Δlac-proAB) F- (traD36 
proAB-lacZΔM15) repA 
(Law et al., 1995) 
 
E. faecalis 
 
  
V583 Sequenced strain containing PAI and plasmids 
pTEF1, pTEF2, and pTEF3 
(Sahm et al., 1989) 
VE14089 Plasmid-free derivative of V583; EryS, GenS (Rigottier-Gois et al., 
2011) 
VE14089ΔluxS VE14089 with luxS in-frame deletion This study 
QA29b Isolated from a Portuguese cheese; fsrABDC+, 
gelE-sprE+, agg+, esp+ and efaAfs+; Cyl-, Gel+ 
(Gaspar et al., 2009) 
 
General DNA techniques 
General molecular biology techniques were performed by standard 
methods (Sambrook et al., 1989). Restriction enzymes, polymerases and 
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T4 DNA ligase were used according to manufacturerʼs instructions. PCR 
amplification was performed using a thermocycler (Biometra GmbH, 
Goettingen  , Germany). When necessary, PCR products and DNA 
restriction fragments were purified with QIAquick purification kits (Qiagen, 
Hilden, Germany). Plasmids were purified using the QIAprep Spin Miniprep 
kit (Qiagen, Hilden, Germany). Electrotransformation of E. coli and E. 
faecalis was carried out as described by Dower et al. (Dower et al., 1988) 
and Dunny et al. (Dunny et al., 1991), using a Gene Pulser apparatus (Bio-
Rad Laboratories, Hercules, CA). Genomic DNA fragments and plasmid 
inserts were sequenced at Baseclear (Netherlands). 
Construction of in-frame luxS deletion mutant in strain VE14089 
Markerless luxS deletion mutant of E. faecalis strain VE14089 was 
constructed essentially as described by Gaspar et al. (Gaspar et al., 2009). 
Briefly, 5ʼ and 3ʼ flanking regions of luxS were amplified from chromosomal 
DNA of each strain by PCR with primers luxS1, luxS2, luxS3, and luxS4 
(Table 5.2). The two cognate PCR fragments were fused by PCR using the 
external primers luxS1 and luxS4, and the resulting product was cloned into 
pGEM-T (Promega Corporation, Fitchburg, WI). The inserted PCR fragment 
was removed from its cloning vector by restriction enzymes and 
subsequently cloned into pG+host9 plasmid (Maguin et al., 1996), which 
was then electroporated into E. faecalis. The luxS single- and double- 
crossover mutants were selected as described by Brinster et al. (Brinster, 
Furlan, and Serror, 2007). Successful targeted mutations of luxS in strains 
VE14089 was first identified by PCR screening and then confirmed by 
Southern blot analysis. 
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Table 5.2. Primers used in this study 
primer 
name 
sequence (5ʼ-3ʼ) position of the 
primer 5ʼ end 
Reference 
luxS1 TCAATCAACCTTTGCTGACG bp 1011 after the 
luxS stop codon 
This study 
luxS2 ATTAGTTTAGATCCATTTGAACG bp 33 before the 
luxS stop codon 
This study 
luxS3 CGTTCAAATGGATCTAAACTAATTTC
AAAACTTTCTACGCGTGC* 
bp 24 in luxS This study 
luxS4 AGGTGGCAACGACTTTTAGC bp 936 upstream of 
the luxS start codon 
This study 
luxS_seq TTACCCATCAAAGGACTATCC bp 64 upstream of 
the luxS start codon 
This study 
*Sequences added for fusion PCR are underlined. 
Quantification of AI-2 
To monitor extracellular AI-2 activity in cell cultures during growth, 
aliquots were collected at the indicated times and cell-free culture fluids 
were prepared by filtration of liquid cultures and then analysed for AI-2 
activity. AI-2 quantification was done using a LuxP-FRET-based reporter 
(FRET — fluorescence resonance energy transfer), as established by 
Rajmani et al. (Rajamani et al., 2007) and optimized for 96-well plate 
reading by Marques et al. (Marques et al., 2011). The binding of AI-2 to the 
CFP-LuxP-YFP chimeric protein causes a dose-dependent decrease in the 
FRET signal, and concentration can be determined by comparing the FRET 
ratios (527 nm/485 nm) of each sample with a calibration curve performed 
with AI-2 samples of known concentration (Figure 5.3A). Concentrations 
between 1 and 60 μM DPD (Omm Scientific, Inc., Dallas, TX) were used for 
the calibration curve, corresponding to the linear range of this assay. All 
assays were performed in duplicate. 
  
 
114 
Biofilm assay on polystyrene microtiter plates 
Biofilm formation on polystyrene was quantified with crystal violet 
staining method as previously described (Thomas et al., 2009). Briefly, 
strains were grown for 16 h in 2×YT (BD, Franklin Lakes, NJ) 
supplemented with 0.5 % glucose (2×YTGlu) broth, at 37 °C, and the 
culture was subsequently diluted 1:100 (v/v) in pre-warmed to 37 ºC 2×YT 
broth. 200 μL of the diluted cell suspension was used to inoculate sterile 
96-well polystyrene microtiter plates (Sarstedt, Nümbrecht, Germany). 
Biofilms were processed after 24 h incubation at 37 ºC, as described 
above. Each assay was performed in hexuplicate, repeated twice, and the 
overall significance of the differences was determined by a two-tailed 
unpaired t-test. All experiments included a blank well (medium without any 
inoculum). 
Adherence assay 
The ability of E. faecalis strains VE14089 and VE14089ΔluxS to 
adhere to Caco-2 cells was determined as previously described (Olier et al., 
2003), with minor modifications. On 24-well tissue-culture plates, an almost 
confluent monolayer of Caco-2 cells was infected with an E. faecalis 
bacterial suspension, with a corresponding multiplicity of infection (MOI) of 
~50. Adhesion of E. faecalis cells to Caco-2 cells was allowed to occur for 
2 h at 37 °C. Adherent bacteria were harvested after lysis of the cell 
monolayers with Triton X-100 and suitable dilutions of the lysates were 
plated. The plates were subsequently incubated for 24-48 h at 37 ºC and 
CFU values for viable bacteria were determined. Adherence assays were 
done in triplicate, and the overall significance of the differences was 
determined by a two-tailed unpaired t-test. 
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H2O2 challenge conditions 
H2O2 challenge was performed based on the method described by 
Giard et al. (Giard et al., 2006), with some adaptations. Briefly, WT and 
mutant cells were inoculated in M17Glu broth and grown for 16 h without 
shaking at 37 ºC. The culture was then diluted 1:100 (v/v) in pre-warmed to 
37 ºC M17Glu broth and incubated, with 150 rpm agitation in an orbital 
shaker (Innova, Edison, New Jersey), at 37 ºC, until reaching an OD at 
600 nm of approximately 0.5. The cells were harvested by centrifugation 
and resuspended in M17 broth with 7 mM H2O2. These cultures were 
placed into a 37 ºC water bath and, every 2 h for 6 h, samples were taken 
and plated in M17Glu agar. The number of CFU was determined after 
incubation at 37 ºC. The growth of the mutant and WT cells in the absence 
of peroxide stress was previously determined and did not reveal any 
difference. Each point is the mean of four independent experiments, each 
with duplicate plating, and the statistical comparison of means was 
performed using a two-tailed unpaired t-test. Survival at any given time 
point was determined as the ratio of the number of CFU after treatment to 
the number of CFU at the zero time point. 
Macrophage Survival Assay 
The macrophage survival assay was mainly performed as described 
by Bennett et al. (Bennett et al., 2007) with some modifications. Confluent 
J774.A1 (mouse monocytes - macrophages) monolayers were infected with 
an overnight bacterial culture. Approximately 4 × 106 bacteria were added 
to J774.A1 monolayers, to yield a MOI of approximately 10, and were 
incubated at 37 °C in 5 % CO2 atmosphere for 1 h to allow bacterial 
adherence and entry, after which gentamicin (250 μg/mL) was added to the 
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cultures to kill extracellular bacteria. At various time points after infection, 
1 % Triton X-100 in PBS was used to lyse cells. Lysates were then serially 
diluted and inoculated on Brain heart infusion (BHI) (Oxoid Ltd, 
Basingstoke, England) plates to enumerate viable intracellular bacteria. 
The assays were performed 5 times and results are reported as 
intracellular Survival Index (SI), i.e. the per cent (mean) of the internalized 
CFUs at each analysed time post-infection that survived after phagocytosis. 
Microarray Analysis 
For all experiments, the strains were inoculated in 5 mL 2×YTGlu 
broth and grown for 16 h without shaking at 37 ºC. The culture was then 
diluted in pre-warmed to 37 ºC 2×YT broth, adjusting the bacterial 
suspension density to the 1,0 McFarland standard. This pre-culture was 
diluted 1:100 (v/v) in 50 mL pre-warmed to 37 ºC 2×YT broth, and 
incubated, with 150 rpm agitation in an orbital shaker (Innova, Edison, New 
Jersey), at 37 ºC, until, for each condition studied, samples for RNA 
isolation were collected and processed accordingly. When needed 10 μM 
DPD was added 15 min prior to the RNA collection. The whole process was 
performed twice, independently. 
Immediate RNA sample stabilization and protection was achieved 
using the RNAprotect Bacteria Reagent (Qiagen, Hilden, Germany). Total 
RNA purification was performed using the RNeasy Midi Kit (Qiagen, Hilden, 
Germany), DNA digestions were executed after RNA isolation using DNase 
I recombinant, RNase-free (Roche Applied Science, Penzberg, Germany) 
and repeated when necessary, and final RNA clean up and concentration 
was carried out with RNeasy MinElute Cleanup Kit (Qiagen, Hilden, 
Germany), all according to the manufacturerʼs instructions. 
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Integrity and overall quality of the total RNA preparations, but also 
DNA contamination, were evaluated by native agarose gel electrophoresis 
and by PCR, respectively, and their corresponding RNA concentration was 
measured using a NanoDrop spectrophotometer (NanoDrop Technologies, 
Inc., Thermo Fisher Scientific Inc., Wilmington, DE). 
Microarray comparative genomic hybridization analysis was carried 
out using the microarray analysis platform of NimbleGen Technologies 
(Roche NimbleGen, Madison, WI). The chosen expression microarray, 
4x72k format (Catalogue Number: A7980-00-01, Design Name: 080625 
Efae V583 EXP X4), covers 3114 genes represented with 11 60mer probes 
per gene and 2 replicates per probe. 
cDNA synthesis, labelling, hybridization, and data acquisition were 
performed by NimbleGen (Reykjavik, Iceland). 
Image analysis was performed with the NimbleScan software (v2.6) 
(Roche NimbleGen Inc., Madison, WI), and feature intensities were 
exported as .pair files, after background correction and quantile 
normalization. All data analysis was carried out using the ArrayStar 3.0 
software package (DNAStar, Madison, WI). Robust multichip averaging 
(RMA) algorithm and quantile normalization were used for probe 
summarization and normalization and applied to the entire data set, which 
consisted of two biological replicates for each condition. Statistical analyses 
were carried out with the normalized data using a moderated t-test with 
false discovery rate (FDR) multiple-test correction (Benjamini-Hochberg) to 
determine differential transcript abundance. Changes in transcript 
abundance were considered significant if they met the following criteria: P 
value < 0.05 and | log2-ratio | > 5.0 in at least one of the three performed 
comparisons.  
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Results and Discussion 
Identification of the luxS gene in E. faecalis 
Genomic database analysis has previously revealed (Surette et al., 
1999; Paulsen et al., 2003) that E. faecalis possessed the gene encoding 
the putative LuxS protein, S-ribosylhomocysteine lyase (EC: 4.4.1.21), a 
152 amino-acids protein encoded by the luxS gene (ef1182) homologous to 
luxS from V. harveyi. The LuxS protein of V. harveyi ATCC BAA-1116 was 
described as having a per cent similarity/identity (S/I) with the putative one 
present in E. faecalis V583 of (60/44) (Surette et al., 1999). 
 
 
Figure 5.1. Sequence alignments of putative LuxS protein from E. faecalis V583 
(ENTFA) and selected organisms for which there is evidence of the existence of 
LuxS at the protein level. The four representatives are Bacillus subtilis 
(BACSU)(Hilgers and Ludwig, 2001; Ruzheinikov et al., 2001; Zhu et al., 2003), 
Campylobacter jejuni (CAMJE) (Elvers and Park, 2002), Escherichia coli (strain 
K12) (ECOLI) (Surette and Bassler, 1998; Surette et al., 1999) and Haemophilus 
influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) (HAEIN) (Lewis et al., 
2001). Under aligned protein sequences there is a line containing characters that 
mean that the column of the alignment contains: “*”, identical amino acid residues 
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in all sequences; “:”, different but highly conserved amino acids; “.”, different amino 
acids that are somewhat similar; blank, dissimilar amino acids or gaps. Metal 
ligands are highlighted in grey. Multiple alignment performed with ClustalW 
(Thompson et al., 1994). 
 
The three highly conserved amino acids H54, H58, and C126 
reported to be the metal ligands from the catalytic centre of LuxS protein of 
Bacillus subtilis (Hilgers and Ludwig, 2001) are also conserved in E. 
faecalis putative LuxS, in the corresponding H53, H57, and C120 positions 
(Figure 5.1). Moreover the amino acids involved in hydrogen bonding and 
electrostatic interactions with the substrate of B. subtilis LuxS (S6, K35, 
E57, R65, D78, I79, S80, C84, and G127, except for Q125) (Hilgers and 
Ludwig, 2001; Ruzheinikov et al., 2001; Zhu et al., 2003; Rajan et al., 2005) 
are also conserved in E. faecalis LuxS. In E. faecalis V583 genome, ef1182 
(luxS) locus is flanked by a 735 bp gene (ef1181) encoding a 
nitroreductase family protein, 84 bp downstream of ef1182 stop codon, and 
a 1068 bp gene (ef1183) encoding an aspartate-semialdehyde 
dehydrogenase (asd), 207 bp upstream of the start codon. Potential 
ribosome-binding site (RBS) was examined using JCVI's RBS finder 
(Delcher et al., 1999) and the rest of the promoter sequences were 
examined manually (Figure 5.2A). The luxS locus appeared to be followed 
by an inverted repeat downstream of the stop codon, which may be a 
transcriptional terminator (Figure 5.2B). This is consistent with the 
prediction of http://biocyc.org (Karp et al., 2005) in which luxS gene does 
not appear to form an operon with any of the genes that surround it. 
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A 
 
B 
 
Figure 5.2. E. faecalis V583 ef1182 (luxS) promoter and terminator sequences. (A) 
Potential -10 and -35 regions, the RBS, and transcriptional terminator sequences 
are underlined, the start codon is indicated by boldface type and underlining, and 
the luxS gene is indicated by boldface type. The mismatches between the luxS 
locus -10 and -35 regions and the canonical -10 and -35 sequences are boxed. (B) 
Putative transcriptional terminator of luxS locus. According to the predicted 
terminators tool WebGeSTer DB (Mitra et al., 2011), the luxS locus appeared to be 
followed by an inverted repeat (ΔG = −20.89 kcal/mol), 17 bp downstream of the 
stop codon, which may be a transcriptional terminator. 
Performing a nucleotide BLAST (Altschul et al., 1997; 2005) with all 
the 55 finished and unfinished E. faecalis genomes and genome projects 
available in the microbial BLAST database from the National Center for 
Biotechnology Information (NCBI) we found that ef1182, the putative luxS 
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gene, has a per cent identity of 99 % or higher, in all the 55 hit results 
obtained. The genomes available in the databases are mainly from clinical, 
unknown or commensal origin. We also analysed the previously amply 
studied food strain E. faecalis QA29b (Gaspar et al., 2009; Gaspar et al., 
2011, submitted), isolated from a Portuguese cheese, for the presence of 
the luxS gene. QA29b has the luxS gene, which sequence is identical to 
the one of V583 strain. Very similar upstream and downstream regions 
were found (data not shown). A 100 % identical nucleotide sequence for 
potential promoter sequence, RBS, and terminator can be found in the up- 
and downstream sequences from the putative QA29b luxS gene. In this 
isolate the putative luxS gene has the same adjacent gene organization as 
in V583: a downstream nitroreductase and an upstream aspartate-
semialdehyde dehydrogenase, both with high amino acid sequence identity 
to the ones in V583. 
Further in vitro analysis using purified LuxS proteins from E. faecalis 
overexpressed in E. coli strain BL21 revealed its activity to produce AI-2 
(Schauder et al., 2001).  
luxS mutagenesis depletes AI-2 activity 
VE14089, a plasmid-cured derivative of E. faecalis V583 (Rigottier-
Gois et al., 2011), was used as the genetic background for a luxS mutant 
construction. Besides removing the effect of plasmid contained genes and 
making easier the markerless in-frame luxS deletion mutagenesis, this 
plasmid-cured derivative was used in assays with animal cells because it is 
gentamicin sensitive. 
In order to conclude on LuxS activity in VE14089, we started by 
measuring the ability of this bacterium to produce AI-2 molecules. Cell-free 
culture supernatants of VE14089 were tested for the presence of AI-2 using 
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LuxP-FRET-based reporter method (Figure 5.3A), using the correlation 
between AI-2 concentration and FRET ratios (527 nm/485 nm) presented in 
Figure 5.3B. As shown in Figure 5.4A, cell-free culture supernatants of 
VE14089 induced a growth phase dependent signal, above the detection 
method threshold, indicating that AI-2 molecules were produced by 
VE14089. The AI-2 activity in the culture supernatant of the WT was 
detectable from the mid-exponential phase onward, reaching maximum 
levels during late-exponential/early-stationary phase and then decreasing, 
while remaining higher than the basal levels detected during lag phase.  
AI-2 internalization and possible subsequent modification, through 
an ATP­binding­cassette transporter (Lsr of Salmonella enterica serovar 
Typhimurium) (Hardie and Heurlier, 2008), has been described for other 
bacteria (Rezzonico and Duffy, 2008), and has been hypothesized to be a 
mechanism to control AI-2 levels in the vicinity of a cell or to prevent AI-2 
signalling by other bacterial species in its environment (Taga et al., 2003; 
Xavier and Bassler, 2005a; Xavier et al., 2007; Pereira et al., 2009). As an 
alternative to QS, after being released as a waste product, AI-2 may be 
reused subsequently as a metabolite, or the molecule may be used as a 
borate scavenger by bacteria (Rezzonico and Duffy, 2008). When 
internalization occurs, extracellular AI-2 concentration typically increases 
during exponential growth and begin to decline during the transition from 
exponential phase to the early stationary phase, by which time there is no 
detectable levels of AI-2 (Xavier and Bassler, 2005b; Azakami et al., 2006; 
De Keersmaecker et al., 2006; Zhu and Pei, 2008; Han and Lu, 2009; 
Marques et al., 2011). The extracellular accumulation of AI-2 described for 
VE14089, as well as its level remaining considerably high, has also been 
described for other bacteria (Learman et al., 2009; Zhao et al., 2010) and 
may indicate the absence of AI-2 transport into the cells, which is in 
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agreement with the genomic predictions previously made for E. faecalis 
(Rezzonico and Duffy, 2008). 
 
A 
 
B 
 
Figure 5.3. (A) Mechanism for ligand-induced fluorescence resonance energy 
transfer (FRET) changes in the cyan fluorescent protein (CFP), LuxP, yellow 
fluorescent protein (YFP) fusion. Schematic representation of the CFP-LuxP-YFP 
protein as a CFP in cyan, LuxP in green, and YFP in yellow fusion protein. In the 
absence of AI-2, CFP exhibits high fluorescence. Following ligand binding a 
conformational-induced change in the distance between CFP and YFP occurs, 
altering the level of FRET between the terminal fluorophores (Rajamani et al., 
2007). (B) Calibration curve performed with AI-2 samples of known concentration. 
Concentrations of 1, 5, 10, 30 and 60 μM AI-2 were used for the calibration curve, 
corresponding to the linear range of this assay. Binding of AI-2 to the CFP-LuxP-
YFP fusion protein causes a dose-dependent decrease in the FRET signal, and 
concentration can be determined by comparing the FRET ratios (527 nm/485 nm) 
of each sample with the calibration curve. 
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Figure 5.4. Growth curves and AI-2 production from VE14089 (A) and 
VE14089ΔluxS (B). 
 
A markerless in-frame luxS deletion mutant was constructed by 
allelic exchange in VE14089 to successfully produce VE14089ΔluxS, so 
that the physiological role of the E. faecalis LuxS as well as the production 
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of AI-2 and its involvement in cell-to-cell communication mechanisms could 
be examined. 
The resulting VE14089ΔluxS mutant generated near-background 
signal levels (Figure 5.4B). No AI-2 activity was detectable in the 
supernatant of the luxS mutant, regardless of cell density. The luxS deletion 
abolished the production of AI-2, demonstrating that LuxS is the key 
determinant in the AI-2 production process in VE14089.  
 
Even if there is no internalization of the AI-2 molecule, a different 
mechanism of AI-2 detection in bacteria, like the one found in V. harveyi, 
can occur (Rezzonico and Duffy, 2008), where just the signal but not the AI-
2 molecule is transduced inside the cell. This mechanism is triggered by the 
interaction of AI-2 with a two­component signal regulator pair (LuxP/LuxQ in 
V. harveyi), followed by a dephosphorylation cascade (Hardie and Heurlier, 
2008). However, none of the published E. faecalis genomes contains 
potential homologues for the LuxP/LuxQ AI-2 signal transduction system 
found in Vibrio spp., which also happens for other bacteria (Altschul et al., 
1997; Doherty et al., 2006; Rezzonico and Duffy, 2008). Thus, if AI-2 is 
deployed as an extracellular signal by E. faecalis, it must be sensed via a 
different, yet to be found, mechanism, for instance the reported two-
component systems in E. faecalis genome. 
Biological role of luxS in E. faecalis 
To characterize the effect of the luxS deletion in VE14089 regarding 
traits that may be involved in the host-pathogen relationship, like host 
recognition, adhesion and survival, four phenotypic experiments were 
carried out in this study: biofilm formation on an abiotic surface, adherence 
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assay to Caco-2 cells, resistance to oxidative stress, and macrophage 
survival assay. 
When using a two-tailed unpaired t-test, no significant differences 
were observed between VE14089 and VE14089ΔluxS regarding biofilm 
formation (Figure 5.5A), adhesion to Caco-2 cells (Figure 5.5B), H2O2 
challenge (Figure 5.5C), uptake by macrophages (Table 5.3) or 
macrophage intracellular survival (Figure 5.5D). Also, even if the lag phase 
is longer for VE14089 than VE14089ΔluxS, when normalization of growth 
conditions was conducted, the luxS deletion did not affect growth of the 
mutant, having no obvious difference in growth from mid-exponential 
onwards and reaching stationary phase at the same time (Figure 5.6). All 
these results indicate that, at least in the conditions used here, E. faecalis 
LuxS does not seem to be involved in the regulation of growth, biofilm 
formation, adherence to epithelial cells, resistance to oxidative stress, and 
survival inside macrophages. 
 
Table 5.3. Macrophage Survival Assay: MOI, uptake percentage at 0 h post-killing, 
and standard deviation values. 
Strain MOI (± SD) % Uptake (± SD) 
VE14089 12.2 (± 2.7) 8.2 (± 2.5) 
VE14089∆luxS 14.3 (± 2.6) 7.7 (± 2.2) 
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A 
 
B 
 
C 
 
D 
 
Figure 5.5. Phenotypic characterization of luxS mutant: VE14089 in grey bars with 
full line outline and VE14089ΔluxS in white bars with a dashed line outline. (A) 
Biofilm formation on polystyrene microtiter plates. The quantification of biofilm 
formation was assayed as a function of crystal violet stain (measured at 595 nm) 
retained by the biofilm biomass grown for 24 h. Data are mean of hexuplicate trials, 
and error bars indicate standard deviations. (B) VE14089 and VE14089ΔluxS 
adhesion to Caco-2 cells. The results are presented as per cent adhesion ± 
standard deviation. (C) Percentage (± standard deviation) survival of growing cells 
of E. faecalis VE14089 and VE14089ΔluxS at 2, 4 and 6 h of a challenge with 
7 mM H2O2. One hundred per cent corresponds to the number of CFU before H2O2 
treatment. All data are means (± standard deviation) of four independent 
experiments. (D) Time course of intracellular survival of VE14089 and 
VE14089ΔluxS strains within murine J774A.1 macrophages. Results correspond to 
the per cent means ± standard deviations of intracellular Survival Index (SI) 
determined at 0, 4, 8 and 24 h post-killing of external bacteria, of five independent 
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experiments. 0 h post-killing corresponds to 2 h post-infection, so time points 
mentioned in the figure correspond to 2, 6, 10 and 26 h post-infection. 
 
 
Figure 5.6. Growth of E. faecalis strains VE14089 ( ) and VE14089ΔluxS ( ) 
in 2×YT medium, after growth conditions optimization. The red arrow indicates the 
growth phase point used for the sampling of RNA used in the transcriptomic 
analysis. The average OD at 600 nm and AI-2 concentration, in μM, with the 
corresponding standard deviation (±SD), for each RNA sampling point was the 
following: VE14089 (OD 600 nm = 0.844 (±0.045); [AI-2] = 5.71 (±0.52)), 
VE14089ΔluxS (OD 600 nm = 0.833 (±0.017); [AI-2] = 0.80 (±0.21)), and 
VE14089ΔluxS + 10 μM DPD (OD 600 nm = 0.842 (±0.008); [AI-2] = 15.09 
(±1.71)). 
 
Similar phenotypes have been studied in other Gram-positive and in 
Gram-negative bacteria. However a thorough analysis of the literature 
reveals no trend for luxS role in growth (Challan Belval et al., 2006; Zhang 
et al., 2008), biofilm formation (Wen and Burne, 2004; Challan Belval et al., 
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2006; Shemesh et al., 2008), adherence to Caco-2 cells (Buck et al., 2009; 
Holmes et al., 2009), and resistance to oxidative stress (Wen and Burne, 
2004; Gao et al., 2009; Holmes et al., 2009). No trend for a luxS role was 
also evident regarding invasion of epithelial cells (Siller et al., 2008; Perrett 
et al., 2009), overall fitness in intracellular growth (Doherty et al., 2006; 
Zhao et al., 2010) and virulence in a mouse infection model (Stroeher et al., 
2003; Perrett et al., 2009). The luxS mutation has been described as being 
able to enhance, reduce or have no detectable effect on these different 
phenotypes. In some cases the supplementation with AI-2 like molecules 
was able to complement the altered phenotypes (Doherty et al., 2006; 
Sztajer et al., 2008; Zhang et al., 2008), but in others AI-2 addition did not 
restore the detected defects (Tannock et al., 2005; Sela et al., 2006; van 
Houdt et al., 2006; Zhang et al., 2008; Learman et al., 2009) 
As luxS and AI-2 production appears to have no role in E. faecalis in 
the phenotypes studied, we decided to look for the intracellular role of luxS 
and AI-2 by performing a transcriptomic analysis of VE14089 and 
VE14089ΔluxS. 
Because both products of LuxS have potentially important functions, 
disruption of the activity of LuxS can have extremely different 
consequences. They can range from the regulation of specific factors (a 
defined QS repertoire of changes), due to cell-cell communication 
disruption, to global influences on transcription (the consequences of major 
metabolic imbalance), affecting cell fitness (Hardie and Heurlier, 2008).  
Impact of luxS at the transcriptional level 
From production experiments (Figure 5.4), we know that high AI-2 
levels were achieved in the transition between late-exponential and early-
stationary phase. Thus, cells were collected at late-exponential phase, 
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which guarantees that, for the tested conditions, AI-2 is present 
extracellularly for the parental strain and that a possible effect for its 
presence may be monitored. The luxS mutant supplementation with DPD 
was performed 15ʼ prior to the cell harvesting, which did not notably 
interfere with VE14089ΔluxS growth, and to a level that would come to the 
one of the parental strain. We chose the use of synthetic pre AI-2 
molecules in the form of DPD, as previously done in other studies (Ahmed 
et al., 2009; Kint et al., 2009; Armbruster et al., 2010), to avoid the use of 
purified culture filtrates that might have been misleading, as they contain 
complex mixture of other signals to which bacteria could respond to 
(Vendeville et al., 2005).  
Genes regulated by AI-2 were identified by performing a pair-wise 
comparison of gene expression in VE14089ΔluxS and VE14089ΔluxS 
supplemented with 10 μM DPD (Table 5.4). Pair-wise comparisons of gene 
transcription in VE14089 and VE14089ΔluxS, supplemented or not with 
10 μM DPD, allowed to determine changes in gene expression affected 
uniquely by the luxS mutation or by the luxS mutation along with the lack of 
extracellular in vitro presence of AI-2, respectively (Table 5.4). 
These comparisons would allow to clarify the role of luxS gene, 
investigate its effect on gene transcription, and attempt to discriminate 
between the transcriptional response induced by this extracellular signal 
and the metabolic role of the LuxS protein. 
With a cutoff value of 5 for the n-fold change of expression (P-value 
< 0.05) in at least one of the three pairwise comparisons, the data revealed 
fundamental changes in gene expression affecting a total of 113 genes of 
all 3114 chromosomal genes present in the microarray, corresponding to 
3.6 % of the whole genome. It is acknowledged that changes in expression 
of lesser magnitude can nonetheless be of profound biological significance 
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and, conversely, statistically significant changes that met the 5-fold 
threshold may not represent biological change of great consequence. 
Transcription patterns remain unaffected by addition of DPD to 
VE14089ΔluxS, when compared to VE14089ΔluxS. No genes were 
significantly up- or downregulated in the luxS mutant upon addition of DPD, 
indicating that there werenʼt any genes that could be assumed to be 
responding to the signalling molecule AI-2. 
 
  
 
132 
Ta
bl
e 
5.
4.
 L
ist
 o
f d
iffe
re
nt
ial
ly 
re
gu
lat
ed
 g
en
es
 in
 a
t l
ea
st 
on
e 
of
 th
e 
pa
irw
ise
 c
om
pa
ris
on
s: 
VE
14
08
9 
an
d 
VE
14
08
9Δ
lux
S,
 a
nd
 
VE
14
08
9 
an
d 
VE
14
08
9Δ
lux
S 
su
pp
lem
en
te
d 
wi
th
 1
0 
μM
 D
PD
. N
o 
sig
nif
ica
nt
ly 
re
gu
lat
ed
 g
en
es
 w
er
e 
ob
ta
ine
d 
in 
th
e 
pa
irw
ise
 
co
m
pa
ris
on
s 
be
tw
ee
n 
VE
14
08
9Δ
lux
S 
an
d 
VE
14
08
9Δ
lux
S 
su
pp
lem
en
te
d 
wi
th
 1
0 
μM
 D
PD
, t
he
re
fo
re
 th
e 
da
ta
 w
as
 o
m
itte
d 
fro
m
 
th
is 
ta
ble
. G
en
es
 b
elo
ng
ing
 to
 th
e 
sa
m
e 
tra
ns
cr
ipt
ion
al 
un
it, 
no
t s
ign
ific
an
tly
 e
xp
re
ss
ed
, o
r 
wi
th
 a
 fo
ld 
ch
an
ge
 b
elo
w 
th
e 
im
po
se
d 
cu
to
ff 
ar
e 
als
o 
ind
ica
te
d.
 V
alu
es
 w
ith
 a
 g
re
y 
ba
ck
gr
ou
nd
 c
or
re
sp
on
d 
to
 a
 P
-v
alu
e 
ab
ov
e 
0.
05
; C
om
pa
ris
on
s 
wi
th
 a
 P
-
va
lue
 b
elo
w 
0.
05
 a
nd
  
| lo
g 2
-ra
tio
s |
 >
 5
.0
 a
re
 in
dic
at
ed
 in
 b
old
 ty
pe
; t
he
 lo
cu
s, 
ge
ne
 n
am
e,
 J
CV
I c
om
m
on
 n
am
e 
an
d 
JC
VI
 
ce
llu
lar
 ro
le 
wi
th
 a
 P
-v
alu
e 
be
low
 0
.0
5 
an
d 
 | 
log
2-r
at
ios
 | 
> 
5.
0 
in 
at
 le
as
t o
ne
 co
m
pa
ris
on
 a
re
 in
dic
at
ed
 in
 b
old
 ty
pe
. 
locus 
gene name 
JC
VI
 C
om
m
on
 N
am
e 
gene orientation 
VE
14
08
9 
vs
 
VE
14
08
9Δ
lu
xS
 
VE
14
08
9 
vs
 
VE
14
08
9Δ
lu
xS
 +
 
DP
D 
[1
0μ
M
] 
JC
VI
 C
el
lu
la
r R
ol
e:
 M
ai
nr
ol
e 
log
2
 ratio 
p value 
log
2
 ratio 
p value 
 
 
 
 
 
 
 
 
 
EF
00
19
 
m
pt
B 
PT
S 
sy
st
em
, I
IB
 c
om
po
ne
nt
 
!
 
7.
30
8 
0.
00
1 
7.
16
8 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
00
20
 
m
pt
A 
PT
S 
sy
st
em
, m
an
no
se
-s
pe
ci
fic
 II
AB
 
co
m
po
ne
nt
s 
!
 
6.
03
8 
0.
00
1 
5.
94
6 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
00
21
 
m
pt
C 
PT
S 
sy
st
em
, m
an
no
se
-s
pe
ci
fic
 II
C 
co
m
po
ne
nt
 
!
 
5.
52
6 
0.
00
1 
4.
70
5 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
00
22
 
m
pt
D 
PT
S 
sy
st
em
, m
an
no
se
-s
pe
ci
fic
 II
D 
co
m
po
ne
nt
 
!
 
13
.2
66
 
0.
00
1 
10
.7
08
 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
00
37
 
pr
oA
 
ga
m
m
a-
glu
ta
m
yl 
ph
os
ph
at
e 
re
du
cta
se
 
"
 
-2
.7
57
 
0.
00
2 
-2
.5
64
 
0.
00
6 
Am
ino
 a
cid
 b
ios
yn
th
es
is 
EF
00
38
 
pr
oB
 
gl
ut
am
at
e 
5-
ki
na
se
 
"
 
-5
.9
89
 
0.
00
1 
-5
.1
56
 
0.
00
2 
Am
in
o 
ac
id
 b
io
sy
nt
he
si
s 
EF
00
66
 
ru
vA
 
Ho
lli
da
y 
ju
nc
tio
n 
DN
A 
he
lic
as
e 
Ru
vA
 
!
 
-1
9.
76
0 
0.
00
1 
-1
4.
01
6 
0.
00
2 
DN
A 
m
et
ab
ol
is
m
 
EF
00
67
 
ru
vB
 
Ho
llid
ay
 ju
nc
tio
n 
DN
A 
he
lic
as
e 
Ru
vB
 
!
 
-3
.5
37
 
0.
00
1 
-2
.9
98
 
0.
00
2 
DN
A 
m
et
ab
oli
sm
 
EF
00
80
 
 
gls
24
 p
ro
te
in 
!
 
2.
29
6 
0.
00
2 
2.
11
1 
0.
00
4 
Ce
llu
lar
 p
ro
ce
ss
es
 
  
133 
Chapter 5 
EF
00
81
 
 
m
em
br
an
e 
pr
ot
ei
n,
 p
ut
at
iv
e 
!
 
5.
53
9 
0.
00
2 
4.
40
4 
0.
00
2 
Ce
ll 
en
ve
lo
pe
 
EF
00
95
 
 
lip
op
ro
te
in
, p
ut
at
iv
e 
!
 
6.
30
7 
0.
00
1 
5.
75
8 
0.
00
2 
Ce
ll 
en
ve
lo
pe
 
EF
01
12
 
 
co
ns
er
ve
d 
do
m
ain
 p
ro
te
in 
!
 
-2
.3
29
 
0.
00
4 
-2
.3
51
 
0.
00
5 
Hy
po
th
et
ica
l p
ro
te
ins
 
EF
01
13
 
 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
-6
.0
83
 
0.
00
1 
-4
.6
49
 
0.
00
2 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
EF
02
37
 
cb
iO
 
AB
C 
tra
ns
po
rte
r, 
AT
P-
bi
nd
in
g 
pr
ot
ei
n 
!
 
-5
.3
81
 
0.
00
1 
-4
.4
71
 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
EF
02
38
 
cb
iO
 
AB
C 
tra
ns
po
rte
r, 
AT
P-
bin
din
g 
pr
ot
ein
 
!
 
-2
.5
90
 
0.
00
2 
-2
.3
09
 
0.
00
9 
Tr
an
sp
or
t a
nd
 b
ind
ing
 p
ro
te
ins
 
EF
02
39
 
 
co
ba
lt t
ra
ns
po
rt 
fa
m
ily
 p
ro
te
in 
!
 
-1
.8
41
 
0.
01
3 
-1
.6
29
 
0.
01
5 
Tr
an
sp
or
t a
nd
 b
ind
ing
 p
ro
te
ins
 
EF
02
44
 
 
ac
et
yl
tra
ns
fe
ra
se
, G
NA
T 
fa
m
ily
 
"
 
-6
.9
24
 
0.
00
1 
-5
.8
54
 
0.
00
3 
Un
kn
ow
n 
fu
nc
tio
n 
EF
02
66
 
hs
lO
 
ch
ap
er
on
in
, 3
3 
kD
a 
!
 
-1
8.
69
0 
0.
00
1 
-1
3.
84
8 
0.
00
2 
Pr
ot
ei
n 
fa
te
 
EF
02
67
 
 
zin
c-
bin
din
g 
TI
M
-b
ar
re
l p
ro
te
in,
 n
ifR
3 
fa
m
ily
, 
pu
ta
tiv
e 
!
 
-3
.1
31
 
0.
00
4 
-3
.0
15
 
0.
00
9 
Un
kn
ow
n 
fu
nc
tio
n 
EF
02
91
 
ce
lA
 
gly
co
sy
l h
yd
ro
las
e,
 fa
m
ily
 1
 
"
 
4.
43
7 
0.
00
2 
3.
85
4 
0.
00
6 
En
er
gy
 m
et
ab
oli
sm
 
EF
02
92
 
ce
lB
 
PT
S 
sy
st
em
, I
IC
 c
om
po
ne
nt
 
"
 
11
.0
25
 
0.
00
1 
10
.0
87
 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
03
59
 
su
gE
-1
 
su
gE
 p
ro
te
in
 
!
 
4.
74
3 
0.
00
1 
5.
11
0 
0.
00
2 
Pr
ot
ei
n 
fa
te
 
EF
03
60
 
su
gE
-2
 
su
gE
 p
ro
te
in 
!
 
2.
55
9 
0.
00
3 
2.
76
4 
0.
00
3 
Pr
ot
ein
 fa
te
 
EF
03
71
 
 
am
in
ot
ra
ns
fe
ra
se
, c
la
ss
 V
 
!
 
-1
4.
02
0 
0.
00
1 
-1
3.
39
5 
0.
00
2 
Un
kn
ow
n 
fu
nc
tio
n 
EF
04
11
 
 
PT
S 
sy
st
em
, m
an
ni
to
l-s
pe
cf
ic
 II
BC
 
co
m
po
ne
nt
s 
!
 
10
.4
44
 
0.
00
1 
9.
74
9 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
04
12
 
m
ltF
 
PT
S 
sy
st
em
, m
an
ni
to
l-s
pe
ci
fic
 II
A 
co
m
po
ne
nt
 
!
 
13
.8
57
 
0.
00
1 
11
.8
65
 
0.
00
1 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
04
13
 
m
tlD
 
m
an
ni
to
l-1
-p
ho
sp
ha
te
 5
-d
eh
yd
ro
ge
na
se
 
!
 
7.
62
6 
0.
00
1 
6.
40
3 
0.
00
2 
En
er
gy
 m
et
ab
ol
is
m
 
EF
04
53
 
 
Os
m
C/
Oh
r f
am
ily
 p
ro
te
in
 
!
 
9.
50
7 
0.
00
1 
9.
14
9 
0.
00
2 
Un
kn
ow
n 
fu
nc
tio
n 
EF
04
68
 
 
Le
m
A 
fa
m
ily
 p
ro
te
in
 
!
 
4.
43
5 
0.
00
1 
5.
06
5 
0.
00
2 
Un
kn
ow
n 
fu
nc
tio
n 
EF
04
75
 
fe
oA
 
fe
rro
us
 ir
on
 tr
an
sp
or
t p
ro
te
in
 A
 
!
 
5.
42
9 
0.
00
1 
4.
24
9 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
EF
04
76
 
fe
oB
 
fe
rro
us
 ir
on
 tr
an
sp
or
t p
ro
te
in 
B 
!
 
2.
08
9 
0.
00
6 
1.
93
0 
0.
00
8 
Tr
an
sp
or
t a
nd
 b
ind
ing
 p
ro
te
ins
 
EF
05
34
 
 
si
te
-s
pe
ci
fic
 re
co
m
bi
na
se
, r
es
ol
va
se
 
fa
m
ily
 
"
 
-5
.9
78
 
0.
00
1 
-3
.9
06
 
0.
00
2 
DN
A 
m
et
ab
ol
is
m
 
EF
05
42
 
 
co
ns
er
ve
d 
hy
po
th
et
ica
l p
ro
te
in 
"
 
-4
.4
98
 
0.
00
1 
-3
.7
47
 
0.
00
9 
Hy
po
th
et
ica
l p
ro
te
ins
 
EF
05
43
 
 
m
em
br
an
e 
pr
ot
ei
n,
 p
ut
at
iv
e 
"
 
-6
.4
06
 
0.
00
2 
-4
.6
52
 
0.
00
7 
Ce
ll 
en
ve
lo
pe
 
  
 
134 
EF
05
66
 
 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
-5
.5
37
 
0.
00
1 
-5
.1
89
 
0.
00
2 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
EF
06
37
 
 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
5.
39
3 
0.
00
1 
4.
47
4 
0.
00
2 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
EF
06
38
 
 
co
ns
er
ve
d 
hy
po
th
et
ic
al
 p
ro
te
in
 
"
 
4.
63
4 
0.
00
1 
5.
07
6 
0.
00
2 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
- c
on
se
rv
ed
 
EF
06
93
 
fru
K-
1 
1-
ph
os
ph
of
ru
ct
ok
in
as
e 
!
 
11
.7
55
 
0.
00
1 
9.
19
3 
0.
00
2 
En
er
gy
 m
et
ab
ol
is
m
 
EF
06
94
 
fru
A 
PT
S 
sy
st
em
, f
ru
ct
os
e-
sp
ec
ifi
c 
fa
m
ily
, 
IIB
C 
co
m
po
ne
nt
s 
!
 
7.
81
1 
0.
00
1 
6.
46
0 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
06
95
 
fru
B 
PT
S 
sy
st
em
, I
IA
 c
om
po
ne
nt
 
!
 
7.
09
3 
0.
00
1 
5.
14
8 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
06
96
 
la
cD
-1
 
ta
ga
to
se
 1
,6
-d
ip
ho
sp
ha
te
 a
ld
ol
as
e 
!
 
6.
26
7 
0.
00
1 
4.
60
3 
0.
00
2 
En
er
gy
 m
et
ab
ol
is
m
 
EF
08
19
 
 
co
ns
er
ve
d 
hy
po
th
et
ic
al
 p
ro
te
in
 
"
 
5.
08
7 
0.
00
2 
4.
04
8 
0.
01
0 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
- c
on
se
rv
ed
 
EF
08
48
 
ac
pS
 
ho
lo
-(a
cy
l-c
ar
rie
r-p
ro
te
in
) s
yn
th
as
e 
!
 
-5
.4
07
 
0.
00
1 
-4
.3
87
 
0.
00
2 
Fa
tty
 a
ci
d 
an
d 
ph
os
ph
ol
ip
id
 m
et
ab
ol
is
m
 
EF
08
49
 
alr
 
ala
nin
e 
ra
ce
m
as
e 
!
 
-3
.7
54
 
0.
00
1 
-3
.1
43
 
0.
00
2 
Ce
ll e
nv
elo
pe
 
EF
08
50
 
 
tra
ns
cr
ipt
ion
al 
re
gu
lat
or
, P
em
K 
fa
m
ily
 
!
 
-3
.7
50
 
0.
00
2 
-3
.6
31
 
0.
00
2 
Re
gu
lat
or
y f
un
cti
on
s 
EF
08
73
 
 
tra
ns
cr
ip
tio
na
l r
eg
ul
at
or
, C
ro
/C
I f
am
ily
 
"
 
-6
.3
25
 
0.
00
1 
-5
.7
38
 
0.
00
2 
Re
gu
la
to
ry
 fu
nc
tio
ns
 
EF
09
01
 
 
iso
pe
nt
en
yl 
dip
ho
sp
ha
te
 d
elt
a 
iso
m
er
as
e,
 
pu
ta
tiv
e 
"
 
-1
.1
84
 
0.
16
3 
-1
.1
80
 
0.
15
9 
Bi
os
yn
th
es
is 
of
 co
fa
cto
rs
, p
ro
sth
et
ic 
gr
ou
ps
, a
nd
 ca
rri
er
s 
EF
09
02
 
 
ph
os
ph
om
ev
alo
na
te
 ki
na
se
 
"
 
-1
.6
39
 
0.
01
0 
-1
.6
24
 
0.
00
8 
Bi
os
yn
th
es
is 
of
 co
fa
cto
rs
, p
ro
sth
et
ic 
gr
ou
ps
, a
nd
 ca
rri
er
s 
/ C
en
tra
l in
te
rm
ed
iar
y m
et
ab
oli
sm
 
EF
09
03
 
m
va
D 
m
ev
alo
na
te
 d
iph
os
ph
at
e 
de
ca
rb
ox
yla
se
 
"
 
-2
.8
54
 
0.
00
1 
-2
.4
91
 
0.
00
3 
Bi
os
yn
th
es
is 
of
 co
fa
cto
rs
, p
ro
sth
et
ic 
gr
ou
ps
, a
nd
 ca
rri
er
s 
/ C
en
tra
l in
te
rm
ed
iar
y m
et
ab
oli
sm
 
EF
09
04
 
m
vk
 
m
ev
al
on
at
e 
ki
na
se
 
"
 
-5
.7
16
 
0.
00
1 
-4
.7
00
 
0.
00
2 
Bi
os
yn
th
es
is
 o
f c
of
ac
to
rs
, p
ro
st
he
tic
 g
ro
up
s,
 a
nd
 
ca
rri
er
s 
/ C
en
tra
l i
nt
er
m
ed
ia
ry
 m
et
ab
ol
is
m
 
EF
09
28
 
 
glu
co
se
 u
pt
ak
e 
pr
ot
ein
 
!
 
-3
.1
57
 
0.
00
1 
-2
.7
04
 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
ind
ing
 p
ro
te
ins
 
EF
09
29
 
 
am
in
o 
ac
id
 p
er
m
ea
se
 fa
m
ily
 p
ro
te
in
 
!
 
-1
7.
81
9 
0.
00
1 
-1
6.
00
2 
0.
00
1 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
EF
09
53
 
 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
-6
.0
52
 
0.
00
1 
-3
.8
28
 
0.
00
4 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
EF
10
06
 
 
co
ns
er
ve
d 
hy
po
th
et
ic
al
 p
ro
te
in
 
"
 
6.
20
4 
0.
00
2 
4.
96
6 
0.
00
4 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
- c
on
se
rv
ed
 
EF
10
12
 
 
PT
S 
sy
st
em
, I
IB
 c
om
po
ne
nt
 
!
 
22
.9
83
 
0.
00
1 
21
.5
58
 
0.
00
1 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
10
13
 
 
PT
S 
sy
st
em
, I
IC
 c
om
po
ne
nt
 
!
 
75
.8
95
 
0.
00
1 
67
.1
13
 
0.
00
1 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
10
14
 
 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
50
.5
48
 
0.
00
1 
44
.4
72
 
0.
00
1 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
EF
10
16
 
 
co
ns
er
ve
d 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
45
.0
73
 
0.
00
1 
37
.9
47
 
0.
00
2 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
- c
on
se
rv
ed
 
EF
10
17
 
 
PT
S 
sy
st
em
, I
IB
 c
om
po
ne
nt
 
!
 
17
.9
94
 
0.
00
1 
17
.4
05
 
0.
00
1 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
  
135 
Chapter 5 
EF
10
18
 
 
PT
S 
sy
st
em
, I
IA
 c
om
po
ne
nt
 
!
 
11
.6
56
 
0.
00
1 
11
.9
43
 
0.
00
1 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
10
19
 
 
PT
S 
sy
st
em
, I
IC
 c
om
po
ne
nt
 
!
 
14
.5
75
 
0.
00
1 
12
.6
76
 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
10
22
 
 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
8.
21
6 
0.
00
2 
6.
89
2 
0.
00
3 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
EF
10
57
 
 
M
n2
+/
Fe
2+
 tr
an
sp
or
te
r, 
NR
AM
P 
fa
m
ily
 
!
 
3.
49
7 
0.
00
4 
2.
71
8 
0.
00
7 
Tr
an
sp
or
t a
nd
 b
ind
ing
 p
ro
te
ins
 
EF
10
58
 
 
un
iv
er
sa
l s
tre
ss
 p
ro
te
in
 fa
m
ily
 
!
 
6.
57
9 
0.
00
2 
3.
76
2 
0.
02
0 
Ce
llu
la
r p
ro
ce
ss
es
 
EF
11
49
 
re
cU
 
re
co
m
bi
na
tio
n 
pr
ot
ei
n 
U 
"
 
-5
.4
60
 
0.
00
1 
-4
.4
83
 
0.
00
2 
DN
A 
m
et
ab
ol
is
m
 
EF
11
72
 
 
te
ic
ho
ic
 a
ci
d 
bi
os
yn
th
es
is
 p
ro
te
in
 B
, 
pu
ta
tiv
e 
!
 
-8
.1
66
 
0.
00
1 
-7
.0
73
 
0.
00
3 
Ce
ll 
en
ve
lo
pe
 
EF
11
73
 
 
gl
yc
os
yl
 tr
an
sf
er
as
e,
 W
ec
B/
Ta
gA
/C
ps
F 
fa
m
ily
 
!
 
-6
.2
72
 
0.
00
1 
-5
.2
54
 
0.
00
2 
Ce
ll 
en
ve
lo
pe
 
EF
11
74
 
 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
-5
.8
08
 
0.
00
1 
-5
.4
54
 
0.
00
2 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
EF
11
82
 
lu
xS
 
au
to
in
du
ce
r-2
 p
ro
du
ct
io
n 
pr
ot
ei
n 
Lu
xS
 
"
 
-1
19
.0
61
 
0.
00
1 
-1
10
.4
75
 
0.
00
2 
Ce
llu
la
r p
ro
ce
ss
es
 
EF
12
06
 
 
m
al
at
e 
de
hy
dr
og
en
as
e,
 d
ec
ar
bo
xy
la
tin
g 
"
 
4.
63
4 
0.
00
1 
5.
10
9 
0.
00
2 
En
er
gy
 m
et
ab
ol
is
m
 
EF
12
07
 
 
cit
ra
te
 ca
rri
er
 p
ro
te
in,
 C
CS
 fa
m
ily
 
"
 
3.
67
9 
0.
00
2 
4.
15
1 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
ind
ing
 p
ro
te
ins
 
EF
13
51
 
 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
6.
63
2 
0.
00
1 
5.
16
1 
0.
00
3 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
EF
13
52
 
 
m
ag
ne
siu
m
-tr
an
slo
ca
tin
g 
P-
typ
e 
AT
Pa
se
 
!
 
3.
33
8 
0.
00
2 
3.
05
9 
0.
00
3 
Tr
an
sp
or
t a
nd
 b
ind
ing
 p
ro
te
ins
 
EF
13
68
 
 
co
ns
er
ve
d 
hy
po
th
et
ic
al
 p
ro
te
in
 
"
 
6.
42
7 
0.
00
1 
5.
52
1 
0.
00
2 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
- c
on
se
rv
ed
 
EF
15
82
 
 
m
aj
or
 fa
ci
lit
at
or
 fa
m
ily
 tr
an
sp
or
te
r 
"
 
-7
.9
98
 
0.
00
2 
-7
.0
75
 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
EF
15
91
 
 
tra
ns
cr
ip
tio
na
l r
eg
ul
at
or
, A
ra
C 
fa
m
ily
 
"
 
5.
42
4 
0.
00
1 
4.
69
3 
0.
00
2 
Re
gu
la
to
ry
 fu
nc
tio
ns
 
EF
15
99
 
 
TP
R 
do
m
ai
n 
tra
ns
cr
ip
tio
na
l r
eg
ul
at
or
, 
Cr
o/
CI
 fa
m
ily
 
"
 
-9
.8
53
 
0.
00
1 
-7
.4
73
 
0.
00
2 
Re
gu
la
to
ry
 fu
nc
tio
ns
 
EF
16
55
 
 
2-
de
hy
dr
op
an
to
at
e 
2-
re
du
ct
as
e,
 p
ut
at
iv
e 
"
 
8.
94
8 
0.
00
3 
7.
60
8 
0.
00
2 
Bi
os
yn
th
es
is
 o
f c
of
ac
to
rs
, p
ro
st
he
tic
 g
ro
up
s,
 a
nd
 
ca
rri
er
s 
EF
16
58
 
bk
dC
 
br
an
ch
ed
-c
ha
in
 a
lp
ha
-k
et
o 
ac
id
, E
2 
co
m
po
ne
nt
, d
ih
yd
ro
lip
oa
m
id
e 
ac
et
yl
tra
ns
fe
ra
se
 
"
 
11
.5
89
 
0.
00
1 
11
.4
84
 
0.
00
3 
En
er
gy
 m
et
ab
ol
is
m
 
EF
16
59
 
bk
dB
 
br
an
ch
ed
-c
ha
in
 a
lp
ha
-k
et
o 
ac
id
 
de
hy
dr
og
en
as
e,
 E
1 
co
m
po
ne
nt
, b
et
a 
su
bu
ni
t 
"
 
30
.4
92
 
0.
00
1 
29
.3
37
 
0.
00
2 
En
er
gy
 m
et
ab
ol
is
m
 
EF
16
60
 
bk
dA
 
br
an
ch
ed
-c
ha
in
 a
lp
ha
-k
et
o 
ac
id
 
de
hy
dr
og
en
as
e,
 E
1 
co
m
po
ne
nt
, a
lp
ha
 
su
bu
ni
t 
"
 
43
.9
55
 
0.
00
1 
44
.7
40
 
0.
00
2 
En
er
gy
 m
et
ab
ol
is
m
 
EF
16
61
 
bk
dD
 
br
an
ch
ed
-c
ha
in
 a
lp
ha
-k
et
o 
ac
id
 
"
 
34
.7
90
 
0.
00
1 
34
.8
04
 
0.
00
2 
En
er
gy
 m
et
ab
ol
is
m
 
  
 
136 
de
hy
dr
og
en
as
e,
 E
3 
co
m
po
ne
nt
, 
di
hy
dr
ol
ip
oa
m
id
e 
de
hy
dr
og
en
as
e 
EF
16
62
 
bu
k 
bu
ty
ra
te
 k
in
as
e 
!
 
18
.4
34
 
0.
00
1 
18
.6
39
 
0.
00
1 
En
er
gy
 m
et
ab
ol
is
m
 
EF
16
63
 
pt
b 
br
an
ch
ed
-c
ha
in
 p
ho
sp
ho
tra
ns
ac
yl
as
e 
!
 
33
.4
05
 
0.
00
1 
33
.7
34
 
0.
00
1 
Fa
tty
 a
ci
d 
an
d 
ph
os
ph
ol
ip
id
 m
et
ab
ol
is
m
 
EF
16
67
 
 
sh
or
t c
ha
in
 d
eh
yd
ro
ge
na
se
 fa
m
ily
 
pr
ot
ei
n 
"
 
8.
32
3 
0.
00
1 
6.
53
7 
0.
00
5 
Un
kn
ow
n 
fu
nc
tio
n 
EF
16
71
 
 
ox
id
or
ed
uc
ta
se
, z
in
c-
bi
nd
in
g 
!
 
6.
52
2 
0.
00
1 
5.
73
0 
0.
00
2 
Un
kn
ow
n 
fu
nc
tio
n 
EF
16
77
 
 
lip
op
ro
te
in
, p
ut
at
iv
e 
!
 
5.
13
3 
0.
00
1 
4.
66
3 
0.
00
2 
Ce
ll 
en
ve
lo
pe
 
EF
17
51
 
 
m
em
br
an
e 
pr
ot
ei
n,
 p
ut
at
iv
e 
!
 
5.
54
1 
0.
00
1 
4.
00
2 
0.
00
4 
Ce
ll 
en
ve
lo
pe
 
EF
17
52
 
 
co
ns
er
ve
d 
hy
po
th
et
ica
l p
ro
te
in 
!
 
3.
05
4 
0.
00
3 
2.
41
6 
0.
00
8 
Hy
po
th
et
ica
l p
ro
te
ins
 
EF
17
71
 
 
co
ns
er
ve
d 
hy
po
th
et
ic
al
 p
ro
te
in
 
TI
GR
00
25
7 
"
 
-8
.3
39
 
0.
00
1 
-6
.5
15
 
0.
00
2 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
- c
on
se
rv
ed
 
EF
17
72
 
 
co
ns
er
ve
d 
hy
po
th
et
ica
l p
ro
te
in 
"
 
-3
.5
28
 
0.
03
0 
-3
.1
15
 
0.
03
1 
Hy
po
th
et
ica
l p
ro
te
ins
 
EF
18
63
 
hk
08
 
se
ns
or
 h
ist
idi
ne
 ki
na
se
 
!
 
-1
.8
39
 
0.
07
3 
-1
.5
91
 
0.
14
4 
Si
gn
al 
tra
ns
du
cti
on
 
EF
18
64
 
rr0
8 
DN
A-
bi
nd
in
g 
re
sp
on
se
 re
gu
la
to
r 
!
 
-5
.7
92
 
0.
00
2 
-2
.9
75
 
0.
00
4 
Re
gu
la
to
ry
 fu
nc
tio
ns
 / 
Si
gn
al
 tr
an
sd
uc
tio
n 
EF
18
99
 
trm
D 
tR
NA
 (g
ua
nin
e-
N1
)-m
et
hy
ltr
an
sfe
ra
se
 
!
 
-2
.1
67
 
0.
00
4 
-2
.0
06
 
0.
00
5 
Pr
ot
ein
 sy
nt
he
sis
 
EF
19
00
 
rim
M
 
16
S 
rR
NA
 p
ro
ce
ss
in
g 
pr
ot
ei
n 
Ri
m
M
 
!
 
-5
.3
11
 
0.
00
1 
-4
.1
09
 
0.
00
2 
Tr
an
sc
rip
tio
n 
EF
19
27
 
glp
F 
gly
ce
ro
l u
pt
ak
e 
fa
cil
ita
to
r p
ro
te
in 
!
 
4.
94
6 
0.
00
2 
4.
89
2 
0.
00
7 
Tr
an
sp
or
t a
nd
 b
ind
ing
 p
ro
te
ins
 
EF
19
28
 
 
alp
ha
-g
lyc
er
op
ho
sp
ha
te
 o
xid
as
e 
!
 
4.
20
0 
0.
00
2 
4.
32
1 
0.
00
2 
En
er
gy
 m
et
ab
oli
sm
 
EF
19
29
 
gl
pK
 
gl
yc
er
ol
 k
in
as
e 
!
 
6.
04
9 
0.
00
1 
6.
24
3 
0.
00
2 
En
er
gy
 m
et
ab
ol
is
m
 
EF
19
81
 
 
hy
po
th
et
ic
al
 p
ro
te
in
 
"
 
12
.8
18
 
0.
00
1 
8.
75
2 
0.
00
3 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
EF
19
82
 
 
un
iv
er
sa
l s
tre
ss
 p
ro
te
in
 fa
m
ily
 
"
 
7.
39
0 
0.
00
2 
6.
39
1 
0.
00
5 
Ce
llu
la
r p
ro
ce
ss
es
 
EF
20
48
 
rlm
N 
co
ns
er
ve
d 
hy
po
th
et
ic
al
 p
ro
te
in
 
TI
GR
00
04
8 
!
 
-5
.7
01
 
0.
00
1 
-4
.6
69
 
0.
00
3 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
- c
on
se
rv
ed
 
EF
21
75
 
 
lic
D-
re
lat
ed
 p
ro
te
in 
!
 
-2
.3
28
 
0.
00
2 
-2
.0
90
 
0.
00
4 
Un
kn
ow
n 
fu
nc
tio
n 
EF
21
76
 
 
gl
yc
os
yl
 tr
an
sf
er
as
e,
 g
ro
up
 2
 fa
m
ily
 
pr
ot
ei
n 
!
 
-6
.6
91
 
0.
00
1 
-5
.0
57
 
0.
00
2 
Ce
ll 
en
ve
lo
pe
 
EF
21
95
 
 
gly
co
sy
l tr
an
sfe
ra
se
, g
ro
up
 2
 fa
m
ily
 p
ro
te
in 
!
 
-1
.6
85
 
0.
00
5 
-1
.5
16
 
0.
01
1 
Ce
ll e
nv
elo
pe
 
EF
21
96
 
 
gly
co
sy
l tr
an
sfe
ra
se
, g
ro
up
 2
 fa
m
ily
 p
ro
te
in 
!
 
-1
.9
17
 
0.
00
7 
-1
.8
22
 
0.
01
6 
Ce
ll e
nv
elo
pe
 
EF
21
97
 
ep
a 
lo
cu
s 
gl
yc
os
yl
 tr
an
sf
er
as
e,
 g
ro
up
 2
 fa
m
ily
 
pr
ot
ei
n 
!
 
-5
.5
37
 
0.
00
1 
-4
.5
16
 
0.
00
3 
Ce
ll 
en
ve
lo
pe
 
  
137 
Chapter 5 
EF
22
09
 
 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
7.
02
2 
0.
00
2 
5.
12
4 
0.
00
9 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
EF
22
52
 
 
hy
po
th
et
ica
l p
ro
te
in 
!
 
-4
.2
10
 
0.
00
1 
-3
.6
41
 
0.
00
3 
hy
po
th
et
ica
l p
ro
te
in 
EF
22
53
 
 
co
ns
er
ve
d 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
-5
.4
58
 
0.
00
1 
-4
.6
20
 
0.
00
2 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
- c
on
se
rv
ed
 
EF
22
75
 
 
hy
po
th
et
ic
al
 p
ro
te
in
 
"
 
-5
.3
32
 
0.
00
2 
-4
.1
86
 
0.
00
6 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
EF
22
76
 
 
hy
po
th
et
ica
l p
ro
te
in 
"
 
-2
.5
36
 
0.
00
1 
-2
.3
62
 
0.
00
2 
hy
po
th
et
ica
l p
ro
te
in 
EF
23
64
 
 
xa
nt
hin
e 
pe
rm
ea
se
 
!
 
-3
.6
13
 
0.
00
1 
-3
.3
35
 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
ind
ing
 p
ro
te
ins
 
EF
23
65
 
xp
t 
xa
nt
hi
ne
 p
ho
sp
ho
rib
os
yl
tra
ns
fe
ra
se
 
!
 
-5
.8
91
 
0.
00
1 
-5
.1
70
 
0.
00
2 
Pu
rin
es
, p
yr
im
id
in
es
, n
uc
le
os
id
es
, a
nd
 n
uc
le
ot
id
es
 
EF
24
83
 
 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
11
.2
34
 
0.
00
2 
8.
39
1 
0.
00
4 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
EF
26
04
 
 
co
ns
er
ve
d 
hy
po
th
et
ica
l p
ro
te
in 
!
 
-1
.3
93
 
0.
14
9 
-1
.6
46
 
0.
01
4 
Hy
po
th
et
ica
l p
ro
te
ins
 
EF
26
05
 
m
ur
AA
 
UD
P-
N-
ac
et
yl
gl
uc
os
am
in
e 
1-
ca
rb
ox
yv
in
yl
tra
ns
fe
ra
se
 1
 
!
 
-5
.9
61
 
0.
00
2 
-5
.3
90
 
0.
00
2 
Ce
ll 
en
ve
lo
pe
 
EF
26
06
 
 
co
ns
er
ve
d 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
-1
1.
82
3 
0.
00
1 
-9
.8
90
 
0.
00
4 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
- c
on
se
rv
ed
 
EF
26
27
 
 
te
ic
ho
ic
 a
ci
d 
gl
yc
os
yl
at
io
n 
pr
ot
ei
n,
 
pu
ta
tiv
e 
!
 
-9
.4
40
 
0.
00
1 
-6
.2
34
 
0.
00
5 
Ce
ll 
en
ve
lo
pe
 
EF
26
28
 
 
N-
ac
et
ylm
ur
am
oy
l-L
-a
lan
ine
 a
m
ida
se
, f
am
ily
 
4 
!
 
-2
.9
21
 
0.
00
2 
-2
.7
55
 
0.
00
4 
Ce
ll e
nv
elo
pe
 
EF
26
29
 
 
hy
po
th
et
ica
l p
ro
te
in 
!
 
-2
.2
30
 
0.
00
4 
-2
.0
63
 
0.
00
5 
hy
po
th
et
ica
l p
ro
te
in 
EF
26
30
 
 
tra
ns
cr
ip
tio
na
l r
eg
ul
at
or
 
!
 
-5
.8
74
 
0.
00
2 
-4
.6
87
 
0.
00
5 
Re
gu
la
to
ry
 fu
nc
tio
ns
 
EF
26
31
 
 
hy
po
th
et
ica
l p
ro
te
in 
!
 
-3
.5
55
 
0.
00
2 
-2
.9
25
 
0.
02
5 
hy
po
th
et
ica
l p
ro
te
in 
EF
26
43
 
 
co
ns
er
ve
d 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
5.
01
5 
0.
00
1 
4.
15
8 
0.
00
2 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
- c
on
se
rv
ed
 
EF
26
46
 
 
gl
yc
er
at
e 
ki
na
se
, p
ut
at
iv
e 
!
 
7.
92
1 
0.
00
1 
7.
12
8 
0.
00
2 
En
er
gy
 m
et
ab
ol
is
m
 
EF
26
47
 
 
pe
rm
ea
se
, G
nt
P 
fa
m
ily
 
!
 
7.
51
0 
0.
00
2 
8.
28
8 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
EF
27
97
 
 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
5.
36
4 
0.
00
1 
3.
68
6 
0.
00
4 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
EF
28
01
 
 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
-7
.2
44
 
0.
00
1 
-6
.3
95
 
0.
00
3 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
EF
28
71
 
na
dD
 
nic
ot
ina
te
-n
uc
leo
tid
e 
ad
en
yly
ltr
an
sfe
ra
se
 
!
 
-1
.6
05
 
0.
00
9 
-1
.6
51
 
0.
00
8 
Bi
os
yn
th
es
is 
of
 co
fa
cto
rs
, p
ro
sth
et
ic 
gr
ou
ps
, a
nd
 ca
rri
er
s 
EF
28
72
 
 
co
ns
er
ve
d 
hy
po
th
et
ica
l p
ro
te
in 
TI
GR
00
25
3 
!
 
-1
.7
18
 
0.
02
0 
-1
.6
51
 
0.
01
8 
Hy
po
th
et
ica
l p
ro
te
ins
 
EF
28
73
 
 
GT
Pa
se
 o
f u
nk
no
wn
 fu
nc
tio
n 
!
 
-2
.4
31
 
0.
00
5 
-2
.4
56
 
0.
00
5 
Un
kn
ow
n 
fu
nc
tio
n 
EF
28
74
 
 
hy
dr
ol
as
e,
 H
AD
 s
ub
fa
m
ily
 II
IA
 
!
 
-5
.8
60
 
0.
00
1 
-4
.7
37
 
0.
00
2 
Un
kn
ow
n 
fu
nc
tio
n 
  
 
138 
EF
28
75
 
ac
cA
 
ac
et
yl-
Co
A 
ca
rb
ox
yla
se
, c
ar
bo
xy
l 
tra
ns
fe
ra
se
 a
lph
a 
su
bu
nit
 
!
 
-1
.5
16
 
0.
00
9 
-1
.4
89
 
0.
01
1 
Fa
tty
 a
cid
 a
nd
 p
ho
sp
ho
lip
id 
m
et
ab
oli
sm
 
EF
28
76
 
ac
cD
 
ac
et
yl-
Co
A 
ca
rb
ox
yla
se
, c
ar
bo
xy
l 
tra
ns
fe
ra
se
 b
et
a 
su
bu
nit
 
!
 
-1
.5
39
 
0.
01
1 
-1
.5
03
 
0.
01
1 
Fa
tty
 a
cid
 a
nd
 p
ho
sp
ho
lip
id 
m
et
ab
oli
sm
 
EF
28
78
 
fa
bZ
-2
 
(3
R)
-h
yd
ro
xy
m
yr
ist
oy
l-(
ac
yl-
ca
rri
er
-p
ro
te
in)
 
de
hy
dr
at
as
e 
!
 
-1
.1
87
 
0.
20
6 
-1
.3
22
 
0.
02
8 
Fa
tty
 a
cid
 a
nd
 p
ho
sp
ho
lip
id 
m
et
ab
oli
sm
 
EF
28
79
 
ac
cB
 
ac
et
yl-
Co
A 
ca
rb
ox
yla
se
, b
iot
in 
ca
rb
ox
yl 
ca
rri
er
 p
ro
te
in 
!
 
-1
.2
74
 
0.
04
7 
-1
.2
74
 
0.
04
0 
Fa
tty
 a
cid
 a
nd
 p
ho
sp
ho
lip
id 
m
et
ab
oli
sm
 
EF
28
80
 
fa
bF
-2
 
3-
ox
oa
cy
l-(
ac
yl-
ca
rri
er
-p
ro
te
in)
 sy
nt
ha
se
 II
 
!
 
-1
.3
86
 
0.
01
9 
-1
.3
52
 
0.
02
7 
Fa
tty
 a
cid
 a
nd
 p
ho
sp
ho
lip
id 
m
et
ab
oli
sm
 
EF
28
81
 
fa
bG
 
3-
ox
oa
cy
l-(
ac
yl-
ca
rri
er
-p
ro
te
in)
 re
du
cta
se
 
!
 
-1
.3
79
 
0.
01
8 
-1
.3
53
 
0.
02
6 
Fa
tty
 a
cid
 a
nd
 p
ho
sp
ho
lip
id 
m
et
ab
oli
sm
 
EF
28
82
 
fa
bD
 
m
alo
ny
l C
oA
-a
cy
l c
ar
rie
r p
ro
te
in 
tra
ns
ac
yla
se
 
!
 
-2
.1
59
 
0.
00
6 
-2
.1
16
 
0.
00
3 
Fa
tty
 a
cid
 a
nd
 p
ho
sp
ho
lip
id 
m
et
ab
oli
sm
 
EF
28
83
 
fa
bK
 
en
oy
l-(
ac
yl
-c
ar
rie
r-p
ro
te
in
) r
ed
uc
ta
se
 II
 
!
 
-5
.1
30
 
0.
00
1 
-4
.5
88
 
0.
00
2 
Fa
tty
 a
ci
d 
an
d 
ph
os
ph
ol
ip
id
 m
et
ab
ol
is
m
 
EF
28
91
 
 
gl
yc
os
yl
 tr
an
sf
er
as
e,
 g
ro
up
 1
 fa
m
ily
 
pr
ot
ei
n 
!
 
-6
.0
88
 
0.
00
1 
-3
.9
83
 
0.
00
2 
Ce
ll 
en
ve
lo
pe
 
EF
29
64
 
ula
A 
pu
ta
tiv
e 
tra
ns
po
rt 
pr
ot
ein
, S
ga
T 
fa
m
ily
 
!
 
4.
30
2 
0.
00
1 
3.
96
4 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
ind
ing
 p
ro
te
ins
 
EF
29
65
 
 
co
ns
er
ve
d 
hy
po
th
et
ica
l p
ro
te
in 
!
 
4.
62
2 
0.
00
3 
4.
58
2 
0.
00
2 
Hy
po
th
et
ica
l p
ro
te
ins
 
EF
29
66
 
 
tra
ns
cr
ip
tio
na
l a
nt
ite
rm
in
at
or
, b
gl
G 
fa
m
ily
 
!
 
6.
42
7 
0.
00
1 
5.
98
9 
0.
00
2 
Re
gu
la
to
ry
 fu
nc
tio
ns
 
EF
30
21
 
 
co
ns
er
ve
d 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
6.
80
1 
0.
00
1 
5.
92
2 
0.
00
3 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
- c
on
se
rv
ed
 
EF
31
01
 
 
co
ns
er
ve
d 
do
m
ai
n 
pr
ot
ei
n 
!
 
-5
.8
07
 
0.
00
1 
-4
.1
63
 
0.
01
6 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
- c
on
se
rv
ed
 
EF
31
02
 
 
hy
po
th
et
ica
l p
ro
te
in 
!
 
-2
.7
91
 
0.
00
2 
-2
.2
23
 
0.
00
3 
hy
po
th
et
ica
l p
ro
te
in 
EF
31
03
 
 
m
em
br
an
e 
pr
ot
ein
, p
ut
at
ive
 
!
 
-3
.1
72
 
0.
00
2 
-2
.8
95
 
0.
01
7 
Ce
ll e
nv
elo
pe
 
EF
31
37
 
 
PT
S 
sy
ste
m
, I
IB
 co
m
po
ne
nt
 
!
 
3.
49
8 
0.
00
3 
3.
17
6 
0.
00
3 
Tr
an
sp
or
t a
nd
 b
ind
ing
 p
ro
te
ins
 / 
Si
gn
al 
tra
ns
du
cti
on
 
EF
31
38
 
 
PT
S 
sy
ste
m
, I
ID
 co
m
po
ne
nt
 
!
 
3.
84
2 
0.
00
3 
3.
44
6 
0.
00
5 
Tr
an
sp
or
t a
nd
 b
ind
ing
 p
ro
te
ins
 / 
Si
gn
al 
tra
ns
du
cti
on
 
EF
31
39
 
 
PT
S 
sy
st
em
, I
IC
 c
om
po
ne
nt
 
!
 
6.
16
4 
0.
00
1 
5.
16
6 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
31
40
 
 
al
co
ho
l d
eh
yd
ro
ge
na
se
, i
ro
n-
co
nt
ai
ni
ng
 
!
 
7.
71
2 
0.
00
1 
6.
70
7 
0.
00
3 
En
er
gy
 m
et
ab
ol
is
m
 
EF
31
41
 
 
D-
is
om
er
 s
pe
ci
fic
 2
-h
yd
ro
xy
ac
id
 
de
hy
dr
og
en
as
e 
fa
m
ily
 p
ro
te
in
 
!
 
8.
64
9 
0.
00
1 
7.
28
4 
0.
00
2 
Un
kn
ow
n 
fu
nc
tio
n 
EF
31
42
 
 
6-
ph
os
ph
og
lu
co
na
te
 d
eh
yd
ro
ge
na
se
 
fa
m
ily
 p
ro
te
in
 
!
 
10
.4
28
 
0.
00
1 
8.
67
9 
0.
00
2 
En
er
gy
 m
et
ab
ol
is
m
 
EF
31
45
 
 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
-6
.5
28
 
0.
00
2 
-5
.1
64
 
0.
00
2 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
EF
31
93
 
lrg
B 
Lr
gB
 fa
m
ily
 p
ro
te
in
 
!
 
27
.5
51
 
0.
00
1 
18
.5
07
 
0.
00
2 
Un
kn
ow
n 
fu
nc
tio
n 
  
139 
Chapter 5 
EF
31
94
 
lrg
A 
Lr
gA
 fa
m
ily
 p
ro
te
in
 
!
 
57
.6
09
 
0.
00
1 
39
.0
02
 
0.
00
2 
Un
kn
ow
n 
fu
nc
tio
n 
EF
32
23
 
 
hy
po
th
et
ic
al
 p
ro
te
in
 
!
 
-5
.5
19
 
0.
00
1 
-4
.1
25
 
0.
00
5 
Hy
po
th
et
ic
al
 p
ro
te
in
s 
EF
32
98
 
 
ch
ro
m
os
om
e 
pa
rti
tio
nin
g 
pr
ot
ein
 P
ar
B 
fa
m
ily
 
!
 
-2
.0
86
 
0.
00
4 
-1
.9
76
 
0.
00
4 
Ce
llu
lar
 p
ro
ce
ss
es
 
EF
32
99
 
 
AT
Pa
se
, P
ar
A 
fa
m
ily
 
!
 
-3
.6
15
 
0.
00
2 
-3
.4
78
 
0.
00
2 
Ce
llu
lar
 p
ro
ce
ss
es
 
EF
33
00
 
gi
dB
 
gl
uc
os
e-
in
hi
bi
te
d 
di
vi
si
on
 p
ro
te
in
 B
 
!
 
-5
.1
30
 
0.
00
1 
-5
.1
04
 
0.
00
2 
Un
kn
ow
n 
fu
nc
tio
n 
EF
33
04
 
m
ip
B 
tra
ns
al
do
la
se
-li
ke
 p
ro
te
in
 M
IP
B 
!
 
9.
69
0 
0.
00
1 
8.
65
6 
0.
00
2 
En
er
gy
 m
et
ab
ol
is
m
 
EF
33
05
 
sr
lA
 
PT
S 
sy
st
em
, s
or
bi
to
l-s
pe
ci
fic
 II
A 
co
m
po
ne
nt
 
!
 
7.
59
0 
0.
00
1 
7.
59
0 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
33
06
 
sr
lB
 
PT
S 
sy
st
em
, s
or
bi
to
l-s
pe
ci
fic
 II
BC
 
co
m
po
ne
nt
s 
!
 
6.
99
9 
0.
00
1 
7.
37
4 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
33
07
 
sr
lE
 
PT
S 
sy
st
em
, s
or
bi
to
l-s
pe
ci
fic
 II
C 
co
m
po
ne
nt
 
!
 
6.
96
9 
0.
00
2 
7.
37
9 
0.
00
2 
Tr
an
sp
or
t a
nd
 b
in
di
ng
 p
ro
te
in
s 
/ S
ig
na
l t
ra
ns
du
ct
io
n 
EF
33
08
 
sr
lR
 
tra
ns
cr
ip
tio
na
l r
eg
ul
at
or
 S
rlR
 
!
 
13
.3
47
 
0.
00
1 
12
.9
00
 
0.
00
2 
Re
gu
la
to
ry
 fu
nc
tio
ns
 
EF
33
09
 
sr
lM
 
pu
ta
tiv
e 
tra
ns
cr
ip
tio
na
l a
ct
iv
at
or
 S
rlM
 
!
 
17
.4
06
 
0.
00
1 
16
.5
03
 
0.
00
2 
Re
gu
la
to
ry
 fu
nc
tio
ns
 
EF
33
10
 
sr
lD
 
ox
id
or
ed
uc
ta
se
, s
ho
rt 
ch
ai
n 
de
hy
dr
og
en
as
e/
re
du
ct
as
e 
fa
m
ily
 
!
 
10
.2
85
 
0.
00
1 
11
.5
30
 
0.
00
1 
Un
kn
ow
n 
fu
nc
tio
n 
 
• 
log
2-r
at
ios
 w
er
e 
ca
lcu
lat
ed
 a
s [
VE
14
08
9Δ
lux
S]
/[ 
VE
14
08
9]
 a
nd
 [V
E1
40
89
Δl
ux
S 
su
pp
lem
en
te
d 
wi
th
 1
0 
μM
 
DP
D]
/[V
E1
40
89
], 
wi
th
 a
 m
inu
s s
ign
s r
ep
re
se
nt
ing
 a
 d
ow
n-
re
gu
lat
ion
.
  
  
140 
 
The full 113 differentially regulated genes, 70 upregulated and 43 
downregulated, were found to be uniquely affected by the luxS mutation, 
independently of DPD addition, when compared to the parental strain. 
Almost 40 % of the down-regulated genes and more than 30 % of the up-
regulated genes in the luxS mutant, when compared to VE14089, are 
annotated as hypothetical proteins or proteins of unknown function. Genes 
significantly expressed but with a fold-change in both comparisons below 5 
were recovered in order to check if they follow the same regulatory trend as 
the transcriptional unit they belong to, as predicted by http://biocyc.org 
(Karp et al., 2005). Consistent transcriptional changes in complete operons 
and clusters were detected each time for every transcriptional unit (Table 
5.4). 
The luxS mutation resulted in changes in nearly every cellular 
process (Figure 5.7), and the affected genes were distributed throughout 
the genome (Table 5.4). Unknown function or hypothetical protein genes 
contributed the largest fraction, more than 35 %, followed by genes 
required for transport and binding, signal transduction, energy metabolism, 
cell envelope, and regulatory functions. Important effects were also 
observed for DNA metabolism, fatty acid and phospholipid metabolism, and 
biosynthesis of cofactors. The luxS mutation induced deep changes in the 
transcription of many genes, and extracellular addition of AI-2 did not 
significantly alter gene expression in VE14089ΔluxS. Below, we will 
therefore discuss several genes that were differentially expressed in the 
luxS mutant, independently of extracellular added DPD. 
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Figure 5.7. Distribution by number of differentially expressed genes, up-regulated 
(in red and shown as positive) and down-regulated (in blue and shown as 
negative), and by JCVI (http://cmr.jcvi.org) cellular mainrole found to be affected by 
the luxS mutation, which was independent of DPD addition, when compared to the 
parental strain VE14089. The genes with more than one cellular mainrole were 
counted twice. Percentage of differentially expressed genes with | log2-ratios | > 
5.0 in each JCVI cellular mainrole: Cellular processes (33 %), DNA metabolism (33 
%), Energy metabolism (50 %), Fatty acid and phospholipid metabolism (33 %), 
Hypothetical proteins (19 %), Hypothetical proteins – conserved (17 %), Protein 
fate (50 %), Regulatory functions (25 %), Signal transduction (47 %), Transport and 
binding proteins (43 %), and Unknown function (33 %).”, should be replaced by: 
“Percentage of differentially expressed genes with | log2-ratios | > 5.0 in each JCVI 
cellular mainrole: Transport and binding proteins (20 %), Signal transduction 
(17 %), Hypothetical proteins (14 %), Energy metabolism (12 %), Cell envelope 
(11 %), Hypothetical proteins - conserved (11 %), Unknown function (11 %), 
Regulatory functions (7 %), Cellular processes (3 %), DNA metabolism (3 %), Fatty 
acid and phospholipid metabolism (3 %), Biosynthesis of cofactors, prosthetic 
groups, and carriers (2 %), Protein fate (2 %), Amino acid biosynthesis (1 %), 
Central intermediary metabolism (1 %), Purines, pyrimidines, nucleosides, and 
nucleotides (1 %), Transcription (1 %). 
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AMC 
In E. faecalis V583, LuxS occupies the same position in the AMC as 
that of most AI-2 type QS system possessing bacteria, which allows the 
production of AI-2 and can contribute to the recycling of the building blocks 
needed for methionine biosynthesis. However, in silico genomic analysis 
showed that there is not a complete AMC (Figure 5.8). According to the Sri 
International Pathway Tools (v15.5) (Karp et al., 2010), that predicts current 
and filled pathway holes, three pathway holes were identified in E. faecalis 
V583 methionine biosynthesis pathway, including the AMC. 
In a complete AMC, SAM is regenerated from SAH via 
homocysteine and methionine, allowing another round of methylation/ 
transmethylation to occur. The conversion of homocysteine to methionine 
can be carried out by either MetE or MetH (Doherty et al., 2010). Despite, in 
E. faecalis V583 genome, ef0395 being annotated as a putative methionine 
synthase, a protein BLAST (Altschul et al., 1997; 2005), against the 
microbial protein database from NCBI, reveals a high identity of EF0395 to 
MetE (2.1.1.14), an enzyme that could catalyse the last step in the 
production of methionine, and to the putative MetE that can be found in E. 
faecalis OG1RF, previously described as being auxotrophic for methionine 
with an OG1 DNA library unable to complement a methionine auxotrophic 
E. coli strain (Murray et al., 1993). CGH-results indicate that V583, the 
parental strain of VE14089, have similar requirements for amino acids as 
OG1RF, which was shown to be auxotrophic for amino acids like histidine, 
isoleucine, methionine, and tryptophan (Murray et al., 1993; Vebø et al., 
2009). This methionine auxotrophy reinforces the effective presence of a 
pathway hole in the biosynthesis pathway for this amino acid in V583. 
Bacteria lacking an intact AMC lose the ability to recycle methionine and, 
thus, are dependent on its uptake or synthesis from environmental sulphur 
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sources. This metabolic gap could be filled by methionine-specific transport 
systems detected in the genome (Figure 5.8), like metNPQ (ef2082-0, 
ef2498-6 and ef3200-198) and mstTUV (ef2154-2), or by methionine-
related ABC transport system involved in the transport of oligopeptides or 
methionine, tomA (ef3081) gene that belongs to the opp family (Rodionov 
et al., 2004; Vitreschak et al., 2008). 
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Figure 5.8. AMC in V583. Possible pathway holes, as identified by Sri International 
Pathway Tools (v15.5) (Karp et al., 2010), are indicated in faded grey; the reaction 
that corresponds to LuxS activity, which is absent in the luxS mutant, is indicated in 
a dashed red box; putative methionine uptake transporters are indicated next to the 
white arrow; differential expression of genes in the VE14089ΔluxS mutant when 
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compared to VE14089, independently of extracellular added DPD, are indicated 
next to the corresponding gene locus (NS: not significantly expressed (P-
value > 0.05 or P-value < 0.05 and | log2 ratio | < 5), DOWN: down-regulation (P-
value < 0.05, log2 ratio < -5). HSE: L-homoserine; CYS: L-cysteine; CYSTA: L-
cystathionine; HCY: L-homocysteine; MET: L-methionine; SAM: S-adenosyl-L-
methionine; SAH: S-adenosyl-L-homocysteine; SRH: S-ribosyl-L-homocysteine: 
DPD: (S)-4,5-dihydroxypentan-2,3-dione. 
 
The absence of a full AMC in VE14089, its putative methionine 
auxotrophy and the indication that Pfs is sufficient for SAH detoxification 
(Challan Belval et al., 2006), would reduce the metabolic impact of the 
added luxS deletion in VE14089ΔluxS, and could explain the lack of 
apparent growth defects.  
The luxS mutation did not significantly alter the expression of any of 
the genes involved in the AMC in VE14089, except for luxS (ef1182), the 
deleted gene (Figure 5.8). There were also no significant alterations in the 
putative methionine transporters expression or the main pathways for 
methionine biosynthesis, from homoserine (or even the from the 
homoserine aspartate precursor) or serine precursors (data not shown). 
However, the lack of significant differential expression of genes 
involved in methionine import and the AMC does not necessarily indicate 
that the metabolite flux on those pathways remains unaltered in the mutant. 
In E. faecalis the regulation of several genes involved in the methionine cell 
metabolism are regulated by RNA mediated mechanisms, the transport of 
methionine and methionine precursors by T-boxes, while the conversion of 
methionine by MetK in the AMC is regulated by SAM availability and its 
interaction with a S-box (Rodionov et al., 2004; Vitreschak et al., 2008). The 
activity of DNA methyltransferases, which are often used for silencing and 
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regulating genes without changing the original DNA sequence as well as 
protecting DNA from enzymatic cleavage, can be inhibited by a reduction in 
the availability of the methyl donor SAM (Kozlova et al., 2008) but also by 
the accumulation of the intermediary SAH, a potent inhibitor of the 
methyltransferases, making its removal from the cell important for normal 
physiology (Keller and Surette, 2006). However, whether luxS inactivation 
reduces SAM concentrations sufficiently to influence these processes 
significantly remains to be seen. 
Having no complete cycle for regeneration of methionine raises the 
question of whether the only function of LuxS in E. faecalis is as a QS 
molecule synthase, with a concomitant homocysteine regeneration, or 
whether LuxS in E. faecalis has another direct or indirect metabolic role, 
like maintaining the homeostasis of AMC metabolites and ensuring 
effective methylation (Heurlier et al., 2009). 
Energy metabolism 
In our study, most of the observed up-regulated genes in the luxS 
mutant had functions related with energy metabolism. All differentially 
expressed components of the phosphoenolpyruvate (PEP) transport 
system (PTS) were strongly upregulated, between 5 and 75-fold. The PTS 
is a multiprotein phosphorelay system that couples the transport of sugars 
across the bacterial cell membrane with their simultaneous 
phosphorylation. The PTS is composed of three distinct proteins: enzyme I 
(EI), histidine protein (HPr) and enzyme II (EII). This PTS is the main sugar 
uptake mechanism in E. faecalis, just like for various other bacteria, but can 
also be associated to amino sugar and nucleotide sugar transport. 
V583 genome contains 35 probable PTS systems and complete 
transport and pathways for exploitation of more than 15 different sugars 
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have been predicted (Paulsen et al., 2003). V583 has been described as 
having the ability to utilize cellobiose, fructose, lactose, galactose, glucose, 
glycerol, maltose, mannitol, mannose, N-acetylglucosamine, ribose, 
sucrose, and trehalose. Although genes from the degradative pathways of 
arabinose, rhamnose and xylose can be identified in the genome, no 
specific transporter has been described and no fermentation for those 
sugars has been observed (Aakra et al., 2007). Energy production from 
these substrates occurs via glycolysis or the pentose phosphate pathways, 
with the tricarboxylic acid (TCA) cycle absent (Paulsen et al., 2003). 
The up-regulated PTSs are involved in the main glucose and 
fructose transport (Muraoka et al., 1991), the mannose PTS (Man family) 
(mptBACD operon— ef0019-22), and putatively involved in the transport of 
cellobiose (Lac family) (ef0292 that belongs to the ef0292-1 operon, 
ef1012, ef1013, ef1017-8 and ef1019), mannitol (Fru family) (ef0411-2 
operon), fructose (Fru family) (ef0694-5 operon), sorbitol/glucitol (other 
family) (srlEBA operon— ef3307-5), and gluconate (ef3139 of ef3139-6 
operon and ef2647, belonging to the GntP family).  
Genes involved in the utilization of these transported carbohydrates, 
like for mannitol (mtlD — ef0413), fructose (fruK-1— ef0693), sorbitol (srlD 
— ef3310) and gluconate (ef3140, ef3141 and ef3142 that belong to the 
ef3142-34 cluster that facilitates gluconate uptake and catabolism via the 
mannonate route (Vebø et al., 2009), and ef2646 a putative glycerate 
kinase, the last step in the non-phosphorylative Entner-Doudoroff pathway), 
were also up-regulated in the luxS mutant. glpK (ef1929) from the glycerol 
catabolic operon glpKOF (ef1929-7), mipB (ef3304), a transaldolase 
important for the balance of metabolites of the non-oxidative phase of the 
pentose phosphate pathway, and maeE (ef1206), coding for a malate 
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oxidative decarboxylating enzyme (Espariz et al., 2011), also had their 
transcription increased.  
Along with the increased transcription srlEBA and srlD, the other 
two regulatory genes of the srl operon (Boyd et al., 2000), srlR (ef3308) that 
codes for a transcriptional regulator and srlM (ef3309) that codes for a 
putative activator, were also up-regulated. ef2966, erroneously annotated 
as a BglG-type antiterminator and lacking an RNA-binding domain (Opsata 
et al., 2010), has PTS domains and PTS regulation domains, may therefore 
be a transcriptional regulator, and belongs to a transcriptional unit (ef2966-
4) with a gene (ef2964) encoding a sugar permease putatively involved in 
the L-ascorbate utilization pathway. This gene was up-regulated as well as 
ef1591, a transcriptional regulator of the AraC family, and lacD-1 (ef0696). 
In contrast to its paralog LacD-2, which is involved in lactose metabolism, 
LacD-1 has been adapted to function as a sensor of its substrates, which 
are the central intermediates of the Embden-Meyerhoff-Parnas glycolytic 
pathway, and has been described to be involved in a unique form of carbon 
catabolite repression (Commichau and Stülke, 2008).  
In E. faecalis the branched-chain alpha-keto acid dehydrogenase 
(BCKDH) complex, encoded in gene cluster ptb-buk-bkdDABC (ef1663-58), 
is devoted to energy generation (Fernández and Zúñiga, 2006). This 
complex catalyses the oxidative decarboxylation of branched-chained-keto 
acids, valine, leucine, and isoleucine, with the concomitant reduction of 
NAD+, supposedly generating the corresponding acyl coenzyme A and ATP 
via substrate level phosphorylation (Solheim et al., 2007). In the luxS 
mutant the whole gene cluster was up-regulated indicating an increased 
usage of branched-chain amino acid (BCAA) possibly as an alternative 
energy source. There is no evidence linking the enterococcal bkd gene 
cluster to the biosynthesis of branched-chain fatty acids, as found in B. 
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subtilis (Solheim et al., 2007). The up-regulation of this operon should 
therefore not be correlated to the observed repression of genes involved in 
fatty acid synthase II (FASII) in the mutant. 
When compared to VE14089, the luxS mutant displays an 
increased transcription of genes involved in the transport and utilization of 
less preferred carbon sources. In S. mutans, the mutation in a 
methyltransferase was associated with the up-regulation of loci dedicated 
to carbohydrate transport, increasing the expression of a mannose/fructose 
PTS that is fructose-inducible, as well as other secondary carbohydrate 
sugar transport operons such as mannitol/sorbitol, cellobiose, and the 
multiple-sugar-metabolism operon, each potentially employing multiple 
mechanisms of regulating expression (Banas et al., 2011). The majority of 
the changes triggered by the loss of DNA methylation resulted in up-
regulation of particular genes, implying that DNA methylation most often 
has a moderating effect on gene expression (Banas et al., 2011). A change 
in the availability of SAM could similarly affect the luxS mutant 
methyltransferases activity, therefore corroborating the observed increase 
of energy metabolism gene transcription. The less common carbohydrates 
are channelled to the energy production pathways available to E. faecalis, 
such as the Embden-Meyerhoff-Parnas glycolytic pathway, the pentose 
phosphate pathway, but also the Entner-Doudoroff pathway. The luxS 
mutant is also up-regulating genes that allow the usage of BCAAs, glycerol 
and malate. This reveals an increased carbon flux from sources other than 
hexose sugars that are rapidly depleted from 2×YT growth media, where no 
glucose has been added. 
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Cell envelope components 
In the luxS mutant we can observe the down-regulation of a number 
of genes associated with the different cell envelope structures. These 
involve the peptidoglycan (ef2605 — murAA), teichoic acids (ef1172 and 
ef1173 genes from the ef1172-4 operon, and ef2627), lipopolysaccharides 
(ef2891), the epa cluster (ef2197 of one of the epa clusters, ef2200-189), 
and the FASII pathway (ef2176 and ef2883 from the ef2886-75 cluster, and 
ef0848 — acpS). Teichoic acids, which are covalently bound to the thick 
peptidoglycan, are believed to be involved in concentrating metal ions from 
the surroundings and to also direct autolytic enzymes to sites of 
peptidoglycan digestion (autolysis), one of the steps in cell wall 
biosynthesis. Regulating the synthesis of these fatty acids, like in the FASII 
pathway, allows bacteria to modify membrane lipid composition and survive 
changes in temperature, pH and other environmental factors (Zhang and 
Rock, 2008). The remodelling of the fatty acid composition of the cell 
membrane has been reported and is common in response to different 
stressors (Vebø et al., 2009; Aakra et al., 2010; Vebø et al., 2010). This 
suggests an adjustment in fatty acid composition and membrane fluidity in 
the luxS mutant, when compared to VE14089. 
Other elements associated with the cell envelope are however up-
regulated in the luxS mutant. The SugE-1 component (EF0359) of multidrug 
efflux system proteins SugE-1 and SugE-2, encoded in the ef0359-60 
operon, suggested to play an important role in the uptake of chaperone 
regulatory compounds (Bay et al., 2008), glsB (ef0081), the last gene of the 
gls24 operon (ef0076-81), which was shown to be induced under a number 
of stress conditions (Choudhury et al., 2011), and a putative membrane 
protein (EF1751), belonging to a gene cluster (ef1751-3) coding for cell 
membrane proteins previously found to be up-regulated in daptomycin-
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resistant E. faecalis (Steed et al., 2011), were also significantly up-
regulated in the luxS mutant, when compared to the WT.  
DNA metabolism, transcription and regulation 
Homologous recombination (HR) supplies one of the main avenues 
for repair of DNA damage and the major cellular pathway to restart arrested 
replication forks. Repair of DNA double-strand breaks involves the 
establishment of a four-way DNA crossover from the pairing of strands from 
homologous duplexes, known as the Holliday junction (HJ) (Carrasco et al., 
2009). This process relies on the action of translocases, such as RuvAB, 
and HJ resolvases, such as RecU. In the luxS mutant both processes, 
involving RuvA (EF0066 coded in the ef0066-7 operon with ruvB) and RecU 
(EF1149), were down-regulated. Genes encoding for a PAI resolvase 
(ef0534 — corresponding to PAI gene ef0061) as well as a PAI putative 
membrane protein (ef0543 — corresponding to PAI gene ef0070), were 
also down-regulated. The genes coding for these proteins showed a 
decreased transcription in the luxS mutant, which may indicate a reduced 
need for DNA repair than in VE14089 or the lack of the necessary signals 
for that repair to occur.  
The methylation of DNA provides an epigenetic signal that 
influences and regulates numerous physiological processes in the bacterial 
cell including chromosome replication, mismatch repair, transposition, and 
transcription (Heusipp et al., 2007), and alterations in the AMC 
intermediaries could interfere. 
Other genes 
The gene coding for FeoA (ef0475 belonging to feoAB operon — 
ef0475-6), a small soluble SH3-domain protein probably located in the 
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cytosol of still unknown specific function, was up-regulated in the luxS 
mutant. Bacteria commonly utilize a unique type of transporter, called Feo, 
to specifically acquire the ferrous (Fe2+) form of iron from their environment 
(Cartron et al., 2006). The Feo system has been associated to increased 
virulence in Streptococcus suis (Aranda et al., 2009) as well as having a 
potentially important role of iron acquisition and metabolism during growth 
in urine in E. faecalis (Vebø et al., 2010). However, an increased FeoAB-
mediated ferrous iron uptake is anticipated to yield hydroxyl radical by the 
Fenton reaction (Guo et al., 2011) and cause oxidative stress that can 
damage that damage DNA, proteins, and membranes (Stevens et al., 2010; 
Cesselin et al., 2011). 
Possibly to compensate this and other increases in oxidative stress, 
the genes coding for the two general stress proteins (Gsps) associated with 
increased survival against organic hydroperoxide and ethanol (Gsp64 and 
Ohr) (Auffray et al., 2011) were up-regulated in the luxS mutant, as well as 
two other putative universal stress protection genes (ef1982 and ef1058). 
ef1058 has been similarly upregulated after Zn2+ metal stress (Coelho 
Abrantes et al., 2011).  
When compared to the WT, the luxS mutant displayed a reduced 
transcription of genes involved in the biosynthesis of osmoprotectant, 
salvage of purines and transport of metabolites. The gene coding for ProB 
(EF0038), a glutamate 5-kinase that catalyses the first step in the 
biosynthesis of proline, was down-regulated when compared to VE14089, 
indicating a decreased need for that amino acid, which has been described 
as being able to function as an important osmostress protectant in B. 
subtilis (Brill et al., 2011). The transcription of xanthine 
phosphoribosyltransferase gene, xpt (ef2365), from the purine salvage 
pathway was also down-regulated in the luxS mutant. This enzyme can 
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help to take up xanthine, allowing these compounds to serve as substrates 
for nucleotide biosynthesis and as sources of carbon and nitrogen, just like 
described for B. subtilis (Belitsky and Sonenshein, 2011). When compared 
to VE14089, the luxS mutant shows a reduced need to activate this salvage 
pathway.  
The transcription of a chaperone and of several of genes involved in 
the regulatory functions was also down-regulated in the luxS mutant. HslO 
(EF0266), along with other chaperones, is involved in the refolding of 
denatured proteins to maintain homeostasis (Santos et al., 2010), 
protecting cells from various stress conditions (Misra et al., 2011). From the 
4 down-regulated genes involved in regulatory functions, ef1864, ef1599, 
ef0873 and ef2630, the gene coding for a response regulator (RR) (RR08 
— EF1864) of a two-component system (Ehk-Err08 — EF1863-4) has 
already been describes as being involved in stress response against heat 
(Le Breton et al., 2003), being linked to DNA mobile elements (Hancock 
and Perego, 2004), and is suggested to be involved in response to 
oxidative stress, other cellular stresses and sensing changes in cell wall 
intermediates and components (Ma et al., 2008), while ef0873 has an 
increased expression level after copper (Cu) exposure (Reyes-Jara et al., 
2010). 
The ef3194-3 operon, that encodes a system made of genes lrgA — 
encoding a putative murein hydrolase regulator holin-like protein — and 
lrgB — encoding an antiholin-like protein, was highly up-regulated. 
Increased expression of lrgAB operon, a negative regulator of autolysis 
whose product negatively affect peptidoglycan hydrolases (Liu et al., 2011), 
has already been described in Staphylococcus aureus in response to 
antibacterial compounds (Liu et al., 2011), in Streptococcus mutans in 
response to multiple environmental signals (playing important roles in 
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biofilm formation, oxidative stress tolerance and regulation of autolysis) 
(Ahn et al., 2010), but also in E. faecalis response to blood (Vebø et al., 
2009). It is proposed that the LytSR two-component regulatory system 
senses decreases in membrane potential caused by proton motive force 
and responds by inducing lrgAB transcription (Bayles, 2007). The exact 
mechanism of lrg genes products in virulence remains however unclear 
(Ahn et al., 2010). In the luxS mutant all the detected differences in gene 
expression associated with metabolism could cause alteration in the 
surrounding media, like pH, which could alter the membrane potential 
therefore serving as a signal for LytSR allowing a responds by inducing 
lrgAB transcription. 
The luxS mutation may have diverse effects in the cell. As a direct 
effect this mutation can shift the equilibrium of the intracellular 
concentrations of SRH, DPD, and homocysteine, as previously described in 
E. coli (Halliday et al., 2010). These metabolites may have some signalling 
roles inside the cell and therefore may globally affect gene expression. 
SRH, though not toxic, may over-accumulate in the mutant and therefore 
disturb metabolite concentration (like promoting the accumulation of SAH, a 
potent inhibitor of the methyltransferases (Keller and Surette, 2006)), which 
may affect the AMC, the carbon usage metabolism, or even promote biofilm 
formation, as seen in L. monocytogenes (Challan Belval et al., 2006). The 
intracellular function of DPD, in cells where no internalization has been 
described, has never been elucidated, and the necessary de novo 
biosynthesis of homocysteine may not be enough to compensate the lack 
of recycling and therefore also affect the cellʼs metabolite homeostasis, as 
previously observed (Halliday et al., 2010). The LuxS protein can also have 
a dual role and not only function as the enzyme catalysing the last step of 
the AMC, belonging to the so called moonlighting protein, as it has been 
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speculated for Salmonella Typhimurium LuxS (Kint et al., 2009). Although 
apparently no effect is detected in the expression of genes involved in the 
AMC, the luxS deletion may nevertheless still alter methionine import 
(methionine participates in initiating protein biosynthesis as well as being a 
constituent of proteins) or SAM production (as an universal methylating 
agent), by altering the homeostasis of intermediary metabolites, as seen in 
E. coli (Halliday et al., 2010). However, luxS may also have an indirect 
effect on global gene expression. 
Global regulators 
By searching the E. faecalis V583 genome using the catabolite 
responsive elements (cre) query consensus sequence 
WTGWAARCGYWWWCW developed for E. faecalis, like previously 
performed by (Opsata et al., 2010), the previously described sequence of a 
rex-box, TGTGANNNNNNTCACA (Mehmeti et al., 2011), and the sigma-54 
consensus sequence YTGGCACNNNNNTTGCW (Opsata et al., 2010), 
developed for B. subtilis, using Virtual Footprint v3.0 and allowing 1 
sequence mismatch, several promoter regions of differentially expressed 
genes between the WT and the luxS mutant were identified (Table 5.5). 
Many processes differentially regulated between the luxS mutant 
and the WT belong to pathways with genes that respond to a number of 
global regulators (Table 5.5). Microorganisms have evolved multiple 
mechanisms to sense and respond to the availability of specific nutrient 
types. However, in order to optimize growth, microorganisms must not only 
sense the availability of a nutrient type (e.g., carbon and energy), but they 
must also adjust their uptake or production of other nutrient types (e.g., 
nitrogen-, phosphorus-, and sulphur-containing compounds) according to 
the availability of carbon. Only in a few cases have such interactions been 
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investigated (Choi and Saier, 2005). Many pleiotropic regulators have been 
described in E. faecalis as being involved in the regulation of these 
metabolic processes. These global regulators are involved in sensing 
carbohydrate availability, the redox turnover in the cell, interaction with 
environment but also a number of different stresses such as oxidative 
stress or starvation. The luxS mutation impact on these intricate regulatory 
networks is clear, though a direct or indirect contribution remains to be 
elucidated. 
The TCA cycle being absent in E. faecalis, the energy is derived via 
glycolysis, the pentose phosphate pathway, but also the Entner-Doudoroff 
pathway. E. faecalis has a carbon catabolite repression (CCR) pathway to 
actively regulate energy metabolism while growing on easily fermentable 
sugars such as glucose (Manson and Gilmore, 2006a). It has been 
previously described that Luria-Bertani broth, which has different amounts 
of the same components as 2×YT broth used in this study, contains <100 
μM fermentable sugar equivalents utilizable (free sugars, sugar 
phosphates, oligosaccharides, nucleotides, etc.) (Sezonov et al., 2007). 
Such concentrations of glucose is below the threshold for release of CCR, 
and the cells thus initiate use of less preferred carbon and energy sources 
(Vebø et al., 2010). In Firmicutes, the global mechanism of CCR is 
mediated by the pleiotropically acting catabolite control protein A (CcpA) 
and involving its target sites, the cre (Fujita, 2009; Suárez et al., 2011). The 
cre-site is located in the 5ʼ-upstream regulatory region or within the reading 
frames of CCR-controlled genes. A protein complex involving CcpA inhibits 
or activates the transcription of CCR-controlled genes or operons 
(Deutscher et al., 2006). CCR seem to be controlling carbon hierarchy 
usage in the luxS mutant, by up-regulating the transport of less preferred 
sugars associated with cre-sites (Table 5.5), which is in agreement with 
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previous findings (Opsata et al., 2010). In E. faecalis the BCKDH complex, 
encoded in gene cluster ptb-buk-bkdDABC (ef1663-58), is devoted to 
energy generation. The control by CCR of this pathway would be consistent 
with its catabolic role in the utilization of branched-chain α-oxoacids as an 
alternative energy source (Fernández and Zúñiga, 2006), with a cre-site 
found in its promoter region. LacD.1 has been adapted to function as a 
sensor of its substrates, which are the central intermediates of the Embden-
Meyerhoff-Parnas glycolytic pathway, implicating LacD.1 as a regulator of 
global carbon catabolite control (Kietzman and Caparon, 2011).  
Other genes are responding to the NADH/NAD+ ratio (Table 5.5). 
This ratio is an important component of the redox state of a cell, a 
measurement that reflects both the metabolic activities and the health of 
cells. Both pyridine nucleotides bind to the Rex protein, but only NADH 
causes Rex to lose affinity for target DNA. The high turnover of NAD(H) 
means that a decrease in oxygen availability, due to cells reaching 
stationary phase, to high cell density, or the inhibition of respiration by other 
means, and can lead to a rapid increase in the NADH/NAD+ redox balance, 
by an increase in the NADH pool. Presumably, the increase in the 
NADH/NAD+ ratio leads to adaptation through the induction of the Rex 
regulon. E. faecalis contains in its genome two ORFs similar to Rex (ef2638 
and ef2933), suggesting that one might respond to other signals like 
NADPH instead of NADH, for instance. 
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Table 5.5. Differential expression of genes associated with the interaction with 
transcriptional regulators, with the consensus motif localized in the intergenic 
region (int) or in the coding region (cod) in the VE14089ΔluxS mutant when 
compared to VE14089, independently of extracellular added DPD. DOWN: down-
regulation (P-value < 0.05, log2 ratio < -5), UP: up-regulation (P-value < 0.05, log2 
ratio > 5). 
 gene name log2 ratio motif 
(localization) 
response to carbon usage:    
fructose usage ef00693-6 UP cre (int) 
cellobiose usage ef1012 UP cre (int) 
cellobiose usage ef1013? UP cre (int) 
transaldolase important for pentose 
phosphate pathway 
ef1207-6 UP cre (int) 
ptb-buk-bkdDABC 
BCAA usage 
ef1663-58 UP cre (int) 
ptb-buk-bkdDABC  
BCAA usage 
ef1663-58 UP cre (cod) 
glpKOF 
glycerol usage 
ef1929-7 UP cre (int) 
gluconate usage ef3142-37 UP cre (int) 
amino acid permease ef0929 DOWN cre (cod) 
teichoic acid biosynthesis ef1172-4 DOWN cre (int) 
HP ef3145 DOWN cre (int) 
    
response to NADH/NAD+ ratio:    
mptBACD ef0019-22 ef0020 UP rex (int) 
HP ef1671 UP rex (int) 
proB - proline biosynthesis ef0037 DOWN rex (int) 
hydrolase ef2874-1 DOWN rex (int) 
HP ef3145 DOWN rex (int) 
    
response to the interaction with the 
environment:  
   
mptBACD ef0019-22 UP sigma-54 (int) 
sugE-1 ef0359 UP sigma-54 (int) 
sugE-2 ef0360 UP sigma-54 (int) 
cellobiose usage PTS ef1012 UP sigma-54 (int) 
cellobiose usage PTS ef1017-8 UP sigma-54 (int) 
murAA / HP peptidoglycan biosynthesis ef2605-4 DOWN sigma-54 (cod) 
FASII pathway ef2883-75 DOWN sigma-54 (cod) 
gluconate usage (in ef3142-37 operon) ef3139 UP sigma-54 (cod) 
 
In the luxS mutant the transcription of some genes, like PTS 
operons, can also be initiated at sigma-54-dependent promoters (Table 
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5.5). The role of sigma-54 has been well documented in a variety of 
bacterial species and implicated as a central player in the control over the 
processes that involve the physical interaction of an organism with its 
environment (Francke et al., 2011), by regulating numerous biological 
properties including those that relate to virulence, like in the colonization of 
a host or the formation of biofilm (Francke et al., 2011; Iyer and Hancock, 
2012). While not belonging to the alternative sigma factors, the role of E. 
faecalis sigma-54 (RpoN — EF0782) has been limited to observations 
made regarding its contribution to sensitivity to class IIa bacteriocins 
through the regulation of sugar PTS systems (Auffray et al., 2011; Iyer and 
Hancock, 2012). 
The luxS mutation altered the expression of several genes that are 
under the regulation of enterococcal pleiotropic regulators. This 
interconnected regulatory network is apparent when observing the 
presence of, for example, dually regulated pathways that link two different 
sensing mechanisms. For example, in the major glucose PTS, the 
mannose-PTS, in addition to the sigma-54 promoter preceding ef0019, a 
Rex box found in front of ef0020, suggesting that this PTS is also regulated 
by the NADH/NAD ratio (Mehmeti et al., 2011). In E. faecalis it is clear that 
there are many genes that appear to be regulated by a network involving 
global regulators and energy and redox sensing aimed at maintaining 
homeostasis. The deletion of luxS gene and the global change in gene 
expression evokes the complexity of the central energy metabolism, 
suggesting intricate direct and indirect regulation on how these bacteria 
cope with their changing access to carbon as well as nitrogen sources.  
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Virulence associated genes 
Besides the already mentioned and described cell component 
ef2197 from the epa cluster, none of the other potential virulence factors 
described by Manson et al. (Manson and Gilmore, 2006b) were significantly 
regulated above the set fold change (Table 5.6). However, significantly 
regulated genes, below the determined cutoff, in the luxS mutant when 
compared to VE14089, were all down-regulated. The possible reduction in 
the availability of AMC intermediary SAM in the luxS mutant may inhibit 
Dam (DNA adenine methylase) and Dcm (DNA cytosine methylase)-
dependent DNA methylation, which have been associated with bacterial 
virulence (Kozlova et al., 2008) and play a role in the pathogenesis (Sun et 
al., 2010). 
 
Table 5.6. Differential expression of potential virulence factors (according to 
Manson et al. (Manson and Gilmore, 2006b)) in the VE14089ΔluxS mutant when 
compared to VE14089 with no extracellular addition of DPD (similar data not 
shown for VE14089ΔluxS mutant when compared to VE14089 with extracellular 
addition of DPD). ns: not significantly expressed (P-value > 0.05), bold type: 
| log2 ratio | > 5.0. 
gene name/symbol gene 
locus 
log2 ratio function 
putative hemolysin ef0700 -3.037  hemolysin/unknown 
putative hemolysin ef0982 -1.722 hemolysin/unknown 
putative hemolysin ef1685 ns hemolysin/unknown 
putative exfoliative toxin 
A 
ef0645 ns toxin/unknown 
putative xanthan lyase ef0818 ns breaking glycosidic 
bonds 
putative xanthan lyase ef3023 ns breaking glycosidic 
bonds 
FsrA ef1822 -1.930 fsr operon 
FsrB ef1821 ns fsr operon 
FsrC ef1820 ns fsr operon 
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GelE ef1818 ns zinc 
metalloprotease 
SprE ef1817 ns serine protease 
Eep ef2380 -3.235 zinc 
metalloprotease 
CylR2 ef0523 -1.555 cytolysin operon 
CylR1 ef0524 -1.736 cytolysin operon 
CylLL ef0525 ns cytolysin operon 
CylLS ef0526 ns cytolysin operon 
CylM ef0527 -2.943 cytolysin operon 
Ace ef1099 -1.892 conjugation 
internalin family protein ef2686 ns  
aggregation substance ef0149 ns conjugation 
aggregation substance, 
putative 
ef0485 ns conjugation 
protein with homology to 
FbpA 
ef1249 ns unknown 
BopD ef0954 -1.614 biofilm 
cps locus ef2495-85 -3.127/-2.225/-2.823/-
2.477/-
2.061/ns/ns/ns/ns/ns/ns 
immune evasion 
epa cluster 1 ef2200-
189 
-1.458/-2.743/-2.281/-
5.537/-1.917/-1.685/-
1.390/ns/ns/ns/ns/ns 
cell wall immune 
evasion 
epa cluster 2  ef2184-77 ns/-2.156/-
1.376/ns/ns/ns/ns/ns 
cell wall immune 
evasion 
dlt operon ef2749-6 ns immune evasion 
homologous to Mprf ef0031 ns homology to 
defensins 
 
Conclusion 
In this study we were able to associate the extracellular production 
of AI-2 in E. faecalis to the presence and expression of luxS gene. When 
compared to the WT, the luxS mutant has no apparent phenotype 
regarding growth, biofilm formation, adhesion to Caco-2 cells, resistance to 
oxidative stress and survival in a macrophage survival assay. Despite no 
apparent phenotype alteration, a microarray transcriptional analysis 
revealed that the luxS mutation caused pleiotropic effects in gene 
expression in the mutant, when compared to its WT. The lack of 
  
  
162 
extracellular AI-2 was not responsible for the pleiotropic effects observed, 
since the extracellular addition of DPD, in a similar concentration to the one 
produced by the WT, had no effect on gene expression. The transcriptional 
analysis indicates that VE14089 and its isogenic luxS mutant are not 
displaying the same gene expression pattern, in the same moment of the 
growth phase, and that the effects of the mutation are global. These global 
differences in gene expression affected all the main gene functional roles 
like energy, DNA, fatty acid and intermediary metabolites metabolism, 
transport and regulatory functions, cell envelope, but mainly affected 
hypothetical and unknown function proteins. No significant differential 
expression was detectable in the genes involved in the AMC in the mutant 
when compared to the WT.  
 
Although not able to sense extracellular AI-2 in our study, VE14089 
showed to be capable of coping with a luxS mutation, displaying no 
significant difference in the performed phenotypic tests, despite the 
observed global transcriptional alterations and consequent metabolic 
rearrangement induced by that mutation. A number of mechanisms have 
already been described in E. faecalis as being able to sense and respond 
to different stresses and metabolic states, not overruling the possibility that 
changes in AMC intermediary metabolites may affect gene expression (e.g. 
SAM influencing DNA methylation). Much more has to be revealed 
regarding LuxS function in E. faecalis and the direct and indirect 
repercussions in general metabolism, as well as the implication of this 
enzyme activity and its products in the establishment maturation and 
composition of multi-species microbial communities. To continue to 
understand the efficient and complex regulatory network of this bacterium, 
which promotes survival in response to changes in the environment, like 
Chapter 5 
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the most diverse stressors, such as carbon and nitrogen availability or 
temperature and oxidative stress, is of the utmost importance. It is tempting 
to speculate that this could allow predicting vulnerabilities in E. faecalis 
main behaviour and therefore attempt control bacterial presence, whether 
eliminating it in the case of host infection, or promoting its occurrence in 
some foods. 
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Problem with enterococci 
Over the past several decades, enterococci have emerged as one 
of the most common sources of hospital acquired infections. Modern 
medical practices using antibiotic therapeutics combined with innate and 
acquired antibiotic resistances in these bacteria have resulted in a rapid 
increase in the incidence of enterococcal diseases (Hancock and Gilmore, 
2000). Multiple antibiotic resistant enterococci are not only more difficult to 
treat, but antibiotic resistance also provides enterococci with a selective 
advantage over competing microbes in the gastrointestinal (GI) tract. These 
intrinsic and acquired antibiotic resistance mechanisms of the genus can, 
upon antibiotic therapy with agents inactive against enterococci, lead to an 
increased enterococcal burden in the gut by eliminating competitors (Jin et 
al., 2011), or maybe even by decreasing the hostʼs killing ability (Albesharat 
et al., 2011). This broad-spectrum antibiotic use is a risk factor for 
developing vancomycin-resistant Enterococcus (VRE) (Rice et al., 2004), 
one of the most disturbing resistances seen in enterococci that is often 
regarded as the antibiotic of last resort for treating various multi-resistant 
Gram-positive cocci infections. Colonization with VRE is in turn associated 
with increased rates of morbidity and mortality (Lin et al., 2012) and with a 
great concern for the transfer of vancomycin resistance from enterococci to 
  
  
170 
methicillin-resistant Staphylococcus aureus (MRSA) (Sievert et al., 2008; 
Tenover, 2008). 
Clinical enterococci and infection 
Along with multiple intrinsic and acquired antibiotic resistances, 
enterococcal persistence has also been related with carriage of certain 
genetic determinants. These putative virulence factors, described in 
Chapter 1, are relevant to some of the different stages of the bacterial 
infection process, including adhesion, colonization, invasion, elusion of the 
immune system and spread through the hostʼs tissues. 
Presence of virulence factors in commensal and food 
strains 
At the time of the beginning of this work researchers were starting to 
realize that not only nosocomial enterococci but also isolates from diverse 
other origins were also harbouring putative virulence genes. Based on more 
work done during these last few years along with the one included in this 
thesis (Chapters 2 and 4) it is clear that, from the putative virulence factors 
described until now, there is no virulence trait exclusive to strains isolated 
from clinical settings. Also, the sole presence of these putative virulence 
traits does not allow the identification of a strainʼs habitat. The issues that 
quickly became imperative to understand switched from the dissemination 
of virulence factors and their responsibility for the virulent behaviour of 
clinical strains to the potential ability of food strains harbouring putative 
virulence factors to behave as pathogenic as clinical strains. 
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Expression of virulence traits in food isolates 
We showed in this thesis for the first time (Chapter 3) that, using the 
simple Galleria mellonella infection model, gelatinase and Fsr virulence 
factors of Enterococcus faecalis contribute to the virulence of food isolates, 
as well as of clinical strains. So, the presence of these tested virulence 
factors in E. faecalis strains proved to have an associated pathogenic 
potential, for the virulence model where they were assayed and 
independently on the environment where they were isolated from.  
But then the next question arose: does the presence of virulence 
genes be assumed as synonymous of their expression? In this thesis, the 
mere presence of specific virulence traits in the genome did not compulsory 
translate into a straightforward pathogenic behaviour. While in the 
aforementioned G. mellonella virulence model one of the tested food 
isolates QA29b revealed to be virulent, as it killed the larvae as efficiently 
as a clinical isolate, due to the presence of specific virulent factors 
(Chapter 3), the same strain, in opposition to a reference clinical strain, 
failed to express another harboured virulence trait, the cps capsule locus, 
and was readily eliminated in a macrophage survival assay (Chapter 4). 
The presence of virulence-associated genes in the genome does not 
necessarily and directly correlate to the expression of that same trait. So, 
the presence of virulence-associated genes, and therefore an associated 
virulence potential, does not necessarily translate to a virulent and 
pathogenic behaviour in E. faecalis isolated from food. 
However, this already mentioned incongruence between phenotype 
and genotype assays was evident regarding the cyl operon (Chapter 2). 
Both genotype and phenotype became always correlated for different 
tested enterococcal species, always independently of environment of 
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isolation, simply by changing the screening methodology. The pursue of 
good experimental design and analysis is essential to avoid misleading 
gene detection that could conceal inactive genes, incomplete operons, and 
therefore a misleading deduction of phenotype. 
Colonization as a stage of infection 
It has been recognized for more than 30 years that commensal 
bacteria, like nosocomial pathogens, are able to adhere to epithelial cells 
and survive in mucus therefore colonizing the humanʼs GI tract (Hartley et 
al., 1979). Since then, they have been described as also being able to 
adhere and colonize the totality of the exposed surfaces of the host, from 
skin to the diverse mucosa. Like pathogenic bacteria, commensal bacteria 
have the ability to follow the same first stages described for the bacterial 
infection process. They are not only able to follow these same stages but, 
in the case of probiotics, some bacteria are chosen for those specific 
characteristics. When colonizing the gut, enterococci are part of a complex 
microbiota where the ability to communicate with the other bacterial species 
may influence the structure and function of the community. 
In Chapter 5 we showed also for the first time for the genus 
Enterococcus that the LuxS enzyme is responsible for the production of the 
interspecies communication molecule, AI-2. Though not sensed by E. 
faecalis in our study, we cannot confirm that in other conditions, or for other 
species, AI-2 could serve as a signalling molecule regulating quorum 
sensing or other processes. However, the production of this universal 
communication molecule may confer E. faecalis the ability to interfere and 
alter the communication in the polymicrobial communities where it naturally 
inhabits, possibly acting indirectly as a virulence factor. 
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Putative virulence factors or complete genome 
responsible for pathogenic and virulent behaviour 
Since the presence of putative virulence traits is not synonymous of 
their expression, and is not a specific feature of enterococcal nosocomial 
population, does pathogenic and virulent behaviour depend on the genome 
of the strain? It is suggested that an adaptation to the hospital environment 
has occurred in E. faecalis and in Enterococcus faecium. The genetic 
subset of E. faecalis clonal complex 2 (CC2) and CC9, which are 
vancomycin and gentamicin resistant, produce β-lactamase, and carry 
pathogenicity islands, and E. faecium CC17, which is characterized by 
quinolone and ampicillin resistance and the presence of a putative 
pathogenicity island carrying esp and hyl genes, seems to be responsible 
for the worldwide emergence of nosocomial infections by these bacteria 
(Rathnayake et al., 2011). The characterization and study of the population 
structure of E. faecalis and E. faecium remains important to investigate how 
nosocomial enterococcal populations are evolving toward a predominance 
of highly specialized enterococcal genetic subpopulations that are capable 
of surviving, spreading, and infecting patients with increasing frequencies in 
the hospital environment.  
Members of these CCs harbour putative virulence traits, antibiotic 
resistances, and pathogenicity islands (PAIs). Like for putative virulence 
traits, these other characteristics are not exclusive of nosocomial 
subpopulation, but are nonetheless accountable for possibly lethal hospital 
acquired infections. An important question is whether whole genome, gene 
expression and metabolic patterns, more than just specific gene content 
among different isolates, is the virulence-defining characteristic of E. 
faecalis. For example, regarding glycerol dissimilation pathways there is an 
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astonishing diversity in metabolism patterns among different E. faecalis 
isolates, demonstrating that the species could not be represented by only 
one model of aerobic glycerol catabolism. However, this diversity was 
based not on different gene contents but rather on differences in gene 
expression, among strains of the same species (Bizzini et al., 2010). In 
Chapter 5 it was evident that the deletion of a single gene, the luxS gene, 
could induce a pleiotropic effect on gene expression in vancomycin 
resistant clinical isolate V583, which was not phenotypically detectable. An 
important gene regulatory network might be in place allowing the correction 
and compensation of disturbances in function. The food strain QA29b was 
also the target of luxS gene deletion. While for the clinical strain no 
phenotype for the mutation could be significantly detected (Chapter 5), for 
the food strain a significant decrease in survival in the macrophage survival 
assay, and a significant enhanced survival in the H2O2 challenge was seen 
(data not shown). In different strains with different genomic backgrounds of 
the same species, the deletion of the same gene can have completely 
divergent outcomes. This reiterates the importance of the whole genome in 
the orchestration of a response when presented to a specific phenomenon, 
being gene inactivation or environmental condition. Not only the presence 
of a specific gene is important to determine the outcome on the persistence 
and resilience of enterococci but the whole genome also plays a role in the 
regulatory network, which may directly or indirectly affect global gene 
expression. 
Besides the obvious influence of the whole genome on enterococcal 
behaviour, the involvement of genes coding for hypothetical and unknown 
function proteins was also evident in the V583 luxS mutant (Chapter 5), 
indicating the possibility of a specific and effective function in metabolism 
for these genes. These hypothetical proteins have no significant sequence 
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identity to other proteins available in the protein databases. In the gene 
content evaluation of QA29b genome, by comparative genomic 
hybridization (CGH) using a macroarray, more than 55 % of the missing 
V583 chromosomal genes probed were hypothetical proteins (Chapter 4). 
Also, a study aiming to detect promoters, employing recombinase-based in 
vivo expression technology (RIVET), on the E. faecalis OG1RF 
chromosome that were specifically activated during the course of infection 
identified approximately one-third of both the sense and antisense loci 
encoding proteins with hypothetical or unknown functions (Frank et al., 
2012). What role are these hypothetical proteins playing? Are they specific 
to certain species, strains, habitat specific isolates, or CCs? Might they be 
involved in the coordination of gene regulation of pathogenic 
subpopulations of E. faecalis and therefore be one discerning factor from 
commensal or food isolates? 
Virulence models for an effective virulence 
assessment 
It has been made clear that the effective expression of virulence 
factors, depending on the virulence model used, results in diverse divergent 
virulent behaviours (Chapters 3, 4 and 5), which is not unusual. The 
construction of mutants of putative virulence determinants and their use in 
specific virulence model remains a well-suited technique to identify host 
and enterococcal factors critical for pathogenesis, thus providing a better 
understanding of the underlying mechanisms and function of that trait in 
bacteria (Chapters 3 and 5). However, most virulence models are dedicated 
to individual and particular aspects of a putative virulence trait. They are 
able to reveal the various effects of a given virulence determinant, but might 
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reveal to be inadequate or insensitive to do the same for others. While 
comparing a wild type and its corresponding isogenic virulence factor 
mutant in a discerning virulence model may allow to test the virulence 
potential of a given bacteria, the comprehensive assessment of the 
virulence potential of a bacteria in a random virulence model may give a 
biased result, dependent of the model used and the virulence traits that 
may be sensed by it. 
The transposition of the pathogenicity potential of bacteria 
determined with a given virulence model to a human host cannot be directly 
done and requires cautious analysis. As previously mentioned, infection 
development is not based on a single and unique process. As it is also the 
case with other nosocomial infections, nosocomial enterococcal disease 
globally occurs by a two-step process. There is an initial, usually 
asymptomatic colonization of patients, mainly of the GI tract or occasionally 
the skin, by strains endemic in a hospital. Once colonized with enterococci, 
patients may carry them for months or even years. For a number of 
patients, however, the second step follows, i.e. tissue invasion from the 
enterococcal reservoir and eventually disease (Vebø et al., 2010). The 
colonization part of this process is identical for probiotic or commensal 
bacteria, so the distinction must be generally made when invasion occurs. 
An efficient bacterial infection is therefore a several stages process for 
which no virulence model has yet been described that globally enables the 
multifactorial aspect of enterococcal putative pathogenicity to be assessed. 
The currently used virulence models do not rely on the monitoring of a 
natural transition from commensalism to virulence but always accentuate a 
specific impairment in the response of the model in order to accomplish an 
effective infection, therefore helping the pathogenesis study. More 
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comprehensive models of virulence are necessary to allow the study of the 
enterococcal virulent behaviour. 
Many described virulence associated features are 
essential for the hostʼs health 
As previously mentioned, the first stages necessary for an effective 
infection are also required in the beneficial interaction of commensal or 
probiotic enterococci with the host. Their existence in the large intestine 
and fundamental functions in nutrition and metabolism (fermentation of non-
degradable oligosaccharides, metabolism of xenobiotics, and activation or 
destruction of mutagenic metabolites) make the colonic microbiota a large 
fermentative organ (Tlaskalová-Hogenová et al., 2011), but also a critical 
stimulus for the adequate maturation of the immune system, which 
contributes to reducing infections and aberrant immune responses (Sanz, 
2011). Intestinal microbiota contributes also to many aspects of host 
defence against invading pathogens both through direct microbial 
antagonism and promotion of maturation of the intestinal immune system. 
Bacterial metabolism results in the production of several by-products with 
an antimicrobial effect that not only inhibit the growth of pathogenic 
microorganisms themselves, but might also potentiate the effectiveness of 
other antimicrobial substances. In addition, production of biosurfactants by 
the microbiota and competition for sites of attachment and nutrients prevent 
the pathogens from establishing themselves within the host (Sekirov and 
Finlay, 2009). So, virulence factors cannot be collectively grouped as 
uniquely promoting pathogenesis, since the supposedly virulent associated 
behaviours supported by them (like adhesion, colonization) can prove 
essential for the resulting health promotion aspects of human health. 
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It is even conceivable to consider bacterial translocation (BT), a 
common event in the healthy host, as a normal and essential process, 
regulating local and systemic immunity, and tolerance to the innumerable 
antigens that make contact with the intestinal epithelium (Wiest and Rath, 
2003). Translocation of viable and non-viable bacteria and microbial 
products in low numbers from gut to extra-gut tissues, especially the gut-
associated lymphoid tissues, is a normal and a beneficial physiological 
process associated with immune stimulation by alerting the local immune 
defence (Wiest and Rath, 2003; Albesharat et al., 2011). 
BT in the nursing mother has also been associated to the essential 
neonatal process of GI tract colonization. For a long time it has been 
considered that bacteria in breast milk were acquired by skin or faecal 
contamination (Albesharat et al., 2011). However, even when collected 
aseptically, breast milk of healthy human mothers contains a low total 
concentration of up to 103 CFU/ml commensal microbes, including several 
predominant bacterial species, such as staphylococci, streptococci, 
micrococci, lactobacilli, lactococci, bifidobacteria, as well as enterococci, 
such as E. faecalis, E. faecium, Enterococcus durans, Enterococcus hirae, 
and Enterococcus mundtii (Donnet-Hughes et al., 2010; Albesharat et al., 
2011; Jin et al., 2011).  
What are the possible benefits of bacterial populations to harbour 
and express factors that allow adhesion, colonization, translocation and 
therefore viability and presence in human milk? Providing not only all the 
required nutrients but also a myriad of soluble factors (Donnet-Hughes et 
al., 2010; Jin et al., 2011; Sanz, 2011), motherʼs milk is also a source of 
bacteria that influences the initiation, development, and composition of the 
infant commensal oral cavity and gut microbiota (Albesharat et al., 2011; 
Jin et al., 2011), that allows the large intestine, that is sterile at birth, to 
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become rapidly colonized with commensal bacteria, that also arise from the 
motherʼs skin or the infantʼs mouth (Donnet-Hughes et al., 2010; Albesharat 
et al., 2011). Commensal bacteria in milk may be a natural maternal 
protective mechanism to promote the health of infants by improving the 
development of their gut and reducing infection (Jin et al., 2011). This 
interesting possibility that breast milk is not sterile harbouring a natural 
bacterial inoculum (Perez et al., 2007; Hunt et al., 2011), without any 
deleterious effect on maternal health (Perez et al., 2007), imply a novel 
form of mother–infant communication, but it also highlights a potentially 
new mechanism of immune regulation in healthy individuals, since the 
blood of normal healthy subjects contains bacterial components. This may 
represent an evolutionary strategy of immune surveillance allowing that 
such bacterial imprinting maintains tolerance to specific bacterial species 
and alerting distant anatomical sites of changes in local lymphoid tissues 
(Donnet-Hughes et al., 2010). 
Previous studies have demonstrated that germ-free animals do not 
develop normal lymph node architecture, with extensive defects in the 
development of gut-associated lymphoid tissue, arrested capillary network 
development in the gut and reduced antibody production (Murgas Torrazza 
and Neu, 2011). Exposure to microbes in early life, which largely occurs 
through the microbial colonization of the newborn baby intestine, has been 
related to a decreased susceptibility to infections and sensitization to 
environmental antigens in early and later life. These observations constitute 
the basis of the “hygiene hypothesis,” according to which the lack of 
microbial exposure due to highly hygienic conditions found in the Western 
world prevents proper maturation of the immune system and predisposes 
individuals to diseases such as type 1 diabetes, asthma, allergies, celiac 
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disease, inflammatory bowel disease, and obesity (Murgas Torrazza and 
Neu, 2011; Sanz, 2011). 
It is therefore clear that genetic features, like some putative 
virulence factors, which allow enterococciʼs prevalence in the GI tract from 
birth, cannot be exclusively linked to a pathogenic potential. Similarly, the 
presence of enterococci and commensal bacteria counts in milk from dairy 
cattle and the resulting fermented products cannot be uniquely associated 
with a poor hygiene, in the milking practice as well as the further 
fermentation processes. Does BT happen in the dairy cattle? When and 
how does BT take place? What precautions must be taken regarding the 
dairy cattle microbiota? Which hygiene indicators must be chosen and how 
can hygiene levels, which could raise public health concerns, be cost-
effectively determined in dairy products? 
Health, disease and the host 
Taken together, the data reported in this thesis regarding food 
enterococcal strains showed a virulence potential in a specific virulence 
model (Chapter 3), while being avirulent in other models (Chapter 4), 
indicating that a pathogenic potential in humans cannot be entirely 
excluded, and therefore reiterating the need to keep a close surveillance on 
their presence in food. This putatively pathogenic effect of enterococci is 
nonetheless highly dependent of the host. Pathogenic nosocomial 
subpopulations have been able to cause disease mainly due to defects in 
the resistance mechanism of the host to these microorganisms (Kayser, 
2003). Enterococci can become pathogenic in patients in intensive care 
units, in hospitalized patients with severe underlying diseases or an 
impaired immune system, and in elderly people (Ogier and Serror, 2008), 
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all of which are more susceptible to infections. Severely ill patients with 
hematologic malignancies and deep neutropenia are especially at an 
increased risk of developing enterococcal bacteraemia (Leendertse et al., 
2009). These microorganisms are mostly observed as part of a mixed flora 
causing infections in these patients (Kayser, 2003; Jin et al., 2011), while 
enterococci alone can only cause sepsis or endocarditis in 
immunocompromised (Kayser, 2003) and elderly persons (Jin et al., 2011). 
Although enterococci rarely cause diseases in healthy individuals 
(Kayser, 2003; Ogier and Serror, 2008), mainly owed to a globally low 
intrinsic pathogenicity and virulence potential (Kayser, 2003), colonization 
with the more virulent nosocomial isolates may have a future impact upon 
switching from a healthful state to healthless one. When presented to a 
switch in habitats, enterococci readjust their behaviour by enhancing the 
many previously mentioned features (Chapter 1) that allow a better chance 
for survival. All these fitness factors are responsible for a pathogenic 
behaviour when entering the sterile core of the host upon infection. How 
may this entrance in the sterile core of the host be avoided or even 
blocked? May adhesion and therefore proliferation be avoided after host 
invasion? Since complex regulatory networks orchestrate the response to 
environmental changes that impact the metabolic state of bacteria, 
continuing to understand stress response, environmental sensing, and the 
corresponding signal cascades might allow interfering with the signal 
transduction and the corresponding adaptation of enterococci to changes 
and therefore the new environmental conditions. 
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Finishing notes 
Besides being targeted as pathogenic, the resilient bacteria of the 
genus Enterococcus are key factors contributing to the ripening, flavour, 
and the organoleptic characteristics of fermented food products, part of the 
microbiota necessary for the stimulation of the gut immune system (e.g. 
occupying a niche that could be occupied by obligate pathogenic bacteria), 
but also, along with other commensal bacteria, thought to be important in 
contributing to prevent the “hygiene hypothesis” in the neonatal period. In 
order to prevent possible infections it is essential to understand how to 
enhance the protection of possibly sensitive human hosts, by continuing to 
comprehend this bacterium regulatory network that allows sensing and 
fitness response to changes in environmental conditions after translocation, 
in order to prevent and control them, therefore avoiding the colonization of 
the hostʼs sterile core leading to disease. 
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